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 Zusammenfassung 
 
Die Blutgefäßbildung ist nicht nur wäherend der frühen Entwicklungsstadien von großer 
Bedeutung, sondern ist auch ausschlaggebend bei der Entstehung von Krebs beteiligt. 
Spezialisierte Zellen, die sogenannten „Tip-Zellen“, können durch die Ausbildung von 
fadenförmigen Ausstülpungen (Filopodien), entweder die Umgebung nach Signalmolekülen aus 
dem umliegenden Gewebe absuchen oder auch als physikalische Anker fungieren, dabei 
stabilisieren sie den Zellkontakt mit der extrazellulaeren Matrix, bei der Vorwärtsbewegung beim 
vaskulären Wachstum. 
Intensive Untersuchungen in den letzten Jahren lieferten einen beständigen Beweis dafür, dass 
„Tip-Zellen“ eine Schlüßelrolle beim Wachstum von Blutgefäßen während der Angiogenese 
spielen. Dies hat das Verständniss der molekularen Mechanismen für die Spezialisierung der 
„Tip-Zellen“ stark beeinflußt.Jedoch ist zum derzeitigen Stand das Wissen über die molekulare 
Mechanerie, welcher die „Tip-Zell“-Lenkung unterliegt nur sehr wenig bekannt. 
Vaskuläre endothel „Tip-Zellen“ gehören zu den gut charakterisierten axonalen 
Wachstumskegeln. Diese spielen eine wichtige Rolle bei der Migration von wachsenden Axone 
während der Vernetzungen des bestehenden Nervensystems. Neben den morphologischen 
Gemeinsamkeiten lassen noch mehr Anhaltspunkte dafür finden, dass der axonale 
Wachstumskegel und die Kapillargefäß „Tip-Zellen“ einige gemeinsame Signalmoleküle teilen. 
Als weiterer Beleg dafür ist das vorhanden sein von verwandten Rezeptoren auf der 
Zelloberfläche von sowohl Nerven- als auch Blutgefäßzellen, desweiteren ist anzuführen die in 
beiden Arten gemeinsame Umwandlung von Signalen aus der Umgebung in eine Zellantwort 
und letztendlich die Anordnung des Nerven- und des Blutgefäßsystems im gesamten Körper. 
Die bidirektionale Signalverarbeitung von Eph-Rezeptoren und ihren Ephrin transmembran 
Liganden machen das wichtigste Leitsingal bei der axonalen Migration aus. EphrinB2 is bekannt 
dafür intrinsische Singale auzulösen, welche für den Umbau von sowohl Blut- als auch 
lymphatischen Gefäßen während der Entwicklung beteiligt sind. Allerdings sind die molekularen 
 Mechanismen, die der EphrinB2 Funktion während der Vaskularisierung unterliegen noch 
weitgehendst unverstanden.  
Die sehr genau definierte Rolle von EphrinB Liganden während des axonalen Wachstums führt 
zur Annahme, dass EphrinB2 vielleicht genauso bei der  Migration von endothelalen „Tip-
Zellen“ beteiligt sein könnte. Die Analyse der Vaskularisierung von mäuse Retinas, isoliert nach 
der Geburt, bei EphrinB2 Signal Mutanten zeigt, dass die Defekte im EphrinB2 PDZ-Signal 
(ephrinB2∆V), jedoch nicht das fehlen der EphrinB2 Tyrosinphosphorylierung (ephrinB25Y), zu 
einem Defekt in der vaskulären Entwicklung bei EphrinB2∆V Mäusen führt. Dieser Defekt führt 
zu einer ernsthaften Reduktion der fadenförmigen Ausstülpungen an der Wachstumsfront des 
sich entwickelnden vaskulären Netzwerkes. Umgekehrt führt die Aktivierung des EprinB2 
„reverse signaling“ in Explantaten gewonnen aus Retina genauso wie die Überexpression von 
EprinB2 in Kulturen von primären Endothelzellen zu einer Ausdehnung der fadenförmigen 
Ausstülpungen.  
Mechanistisch konnte in dieser Arbeit zum ersten Mal gezeigt werden, dass EprihnB2 als 
Schlüsselregulator beim vaskulären endothel Wachstums Faktor Rezeptor2 (VEGFR2) fungiert. 
Dies konnte bei den verschiedensten Versuchssystemen, wie zum Beispiel ex vivo, in vitro und 
biochemischen Versuchen, gezeigt werden. Daher bietet diese Arbeit einige starke Hinweise 
auf die äußerst wichtige Rolle der EphrinB2 PDZ- abhängigen Signale während der 
Internalisierung von VEGFR2 von der Zelloberfläche. Doch weitaus wichtiger, gegen das 
frühere Dogma, ist die Internalisierung von VEGFR2 notwendig für die anhaltende Signal 
Aktivierung des Rezeptors. Ausserdem, können die fadenförmigen Ausstülpungen als Antwort 
auf die Stimulation mit VEGFR2, auch endozytotische Prozesse erfüllen, dies konnte in 
Explantaten aus der Retinas gezeigt werden. Ferner wurde die funktionelle relevanz der 
Rezeptorinternalisierung für die einwandtfreie Signalweiterleitung bewiesen. In pathologischen 
Ansaetzen, wurde das EphrinB2 PDZ-Signal blockiert und somit eine Reduktion des 
Tumorwachstums erreicht, diese Verringerung ging einher mit der  Abnahme der 
Tumorvaskularisierung. Die angiogene Bildung der Tumorblutgefäße ist vergleichbar mit der 
Tumorvaskularisierung in EphrinB2∆V Mutanten Mäusen. Diese Funktion von EphrinB2 bei der 
 Regulation von Angiogenese bei der Tumorblutgefäßbildung ist auf die spezifität der 
Endothelzellen zurückzuführen und kann in Mäusen, welchen das EphrinB2 (ephrinB1i∆EC) 
fehlt ebenfalls beobachtet werden. 
Abschließend lässt sich sagen, dass diese Arbeit einen neuen molekularen Mechanismus bei 
der Kontrolle des vaskulären Wachstum aufzeigt. Wobei EphrinB2, durch die PDZ- 
Wechselwirkung, sowohl bei der Endozytose als auch die Aktivierung des VEGFR2 Signalweg 
benötigt, um die Funktion der gerichteten Migration von endothel „Tip-Zellen“ sowohl während 
der Entwicklung als auch in pathologischen Ansätzen zu aktivieren. Die direkte Regulation der 
VEGFR2 Funktion durch EphrinB2 PDZ Wechselwirkung verkörpert eine reizvolle 
kombinatorisch oder alternative anti-angiogene Therapie mit einer sehr viel höheren spezifität 
für die Behandlung gegen Tumore. 
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4. Summary 
 Vessel sprouting is not only essential for normal development in the early stage of 
life, but also a decisive process for the progression of cancer. Specialized cells so called „tip 
cells‟, by dynamically extending and retracting filopodial processes, function as a sensor for 
guidance cues in the surrounding tissues and might also serve as physical clutches that 
stabilize cell-extracellular matrix contacts to facilitate forward movement of vascular sprouts. 
Extensive studies in these recent years have provided a solid proof of the pivotal role of 
these tip cells in angiogenic growth of blood vessel and pushed forward our understanding 
of the molecular players in control of tip cell specification. On the contrary, our current 
knowledge of the molecular machineries that regulate guidance of tip cells is very limited. 
Vascular endothelial tip cells bear striking resemblance to the well-characterized axonal 
growth cones that lead the migration of growing axons during nerve wiring. In support of 
their morphological similarities, emerging evidences suggest that axonal growth cones and 
capillary tip cells share several guidance molecules that, upon engagement with their 
cognate receptors on the cell surfaces, transduce environmental signals into internal 
molecular responses and ultimately dictate the direction of growing nerves and vessels 
through the body. Bidirectional signaling from the Eph receptors and their transmembrane 
ligands ephrins represents one of the most important guidance cues involved in axon path 
finding. EphrinB2 is well-known to possess intrinsic signaling capabilities that are critical for 
angiogenic remodeling of both blood and lymphatic vessels during development. However, 
the cellular and molecular mechanisms underlying ephrinB2 function in the vasculatures are 
poorly understood. 
 The well-defined role of ephrinB ligands in axon guidance leads to an attractive 
speculation that ephrinB2 might be involved in guided migration of endothelial tip cells. 
Analysis of postnatal retinal vasculatures of ephrinB2 signaling mutant mice reveals that the 
deficiency in ephrinB2 PDZ-signaling (ephrinB2∆V), but not the lack of ephrinB2 tyrosine-
phosphorylation (ephrinB25Y), causes defective vascular development. EphrinB2∆V mice 
exhibit a severe reduction of filopodia extensions at the sprouting front of growing vascular 
network. Conversely, activation of ephrinB2 reverse signaling in explanted retinas as well as 
overexpression of ephrinB2 in cultured primary endothelial cells can promote the extension 
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of filopodia processes. Mechanistically, it has been shown for the first time here that 
ephrinB2 serves as a key regulator of the vascular endothelial growth factor receptor 2 
(VEGFR2) signaling. Employing a broad range of ex vivo, in vitro, and biochemical assays 
the work presented here has provided several evidences of the crucial requirement of 
ephrinB2 PDZ-dependent signaling in the internalization of VEGFR2 from cell surface. More 
importantly, against earlier dogma, internalization of VEGFR2 is necessary for the activation 
of prolonged signaling activities downstream of the receptor. Moreover, extension of 
filopodia structures in response to stimulation of VEGFR2, as demonstrated in explanted 
retinas, also requires functional endocytic process, further proven the functional relevance of 
receptor internalization for the proper signal transduction. In pathological settings, blockade 
of ephrinB2 PDZ-signaling reduces tumor growth associated with decreased tumor 
vascularization. Angiogenic sprouting of tumor blood vessels is compromised in tumors 
grown in ephrinB2∆V mutant mice. The function of ephrinB2 in the regulation of angiogenic 
growth of tumor blood vessel is endothelial-specific given that the defect in tumor 
vascularization is reproduced in mice lacking ephrinB2 specifically in endothelial cells 
(ephrinB1i∆EC).  
Taken together, the work presented in this thesis reveals the novel molecular 
machinery in control of vascular sprouting whereby ephrinB2, through PDZ-interactions, 
regulates endocytosis and activation of VEGFR2 signaling required for endothelial tip cell 
function during guided migration of growing vessels in both developmental and pathological 
settings. The direct regulation of VEGFR2 function by ephrinB2 PDZ-interactions represents 
an attractive combinatorial or alternative anti-angiogenic therapy with a more specific target 
for tumor treatment.                          
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5. Introduction     
The development of the vascular system is among the earliest events in vertebrate 
organogenesis. The complex closed circuit that consists of numerous interconnected 
conduits of the vascular tree is essential for supplying individual organs with oxygen, 
nutrients, signaling molecules, and immune cells, as well as efficient removal of CO2 and 
waste products, all of which is required from early embryogenesis and sustained throughout 
life. In adults, growth and remodeling of the vascular network is essential for tissue 
metabolism and wound repair processes. Excessive growth of the vasculature, on the other 
hand, could lead to chronic inflammatory diseases. Moreover many tumors recruit host 
blood vessels to support their own growths and to facilitate their metastasis to distant 
tissues. Understanding the mechanisms that govern the complex process of vessel 
formation might therefore yield therapeutic benefits for example in cancer therapy. Largely 
driven by the need for therapeutic improvements, a number of key players and signaling 
events involved in the process of vascular formation have been identified (Coultas et al., 
2005). However, given the complex nature of the vascular formation process that requires 
the tight coordination of many cellular and molecular events controlled by different signaling 
pathways, our knowledge of the process is still far from completed. 
Our recent understanding about the cellular and molecular mechanisms underlying 
the formation of blood vessels during development and tumor progression, and the brief 
overview about the well-known key regulator of vascular development, the vascular 
endothelial growth factor (VEGF) receptors will be introduced first. Secondly, I will introduce 
the Eph/ephrin system and signaling, whose role in axon guidance had been well 
established, and has previously been shown to be essential in blood vessel remodeling. 
Deciphering the role of ephrin in the process of blood vessel formation in both physiological 
and pathological conditions at the molecular level was the main focus of this thesis project.  
 
5.1 Blood vessel formation  
During development, as soon as the early mesoderm has developed via gastrulation, 
the first step in the formation of the blood vasculature, process termed “vasculogenesis” 
begins. Vasculogenesis involves in the differentiation of mesodermal precursors to 
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endothelial progenitors (so called „angioblasts‟) and the de novo formation of a primary 
capillary structure from those progenitors (Risau and Flamme, 1995); Fig. 5-1).  
Further expansion and 
remodeling of the 
primitive capillary plexi 
occurs through a 
process called 
“angiogenesis”, the 
formation of new blood 
vessels from the pre-
existing ones (Carmeliet 
and Jain, 2000). Two 
distinct mechanisms 
during angiogenic 
growth of blood vessels, 
sprouting and non-
sprouting or 
intussusception, have 
been described (Djonov 
et al., 2002). Through 
angiogenesis 
remodeling and 
recruitment of pericytes 
and smooth muscle 
cells, the primitive uniformed capillary plexi are developed in to hierarchically organized 
structure consisting of arteries, veins, and capillaries. 
 
5.1.1 Vasculogenesis 
Cellular mechanisms The earliest sign of vascular system development and therefore the 
first signature of vasculogenesis is the emergence of the yolk sac blood islands, clusters of 
Figure 5-1 Development of blood vasculature. Schematic representation 
of vasculogenic assembly of endothelial precursors into primitive capillary 
structure which further remodel into highly ordered vascular networks via 
angiogenic sprouting. Scheme is adapted from Adams and Alitalo, 2007.  
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mesodermal cells that differentiate into solid clumps of hematopoietic cells enclosed with 
angioblasts. Subsequent fusion of blood islands gives rise to the primitive vascular plexus 
(Risau and Flamme, 1995). Inside the embryo, the dorsal aorta (which will later on fuse into 
one single vessel) and the vitelline arteries and veins are formed by direct aggregation of 
angioblasts without plexus intermediates (Ambler et al., 2001; Coultas et al., 2005; Patan, 
2000).  
The cardinal vein was thought to form by the same mechanism until very recently. 
Employing the zebrafish (Danio rerio) model, a third mode of blood vessel formation, where 
dorsal aorta and cardinal vein arise from a common precursor vessel, has been proposed. 
This process involves selective sprouting and migration of venous-fated endothelial 
progenitors from the precursor vessel, which results in the segregation of the cardinal vein 
from the dorsal aorta (Herbert et al., 2009).    
The precise mechanism of the generation of endothelial cells and hematopoietic 
cells from mesodermal precursors remains debatable. A model involving bipotential common 
precursor known as „hemangioblast‟ which could differentiate independently to produce 
hematopoietic and endothelial progenitor cells has long been postulated. The strongest 
evidence in favor of this model came from an in vitro clonal analysis of mouse embryonic 
stem (ES) cells which could directly differentiate into both hematopoietic and endothelial 
cells (Choi et al., 1998). A more recent model involves the generation of hematopoietic 
progenitor cells from hemangioblasts through a subset of early endothelial cells called 
„hemogenic endothelial cells‟. Several recent studies provide compelling evidences in 
support of this model (Chen et al., 2009; Eilken et al., 2009; Lancrin et al., 2009).  
Cells with endothelial characteristics circulating in the blood stream, so called 
„circulating endothelial cells‟ (CECs), were observed and more importantly were found to be 
increased in many pathological conditions (Blann et al., 2005). Among these CECs which 
exhibit mature endothelial cell characteristics, a subpopulation with progenitor-like 
phenotype known as „circulating endothelial progenitor cells‟ was also observed (Bertolini et 
al., 2006). Growing evidences suggest the contributions of these progenitor cells in 
neovascularization during regenerative and pathological conditions in the adult (Bertolini et 
al., 2006; Rafii et al., 2002). 
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Molecular regulators Bone marrow-derived circulating progenitor cells have been 
suggested to contribute to the formation of new vessels by differentiation into endothelial cell 
(EC) and incorporation into the developing vessels as well as retaintion in the perivascular 
area to promote vascular sprouting. Recruitment of these circulating cells to the growing 
vasculature requires chemotactic signals and adhesive molecules (Adams and Alitalo, 
2007). VEGF secreted into the tissue microenvironment can recruit VEGFR1-positive bone-
marrow-derived circulating cells, predominantly expressing hematopoietic markers, to 
specific sites of the body to facilitate adult neovascularization (Grunewald et al., 2006). 
Interestingly, the CXC-motif chemokine receptor-4 (CXCR4) which is also expressed in 
these circulating cells retains the cells in the perivascular space where its ligand stromal-
derived factor-1 (SDF1) is locally secreted by fibroblast and smooth muscle cells in 
response to VEGF (Grunewald et al., 2006). Similarly, a subpopulation of circulating 
monocytes expressing TIE2 (tunica internal endothelial cell kinase 2) known as TIE2-
expressing monocytes (TEM) homes to perivascular regions and acts in a paracrine manner 
to induce outgrowth of blood vessels without being incorporated into the endothelium (De 
Palma et al., 2005). 
 
5.1.2 Sprouting angiogenesis  
Upon stimulation with growth factors and chemokines, a subpopulation of endothelial 
cells lining inside the vessel wall acquires a motile and invasive activity which drive the 
modulation of cell-cell contact and local basement membrane matrix degradation. This leads 
to the sprouting of these activated endothelial cells from the pre-existing vessels. Endothelial 
sprouts migrate directionally toward areas with insufficient blood supply via the 
concentration gradient of growth factors and several guidance cues. Longitudinal and 
circumferential growth of the sprouts is acquired by proliferation of endothelial cells. 
Subsequent fusion of adjacent sprouts and lumen formation leads to the establishment of 
vascular tubules and the initiation of blood flow. To maintain vascular integrity of the newly 
formed tubules endothelial cell junctions need to be established. Blood flow and deposition 
of basement membrane together with the recruitment of mural cells contribute to maturation 
of the new vessels (all the cellular processes are depicted in figure 5-2). 
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Figure 5-2 Cellular events during angiogenic sprouting of a blood vessel. A balance between pro- 
(+) and anti-angiogenic (-) stimuli derived from endothelial cells themselves, pericytes which have direct 
contact to the endothelium, guidepost cells and extracellular matrix along the migration path of the 
endothelial sprout determine the progression of each event. Model is adapted from Adams and Alitalo, 
2007.   
5.1.2.1 Selection of sprouting endothelial cells 
VEGF (see topic 5.3 for detail) has been long known as the most prominent 
chemoattractant for endothelial cells. VEGF produced in response to local hypoxia promotes 
polarized EC sprouting and migration along VEGF gradients as shown in the well-
established angiogenesis model in mammals, the retina (Gerhardt et al., 2003; Stone et al., 
1995). Interestingly, ECs within the vessel wall respond differentially upon receiving VEGF 
stimulant. Only some ECs are selected to initiate sprouting. These cells, so called „tip cells‟, 
extend long dynamic filopodia to probe their environment for guidance cues and lead the 
migration of the new sprouts. Not only their morphology, but also their gene expression 
profiles distinguish these tip cells from the adjacent „stalk cells‟ that follow them in the 
growing sprouts. Expression levels of VEGFR2, VEGFR3, Dll4 (Delta-like 4), PDGFβ 
(Platelet-derived growth factor beta), and Unc5b (Uncoordinated-5 homolog B) are higher in 
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tip cells as compared to stalk cells (Phng and Gerhardt, 2009). Specification of tip and stalk 
cells is of great importance in the initiation of sprouting angiogenesis. ECs, in close contact 
to each other, are exposed to similar concentrations of VEGF. Without a signaling regulator 
to specify which cells become tip or stalk cells, all ECs will response indifferently. This would 
lead to an imbalance in the number of tip/stalk cells which may cause vascular 
disintegration. The best known regulator of endothelial tip and stalk cell specification to date 
are the Notch receptors and their ligands Dll4 and Jag1 (Jagged1). 
  
Notch signaling in control of ECs specification First discovered in Drosophila 
melanogaster in which mutant allele causes notched wing, four Notch receptors (Notch1-
Notch4), and five ligands (Dll1, Dll3, Dll4, Jag1, and Jag2, collectively called DSL from 
Delta, Serrate, LAG-2) have been identified in mammals. Notch receptors are expressed on 
the cell surface as heterodimers consist of an extracellular domain (NECD) and a 
transmembrane intracellular domain (NICD) linked together by a non-covalent bond (Roca 
and Adams, 2007). Upon trans-interaction of Notch and its ligand between adjacent cells the 
extracellular region of Notch is cleaved by a member of disintegrin and metalloprotease 
(ADAM) leaving the transmembrane region susceptible to -secretase, by which cleavage 
release the NICD from the cell surface. NICD translocates to the nucleus where it binds to 
the transcription factor RBPJ (recombination signal binding protein for immunoglobulin 
kappa J region, also known as CSL from mammalian CBF1, Drosophila Su(H), and 
Caenorhabditis elegans LAG1) and results in the replacement of the corepressor complex 
bound to CSL with the transcriptional activation complex. This process turns on the 
transcription of Notch target genes such as Hes (Hairy/Enhancer of Split), Hey (Hes-related 
proteins), Nrarp (Notch-regulated ankyrin repeat protein), and efnb2 (EphrinB2) (Grego-
Bessa et al., 2007; Phng and Gerhardt, 2009). Hes and Hey proteins, in turn, act as 
transcription repressors of genes further downstream (Phng and Gerhardt, 2009). 
The crucial role of Notch and Dll4 in the regulation of endothelial tip/stalk cells 
specification has been demonstrated by several recent studies employing different model 
systems. Endothelial-specific inducible knockout of Notch1 or global deletion of one allele of 
Dll4 causes excessive tip cell formation in mouse retinas. In addition, in this model, where 
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Figure 5-3 Regulatory mechnisms in control of tip/stalk 
cell specification. VEGF-stimulated activation of VEGFR2 
induces expression of Dll4 which, in turn, activates Notch 
signaling to suppress tip cell phenotype in adjacent cells by 
downregulation of VEGFR. Concurrently, Jagged1 (Jag1) in 
these stalk cells antagonizes Dll4 to prohibit activation of 
Notch in tip cells.  Dotted lines represent regulation of protein 
expression; filled lines represent signaling activation. Scheme 
is adapted from Benedito et al., 2009    
there is a mosaic expression pattern of Notch1 due to the different degrees of Cre 
recombination, the majority of Notch1-deficient cells displayed tip cell characteristics 
(Hellstrom et al., 2007). In zebrafish, Rbpj or Dll4-deficient embryos exhibit enhanced 
sprouting and dramatic increased number of cells within the intersegmental vessel sprouts. 
Furthermore, in the chimeric setting, Rbpja knockdown cells transplanted into wild type 
embryo failed to integrate to the dorsal aorta and preferentially localized to tip cell position in 
the intersegmental sprouts (Siekmann and Lawson, 2007). Acquisition of tip cell 
characteristics in the Notch signaling-deficient cells therefore indicates that Notch is required 
to suppress these highly motile 
behaviors to allow only a 
subpopulation of cells to become 
tip cells.  
Although the role of Notch 
in coordinating the balance of tip 
and stalk cells is widely 
appreciated, the downstream 
molecular mechanism mediating 
this function of Notch is not fully 
resolved. The most prominent 
angiogenesis regulator VEGFR2 
(detail in topic 5.3) enters the 
scheme from several evidences 
demonstrated that Notch signaling 
negatively regulates its expression 
(Henderson et al., 2001; Holderfield 
et al., 2006; Suchting et al., 2007; Williams et al., 2006), possibly through the transcriptional 
repressor Hey1 (Holderfield et al., 2006). Retinal endothelium of Dll4 heterozygous mice 
shows an up-regulation and wider distribution of VEGFR2 mRNA, normally abundant in the 
sprouting front, also in the vascular bed. Furthermore, VEGF has been shown to induce Dll4 
expression in angiogenic active vessels (Hainaud et al., 2006; Lobov et al., 2007; Patel et 
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al., 2005), which is in agreement with the ligand prominent (albeit not exclusive) expression 
in the tip cells localized at the sprouting front of growing vessels (Hellstrom et al., 2007; 
Hofmann and Iruela-Arispe, 2007). There, they are exposed to higher concentrated gradient 
of VEGF as compared to vascularized regions within the vascular bed.   
These findings together prompt a model in which VEGF triggers expression of Dll4 
which, in turn, activate Notch signaling in the adjacent cells. As a consequence, VEGFR2 in 
the Notch-activated cells is down-regulated and the cells are thereby non-responsive to 
VEGF stimulus. Cells that produce more Dll4 are then selected as tips, whereas their 
neighbors with active Notch remain stalks (Fig. 5-3). The specification of tip/stalk fates is 
most likely a very dynamic process. Live microscopy of Dll4-deficient zebrafish embryo 
shows that the tip cells abnormally sprout from the dorsal longitudinal anastomotic vessel 
(DLAV) at the dorsal-most aspect of the somites with invasive migratory behavior can be 
readily integrated into the DLAV (Leslie et al., 2007). It has also been shown that Dll4 can be 
up-regulated not only by VEGF but also by Notch (Benedito et al., 2009; Carlson et al., 
2005), adding complexity to the Dll4-Notch-VEGF reciprocal regulation model. Another 
Notch ligand, Jag1, has recently been shown to play a part in the scheme. Jag1 is enriched 
in stalk cells and very weakly expressed in tip cells. Jag1-deficient ECs preferentially occupy 
tip cell positions, whereas overexpression of Jag1 results in the stalk sorting of ECs in the 
growing mouse retinal vasculatures (Benedito et al., 2009). Glycosylation of Notch by the 
glycosyltransferase Fringe has been reported to enhance the receptor activation by Delta-
like ligand, but inhibit its response to Serrate/Jagged ligands (Yang et al., 2005). Combining 
Dll4 and Jag1 stimulation in EC overexpressed Manic Fringe reduces Dll4-stimulated Notch 
response, suggesting that Jag1 antagonizes Dll4 when Notch is glucosaminylated (Benedito 
et al., 2009). It has therefore been proposed that Jag1 highly expressed in stalk cells might 
antagonize the more potent ligand Dll4 to prohibit activation of Notch in adjacent tip cells 
(Fig. 5-3). Jag1 counteraction of Dll4-induced Notch activation between stalk cells might also 
be required to sustain VEGFR2 expression which is important for proliferation of these cells 
during active angiogenesis (Benedito et al., 2009).        
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Figure 5-4 Morphological 
similarities between axonal growth 
cone and endothelial tip cell. Left; 
growth cone of fruit fly motor neuron 
(Sanchez-Soriano et al., 2007). Right; 
endothelial tip cell of mouse retina, 
visulaized with membrane markers.   
5.1.2.2 Directional migration of endothelial sprouts 
Wiring of the vascular system into a complex hierarchical network that is capable of 
effective delivery of oxygen and nutrients to different organs throughout the body is of 
utmost importance and requires the precisely 
coordinated series of guidance decisions. Clues to the 
complex nature of vessel guidance come from the 
anatomical similarities of the vascular and nervous 
network and moreover, the paralleled patterns of blood 
vessels and peripheral nerve fiber (Mukouyama et al., 
2002). The task of axon navigation through a complex 
environment over considerable distances to reach the 
appropriate targets is carried out by a specialized 
structure at the leading tip of growing axons, the growth 
cones. The filopodia-riched structure and the dynamic 
nature of the growth cone that continuously extend and 
retract their filopodia to reassess the environment and to 
select the correct routes hold striking similarities to the 
endothelial tip cell (fig. 5-4). A complement of these structural and behavioral similarities 
comes from increasing evidences demonstrated that nerves and vessels share several 
guidance molecules (fig. 5-5), which transduce environmental cues to cytoskeletal changes 
required for cell migration (Carmeliet and Tessier-Lavigne, 2005).   
 
5.1.2.2.1 Neurovascular guidance cues in angiogenesis      
Netrin-DCC/Unc5 The laminin-related Netrin family consists of secreted matrix-bound 
proteins that interact with two canonical receptor families, the deleted colorectal carcinoma 
receptor (DCC) and the uncoordinated (UNC) 5 families. Among the Netrin receptors, 
UNC5B has been shown to express in arteries, capillaries and, in particular, strongly 
express in endothelial tip cells (Lu et al., 2004). Loss of UNC5B in mice causes embryonic 
lethality associated with excessive vessel branching and tip cell filopodia extension. 
Treatment with Netrin-1 causes tip cell filopodia retraction and this effect is abolished in 
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UNC5 knockout mice. In line with these findings, morpholino knockdown of either UNC5B or 
the ligand Netrin-1a, whose expression is strongest in the horizontal myoseptum midway 
along the the intersomitic vessel dorsal migration path, result in aberrant extension of tip cell 
filopodia and deviation from stereotyped path of the sprouting intersomitic vessels in 
zebrafish embryo (Lu et al., 2004). These evidences point to a role of UNC5B as a repulsive 
cue in endothelial sprouting, which is likely to act upon binding to its ligand Netrin-1. 
However, some studies have reported the function of Netrin-1 as a pro-angiogenic factor 
(Park et al., 2004; Wilson et al., 2006) via an unknown receptor. A possible explanation for 
the discrepancies between pro- and anti-angiogenic effects of Netrin-1 is the differential 
expression of its receptors as account for axon guidance. Besides, different mode of action 
of Netrin receptors depending on its ligation state has also been demonstrated (Eichmann et 
al., 2005; Nishiyama et al., 2003). Unligated UNC5B could induce vessel regression, while 
Netrin-1 stimulates EC survival and promotes angiogenesis by blocking its receptor 
proapoptotic activity (Castets et al., 2009).   
 
Slit-Robo The vascular-specific Robo4 has been implicated in angiogenesis. Zebrafish 
embryos in which Robo4 is knocked down show defects in their intersomitic vessel sprouting 
and pathfinding (Bedell et al., 2005). These phenotypes are, however, not enough to 
pinpoint whether Robo4 mediates attractive or repulsive signals. Impaired sprouting may 
due to loss of an attractive cue, whereas misrouting of the sprouts may be a result of the 
absence of repulsive cues to direct their migration to the appropriate path. Several proteins 
important for actin nucleation were identified as Robo4 binding partners, in consistency with 
the suggested role of Robo4 in the regulation of filopodia formation in cultured endothelial 
cells (Sheldon et al., 2009). However, mice in which Robo4 is replaced with alkaline 
phosphatase reporter gene are viable and fertile with normal intersomitic and cephalic 
vessel patterning, suggesting that Robo4 is unlikely to be essential for developmental 
angiogenesis in mammals. Besides, expression of Robo4 which seems to be predominant in 
stalk cells in postnatal mouse retinas implies that this receptor is not required for vascular 
guidance (Jones et al., 2008a). Instead, Slit2 was shown to inhibit VEGF-induced EC 
migration in vitro and vascular hyperpermeability in vivo, and these effects were abolished in 
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Figure 5-5 Common cues for neural and vascular 
guidances. Scheme is adapted from Adams and 
Alitalo, 2007  
   
absence of Robo4, suggesting a role of Robo4-Slit2 receptor-ligand pair in stabilizing the 
vasculature by counteracting with the angiogenic effects of VEGF (Jones et al., 2008a). By 
contrast, X-ray crystallography suggested that Robo4 does not bind Slit2 directly as it lacks 
many of the critical Slit2 binding residues (Morlot et al., 2007). Indeed, Robo4 has been 
shown to interact with Robo1, a potential receptor for Slit2 which is also express in 
endothelium (Sheldon et al., 2009). 
Interestingly, Slit2 binding to Robo1 has 
been reported to promote tumor 
angiogenesis (Wang et al., 2003). During 
axonal outgrowth, Robo3 and Robo1 
heterodimerization inhibits Robo1 function 
(Sabatier et al., 2004). Therefore, while it is 
not yet clear which ligand is responsible for 
the anti-angiogenic function of Robo4, it is 
likely that this receptor inhibits the pro-
angiogenic effects of Slit2-Robo1.  
 
Semaphorin-Neuropilin/Plexin 
Semaphorin (Sema) is a large family of 
secreted (class 3) proteins that are capable 
of long range diffusion and membrane-
bound proteins that act at short distances. 
Semaphorins signal through two receptor families, Plexins (Plxn) and Neuropilins (Nrp). 
Membrane-bound Semaphorins directly bind Plexin, while the secreted class 3 Semaphorins 
bind to Neuropilins which signal through Plexins as co-receptors. Semaphorin 3E (Sema3E) 
which directly binds and signals through PlexinD1 (Plxnd1) is an exception to this rule 
(Carmeliet and Tessier-Lavigne, 2005). In zebrafish, Intersomitic vessels expressing Plxnd1 
migrate through corridors between Sema3A-expressing somites. Knockdown of Plxnd1 
results in irregular sprouting of intersegmental vessels from dorsal aorta and the growing 
sprouts do not track along the somite boundaries, suggesting that Plxnd1 mediates a 
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repulsive signal in the endothelium. The ligand that activates Plxnd1 in zebrafish is 
presumably Sema3a as implicated in the similar, albeit less severe, phenotypes in Sema3a 
knockout fish (Torres-Vazquez et al., 2004). In the mouse model, either global or 
endothelial-specific knockout of Plxnd1 causes perinatal lethality associated with severely 
disrupted vascular patterning (Gu et al., 2005; Zhang et al., 2009). The marked 
disorganization of intersomitic vessels which extend through the entire somites in Plxnd1-
deficient mice confirms the role of Plxnd1 as a repulsive cue in vascular sprouting. The 
ligand that mediate this function in mice appears to be Sema3E which is strongly expressed 
in the caudal region of each somites and immediately adjacent to PlxnD1-expressing 
vessels. Loss of Sema3A results in the markedly similar phenotypes observed in Plxnd1 
knockout mice, whereas Sema3A-deficient mice show a mild vascular branching defect (Gu 
et al., 2005; Serini et al., 2003). Importantly, Sema3E-Plxnd1 regulates vascular guidance 
independent of Neuropilins as double-mutant mice with loss of Sema3-binding site in Nrp-1 
and complete loss of Nrp-2 have no vascular defect (Gu et al., 2005). Instead, the vascular 
function of Nrp1 receptor is depended on its binding to VEGF, possibly by acting as a co-
receptor for VEGFR2 to mediate tip cell extension in guided vessel sprouting as revealed by 
genetic deletion of Nrp1 in mice and administration of the antibody that specifically blocks 
their VEGF binding site and complex formation with VEGFR2 (Gerhardt et al., 2004; Jones 
et al., 2008b).       
 
5.1.2.3 Converting sprouts into vessels 
 Although the dynamic process of vessel sprout fusion has so far not been observed 
in vivo, the close proximity of endothelial tip cells that lead each new sprout and the 
filopodia-rich bridge-like structures frequently seen in the active sprouting area suggests that 
tip cells fuse together to give rise to new tubules (Roca and Adams, 2007). Given the motile 
and explorative behavior of tip cells, establishment of new vascular connections with other 
sprouts or existing capillaries requires strong adhesive forces along with the suppression of 
the tip cell invasive behavior. Indeed, the endothelial cell-specific transmembrane adhesion 
protein, vascular endothelial cadherin (VE-cadherin), which play a major role in the initiation 
of endothelial cell-cell contacts and establishment of adherens junctions, is also a known 
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suppressor of VEGFR2. VE-cadherin can form complex with VEGFR2 and negatively 
regulate its signaling properties by limiting its internalization (Lampugnani et al., 2006). 
 Establishment of blood flow in the newly formed interconnected vascular tubules 
requires lumen formation. Our current understanding of cellular and molecular mechanisms 
of vascular lumen formation is still modest. Two cellular mechanisms have been suggested 
to govern lumen formation in the vasculature; cord hollowing, by which central spaces are 
created inside cord of packed cells via cell flattening (Iruela-Arispe and Davis, 2009), and 
cell hollowing, in which intracellular vesicles generated in individual cells become exocytose 
and enable the interconnection of neighboring cells to form a multicellular lumen (Iruela-
Arispe and Davis, 2009; Kamei et al., 2006). Integrins and several downstream partners 
have been demonstrated to have critical functions in lumenogenesis and tubular 
stabilization. Pharmacological inhibition of β1 integrins in chick embryo resulted in a 
complete loss of lumens in the aorta (Drake et al., 1992). EC-specific knockout of an integrin 
signaling molecule FAK (Focal adhesion) kinase shows defective tubular stabilization, while 
early vasculogenesis appears to be normal (Shen et al., 2005). Several in vitro studies 
reported the requirement of small GTPase proteins, Rac1 (RAS-related C3 botulinum 
substrate 1) and Cdc42 (cell division cycle 42), known regulators of cell cytoskeleton 
dynamics downstream of integrins, in the process of endothelial lumen formation (Davis and 
Bayless, 2003). The p21-activated kinase (PAK), a downstream effector of Rac1 and Cdc42 
has recently been implicated in ECs lumen formation in an in vitro setting (Koh et al., 2008). 
In line with these in vitro studies, lumenogenesis during mouse and zebrafish embryonic 
development has been shown to be regulated by cerebral cavernous malformation (CCM) 
signaling proteins through Rho GTPase signaling (Kleaveland et al., 2009; Whitehead et al., 
2009).  
 The generation of vascular lumens and initiation of blood flow, which subsequently 
leads to improvement of tissue perfusion, also contributes to the stabilization of new 
vascular connections. Decreased local expression of VEGF as a result of improved oxygen 
delivery, together with recruitment of pericytes and extracellular matrix proteins to the 
subendothelial basement membrane, promote maturation of vessels. Once the blood flow is 
established and oxygen supply meets local demands, some newly formed vascular 
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Figure 5-6 Molecular regulators of arterial and 
venous differentaion. Model is adapted from 
Adams and Alitalo, 2007  
connections may undergo „prunning‟, the process involving EC retraction or apoptosis to 
eliminate redundant vessels. Pruning may also occur during other stages of vessel 
development by alteration of factors that promote active angiogenesis and those that induce 
quiescent and maturation of vessels (Adams and Alitalo, 2007). 
 
5.1.3 Intussusceptive angiogenesis 
An alternative mode of angiogenesis remodeling with a clear distinction in the 
cellular mechanisms to the process of angiogenic sprouting has been reported in various 
tissues of several vertebrate species. In this alternative process, expansion and remodeling 
of the vascular networks proceed through the formation of transvascular pillars and 
subsequent vessel splitting, a mechanism called intussusception. Generation of the 
transcapillary pillars, the cylindrical tissue bridges enclosed by endothelial and mural cells 
occurs via establishment of transendothelial contacts of double layers of endothelium, which 
may take place within the same vessel after protrusion of the capillary walls into the lumen 
or between adjacent vessels. Although morphological evidences implicate the role of 
intussusception in the expansion of the capillary network and vascular pruning (Burri et al., 
2004), our understanding of its physiological significance and molecular regulation is still 
very limited. 
 
5.1.4 Arteriovenous differentiation 
 Arteries are wrapped extensively by extracellular matrix, elastic fibers, and vascular 
smooth muscle cells, to provide these 
vessels with the strength and flexibility 
necessary to absorb shear stress and high 
pressure from pulsatile flow produced by 
cardiac contractions. On the contrary, veins 
have less vascular smooth muscle 
coverage and contain valves to prevent 
backflow (fig. 5-6). In fact, not only areteries 
and veins are distinct in their morphological 
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and functional properties, but also their respective endothelial cells are distinguished in their 
gene expression profiles. Several proteins have been found to express predominantly in 
either arterial or venous endothelial cells. One of the best known arterial markers is 
ephrinB2, and correspondingly one of its cognate receptor, EphB4, is largely confined to 
venous endothelial cells.  
Two signaling pathways have been demonstrated to be involved in the regulation of 
ephrinB2 expression, VEGFR and Notch (Fig. 5-6). Stimulation of cultured endothelial cells 
by VEGF leads to increased expression of Dll4 ligand and subsequent activation of Notch 
signaling which, in turn directly controls an upregulation of ephrinB2 (Hainaud et al., 2006; 
Williams et al., 2006). In vivo VEGF secreted by peripheral nerves has also been 
demonstrated to promote arterial differentiation in mouse embryonic skin (Mukouyama et al., 
2002). Knockdown of the zebrafish gridlock (grl), the ortholog of the mammalian Notch 
target genes Hes1 and Hey1 (see topic 5.1.2.1.1), causes loss of dorsal aorta and 
enlargement of axial vein, in association with reduced expression of arterial markers, 
including ephrinB2 and increase expression of venous markers. Conversely, overexpression 
of gridlock results in the reduction in size of axial vein, with no apparent increase of arteries. 
This suggests that gridlock functions rather as a suppressor of venous differentiation than an 
inducer of arterial fate (Zhong et al., 2001). Similarly, Hey1 and Hey2 double knockout mice 
show severe vascular defects and expression of arterial markers are largely absent (Fischer 
et al., 2004). The Forkhead transcription factor FoxC has also been shown to play a role in 
VEGF-induced Notch signaling pathways in the regulation of arterial fate by regulation of 
Hey2 and Dll4 expression (Hayashi and Kume, 2008). FoxC1 and FoxC2 double knockout 
mice show loss of arterial markers including Notch receptors and ligands, in association with 
arterio-venous shunts (Seo and Kume, 2006).  
Several lines of evidences indicate that the nuclear receptor COUP-TFII, whose 
expression is limited to veins and lymphatic vessels, plays a key role in promoting venous 
endothelium differentiation. Veins show ectopic expression of arterial markers including 
Nrp1 and Notch1 in COUP-TFII null mice (Pereira et al., 1999; You et al., 2005), whereas 
EC-specific overexpression of the receptor suppresses arterial marker expression (You et 
al., 2005). Taken together, two different models have been proposed; 1) venous fate is a 
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Figure 5-7 Development of the blood vessels of postnatal mouse retina 
(reproduced from Dorrell and Friedlander, 2006). A, The highly reproducible 
temporal and sptial pattern of superficial retina vessels formed after birth 
Vessels are visualized by collagen IV staining. B, Tranversal section of 
mouse retina stained with DAPI (blue) and CD31 (red). C, Model shows 
developmental time frames of each layer of retinal vasculatures.  
default mode of EC differentiation and acquisition of arterial fate required activation of Notch 
signaling. 2) venous fate is acquired by COUP-TFII-mediated suppression of Notch-
activated arterial fate (fig. 5-6).   
In addition to genetic factors, the microenvironment within the vasculature is 
important in the regulation of arteriovenous differentiation. Changing of pulsatile, high-
pressure arterial blood flow to low pressure venous flow in the yolk sac of chick embryos can 
suppress arterial differentiation as indicated by the lack of NRP1 and ephrinB2 expression 
(le Noble et al., 2004). Expression of ephrinB2 has also been shown to increase in adult 
neovascularization sites in physiological and pathological settings, reflecting the dynamic 
rather than fixed cell fate depending on local demand of angiogenic activity most likely 
through the alteration of VEGF levels (Gale et al., 2001). 
 
5.1.5 Mouse retinal angiogenesis model 
The post-natally developed highly organized vascular anatomy is the central 
attractiveness of the retina, which has been widely used to study developmental 
angiogenesis. Due to the well-defined temporal and spatial pattern of the retinal vasculature 
development, defects at different stages during angiogenic growth of these vessels can be 
easily recognized. 
Besides, initiation of 
vascular formation 
occurs after birth in 
mouse retinas and 
therefore it is possible 
to administer 
exogenous 
substances to 
examine their effects 
on vessel growth.  
During the first 
week of life in mice, 
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retinal vascularization begins within the retinal ganglion cell (RGC) layer, when a laminar 
network of vessels sprouts outward from the optic nerve head toward the retinal periphery. 
Around postnatal day (P) 8, when the superficial vascular plexus reaches the periphery, 
these vessels start to branch downward into the packed layer of amacrine, bipolar, and 
horizontal cells called inner nuclear layer (INL). First at the outer edge of the INL the deep 
vascular layer is developed, and later on during the third week after birth the intermediate 
vascular layer spreads throughout the inner edge of the INL (Fig. 5-7).  
 Interestingly, the developmental pattern of the superficial vascular plexus appears to 
precisely overlay the pre-existing astrocytic meshwork, which radiates from the optic nerve 
head and reaches the retinal periphery by birth. Consistent with this, endothelial tip cells 
filopodia are found to extend along the underlying processes of the astrocytes (Gariano and 
Gardner, 2005; Gerhardt et al., 2003). Retinal gial cells, including astrocytes and Mueller 
cells, produce VEGF in response to hypoxia (Dorrell and Friedlander, 2006; Stone et al., 
1995). Adequate distributions of the different isoforms of the astrocyte-secreted VEGF, 
which remains on the cell surface and diffuses in the proximate extracellular surroundings, is 
crucial for vascular patterning (Carmeliet and Tessier-Lavigne, 2005; Gerhardt et al., 2003; 
Stalmans et al., 2002).  Furthermore, Interaction between endothelial and gial processes 
mediated by adhesion molecule, R-cadherin, also play a role during the vessel guided 
migration events. Blockage of R-cadherin function results in underdeveloped retinal 
vasculature that fails to associate with the astrocytic network and migrates to normally 
avascular areas (Dorrell and Friedlander, 2006). These observations suggest a model in 
which initial interaction of VEGF produced by astrocytes and its receptor VEGFR2 
expressed prominently on the filopodia processes of tip cells (Gerhardt et al., 2003) and 
subsequent R-cadherin mediated cell-cell adhesion are required to stabilize the filopodia 
contact to the astrocytic network and lead the migration of the the growing vessels (Dorrell 
and Friedlander, 2006; Gariano and Gardner, 2005). 
 
5.2 Tumor angiogenesis  
 Like normal tissues, solid tumors require a functional vascular system which 
provides them with oxygen and nutrients as well as removes waste products to continue 
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Figure 5-8 Tumor-induced angiogenic growth of blood 
vessels. Several growth factors such as basic fibroblast growth 
factors (bFGF), platelet-derived growth factor (PDGF), and most 
commonly VEGF are secreted from tumors to induce angiogenic 
responses through their cognate receptors expressed in the 
vascular endothelium. Matrix metalloproteinases (MMPs) are 
prodiced from VEGF-activated endothelial cells. Competitive 
binding of angiopoietin 2 secreted by some tumor cells which can 
sequester angiopoietin1 from the TIE2 receptor as well as 
signaling downstream of endothelial integrins might contribute to 
the pro-migratory stimuli. Scheme is adapted from Folkman, 2007. 
their growth. Furthermore, the vasculature is the main route used by tumor cells for 
metastatic spread to remote tissues. Tumor vessels, on the other hand, develop apparent 
distinct characteristics from 
normal vascular system. These 
vessels, often dilated and 
tortuous, usually form chaotic 
branching patterns rather than 
organized into a hierarchical 
order of definitive arteries, veins, 
and capillaries as in normal 
vascular networks (Bergers and 
Benjamin, 2003). Endothelial 
cells lining tumor vessels often 
present in irregular shapes with 
uneven luminal membrane and 
loose intercellular contacts. 
These abnormalities in the 
endothelium, in association with 
the structurally atypical 
basement membrane and loose 
pericyte-endothelium 
connections, contribute to high 
permeability and even leakiness 
of the tumor vessels (Tozer et 
al., 2005). These abnormal 
features, often described as 
immature, reflect an imbalance in the control of the multistage neovascularization induced 
by tumors. Various pro-angiogenic factors are produced by tumor cells, including the most 
prominent factor, VEGF, which also seems to be the most ubiquitously expressed (Bergers 
and Benjamin, 2003; Folkman, 2007). Tumors may initially grow independently of the 
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vascular system or co-opt existing normal vessels for blood supply. Enlargement in size due 
to a rapid proliferation gives rise to necrotic and hypoxic areas inside the tumor mass, which 
demands increased nutrients and oxygen supply. As in normal tissue, oxygenation 
influences vessel growth through direct control of level and activity of the transcription factor 
HIF1 (Hypoxia-inducible factor 1, alpha subunit), a positive regulator of VEGF production 
(Carmeliet, 2003). Elevated levels of VEGF then induce the process of angiogenic sprouting 
of surrounding vessels into the tumors (Fig. 5-8). In addition to high levels of VEGF 
production, the potent angiogenesis inhibitor thrombospondin 1 (TSP1) has been shown to 
be down-regulated in tumor beds as a prerequisite for induction of tumor neovascularization 
and subsequent progression (Dameron et al., 1994; Rastinejad et al., 1989). The tightly 
regulated balance between pro- and anti-angiogenic factors during physiological 
angiogenesis is thus shifted during tumor-induced vessel formation. In normal vessel 
formation, pericyte coverage is important for acquisition of quiescent state of endothelial 
cells during the maturation of the newly formed vessels (Armulik et al., 2005). The defective 
pericyte coverage in tumor vessels therefore suggests that these vessels fail to become 
quiescent, enabling continuous induction of new vessel growth. 
 Given that tumor progression relies heavily on angiogenesis, several anti-angiogenic 
agents have been developed in an attempt to inhibit tumor growth. Numbers of agents have 
been generated to target VEGFR signaling mechanisms including neutralizing antibodies 
specific to VEGF or VEGFRs, soluble decoy VEGFRs, and inhibitors of tyrosine kinase with 
preference for VEGFRs. Various degrees of therapeutic benefits from these anti-angiogenic 
drugs are achieved in different cases owing to the complex nature of tumor cells, which may 
be able to overcome their angiogenic dependency. An increased vessel co-option was 
observed in a glioblastoma xenograft model after anti-VEGF treatment (Rubenstein et al., 
2000). Tumor cells with an alteration in their gene expression which allow them to survive 
under hypoxic conditions after deprivation of blood supply may be selected for further 
progression as has been demonstrated in the mutation in p53 gene (Yu et al., 2002). 
Furthermore, withdrawal of functional vascular system from tumors might trigger the more 
invasive behavior of tumor cells as a mechanism to escape from the area with low blood 
supply and subsequently metastasize to remote tissues (Bergers and Hanahan, 2008). 
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Combinatorial strategies to target both tumor cells themselves and the tumor vasculature 
are likely to be the most efficient approaches. New agents that act at different stages of 
angiogenesis as well as invasion of tumor cells are therefore of great necessity.            
  
5.3 VEGF and their receptors (VEGFR)  
5.3.1 General characteristics of VEGFs and VEGFRs   
VEGF ligands Mammalian VEGF family consists of five members, VEGFA, VEGFB, 
VEGFC, VEGFD, and placenta growth factor (PlGF) (Ferrara et al., 2003). VEGFA (also 
referred to as VEGF) was firstly identified as an inducer of tumor microvascular permeability 
(Senger et al., 1983), and has been the focus of intensive studies in the field of vascular 
biology and cancer for almost 3 decades. Multiple isoforms of VEGFA generated from 
alternative splicing of an mRNA precursor (Robinson and Stringer, 2001) with strikingly 
different binding abilities and subsequent biological activities were described (Harper and 
Bates, 2008). Different spliced variants of VEGFA with pro-angiogenic activity detected in 
human were VEGFA121, VEGFA145, VEGFA148, VEGFA165, VEGFA183, VEGFA189, and 
VEGFA206 owing to number of amino acids in the mature proteins. Recently, another spliced 
variant, VEGFA165b with a difference in the last six amino acid residues at the C-Terminus 
has been identified (Harper and Bates, 2008). Interestingly, VEGF165b was reported to have 
anti-angiogenic activity (Bates et al., 2002; Perrin et al., 2005). The smallest isoform, 
VEGFA121 is readily diffusible, whereas the bigger isoforms show binding affinity to 
heparan sulfate proteoglycan on the cell membrane and in the extracellular matrix.  
 
VEGF receptors Secreted VEGF in dimeric form binds to VEGF receptor and activate its 
downstream signaling. Three structurally-related receptors, VEGFR1 (Flt-1), VEGFR2 (Flk-
1), and VEGFR3 (Flt-4) are members of the receptor tyrosine kinase (RTK) superfamily. The 
extracellular region of VEGFR1 and VEGFR2 consists of seven immunoglobulin (Ig)-like 
domains, while disulfide bridge replaces the fifth domain in VEGFR2. All the three receptors 
possess a single transmembrane domain, two kinase domains, split by a kinase insert 
domain, and a C-Terminal tail (Fig. 5-9).  Binding of VEGFRs to VEGF induces homo- and 
heterodimerization of the receptors and subsequent activation of tyrosine kinase activities 
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(Dixelius et al., 2003; Olsson et al., 2006). VEGFR1 binds to VEGFA, VEGFB, and PlGF, 
whereas VEGFR2 binds exclusively to VEGFA. VEGFR3 bind specifically to VEGFC and 
VEGFD. Proteolytic processed VEGFC and VEGFD are able to bind also to VEGFR2 
(Holmes et al., 2007). Regulatory mechanisms and signaling downstream of the pivotal 
angiogenic mediator VEGFR2 is a focus of the work presented in this thesis and will be 
further described here in detail.   
 
Regulation of VEGF/VEGFR activities A wide range of biological activities in response to 
the VEGF/VEGFR signaling is restrictively regulated by several mechanisms. The first to 
mention is the differential expression of the receptors and ligands depending on local 
requirement of active angiogenic activities. Hypoxia, a low oxygen supply condition 
commonly observed during development and typical in overgrowth tumors, has been shown 
to up-regulate expression of VEGFR (Ezhilarasan et al., 2007; Gerber et al., 1997; Nilsson 
et al., 2004) as well as the ligand VEGFA (Pugh and Ratcliffe, 2003). Notch signaling, on the 
contrary, enhances VEGFR1 expression while induces a down-regulation of VEGFR2 via 
unknown mechanism (Suchting et al., 2007).  
In addition to the differential expression of both receptors and ligands, the existence 
of different spliced isoforms of VEGF with distinct binding abilities to the co-receptor 
neuropilin and heparan sulfate proteoglycans greatly affect the signal transduction upon 
their binding to VEGFRs. A clear example is VEGFA165b with an altered C-terminal tail, 
which is unable to bind neuropilin-1 (Kawamura et al., 2008) and has a reduced binding 
ability to heparin sulfate proteoglycans (Cebe Suarez et al., 2006) and rexerts anti-
angiogenic activity upon binding to VEGFR2. Binding of VEGFA to heparan sulfate 
proteoglycan was previously reported to be essential to prolong and enhance signal 
transduction downstream of VEGFR2 (Jakobsson et al., 2006). Secreted variant of VEGFR1 
and VEGFR2 generated by proteolytic processing were also reported (Ebos et al., 2004; 
Kendall and Thomas, 1993). With its higher binding affinity as compared to VEGFR2, 
secreted VEGFR1 can negatively regulated VEGFR2 signaling by competing with the 
VEGFR2 to bind to VEGFA (Hiratsuka et al., 1998). Different tyrosine phosphatases, for 
example T-cell protein tyrosine phosphatase (TCPTP) and high cell density-enhance PTP 1 
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(DEP-1), have been shown to dephosphorylate and thereby inhibit the signaling that 
required the kinase activity of VEGFR2 (Grazia Lampugnani et al., 2003; Mattila et al., 
2008). 
 
5.3.2 VEGFR2 signaling 
 The critical role of VEGFR2 in vascular development has been highlighted in the 
analysis of VEGFR2 null mice. Loss of VEGFR2 causes lethality of the mutant embryo as 
early as E8.5-9.0 due to defects in the formation of blood islands, indicating that the receptor 
is required from the very first step of vascular development (Shalaby et al., 1995). Haploid 
insufficiency of VEGF, as demonstrated in mice having only one allele of the ligand that 
phenocopied the defect found in VEGFR2 null mice (Carmeliet et al., 1996), underlined the 
crucial importance of VEGF/VEGFR2 signaling in vessel formation. Complex cascades of 
signaling mechanisms operated downstream of VEGFR2 serve to mediate the receptor 
stimulatory effects on a vast array of cellular activities ranging from cell proliferation, 
migration, survival, to vascular permeability. 
 
Cell Proliferation Ligand binding triggers receptor dimerization and subsequent 
autophosphorylation of specific tyrosine residues in the receptors (Fig. 5-9), which thereby 
serve as docking sites for the recruitment of Src homology 2 (SH2) domain containing 
proteins. One of the few SH2 domain containing proteins that has been shown to interact 
with VEGFR2 is Phospholipase C- (PLC-). The importance of PLC- in normal 
development of blood vessels was demonstrated by the embryonic lethality of the PLC-
knockout mice due to defective vasculogenesis (Ji et al., 1997). PLC- has been shown to 
be recruited to the phosphorylated Tyrosine (Tyr) 1175 of VEGFR2 (Takahashi et al., 2001). 
Subsequent phosphorylation of PLC-gives rise to its active form which mediates the 
hydrolysis of phosphatidylinositol-4,5-bisphosphate (PIP2) to generate inositol-1,4,5-
triphosphate (IP3) and diacylglycerol (DAG). DAG and the increased intracellular calcium 
concentration by IP3, in turn, activate protein kinase C (PKC). Mitogen-activated protein 
kinase (MAPK) / extracellular-signal-regulated kinase-1/2 (ERK1/2) cascade which is 
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Figure 5-9 VEGFR2 signaling. Schemetic representation of some of 
the signaling pathways triggered upon VEGFA-stimulated activation of 
VEGFR2. Yellow circles marked with P represent phosphorylated 
tyrosines at the amino acid residues indicated with number of the 
human VEGFR2 homolog.  
activated downstream of PKC can induce endothelial cell proliferation (Fig. 5-9) (Takahashi 
et al., 2001).  
 
Migration Tyr1175 is a focal point of VEGFR2 signaling. Mutation of the tyrosine residue at 
this specific site to phenylalanine causes embryonic lethality in mice from a severe defect in 
vascular formation, resembling the phenotype of the VEGFR2 knockout mice (Sakurai et al., 
2005). In addition to PLC-, 
the SH2 domain-containing 
protein B (Shb) (Holmqvist 
et al., 2003) and the Shc-
related adaptor protein 
(Sck) (Warner et al., 2000) 
have also been shown to be 
recruited to VEGFR2 by 
binding to Tyr1175. Shb 
has been implicated in 
VEGFA-mediated cell 
migration via 
phosphoinositol 3-kinase 
(PI3K) (Holmqvist et al., 
2003). PI3K mediated 
generation of 
phosphatidylinositol-3,4,5-trisphosphate is known to activate the Rho GTPase Rac which, in 
turn, trigger cell motility (Fig. 5-9) (Innocenti et al., 2003). The actin binding protein IQGAP1 
might also play a role in VEGFR2-mediated activation of Rac (Yamaoka-Tojo et al., 2004). 
IQGAP1 can bind and activate Rac1 by inhibiting its intrinsic GTPase activity and thereby 
increases active (GTP-bound) Rac1 (Hart et al., 1996). In agreement with this model, VEGF 
stimulation has been shown to promote the association of Rac1 and IQGAP1 complex to 
phosphorylated VEGFR2 to facilitate endothelial cell migration in an in vitro setting (Fig. 5-9) 
(Yamaoka-Tojo et al., 2004).  
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Activation of PI3K results in creation of the membrane bound PIP3 and subsequent 
membrane targeting and activation of protein kinase B (PKB/Akt) (Cantley, 2002). An Akt 
substrate actin-binding protein, Girdin (Girders of actin filament), has recently been shown to 
play an important role in angiogenesis by facilitating endothelial cell migration (Fig. 5-9). 
Mice lacking Girdin show severe defect in angiogenic sprouting of blood vessels in the retina 
model. In vitro Girdin knockdown endothelial cells are defective in lamellipodia formation and 
migration (Kitamura et al., 2008). In accord to the role of Akt in endothelial cell migration 
shown in this study, kinase-dead mutation of the p110 catalytic subunit of PI3K which is 
unable to phosphorylate Akt causes lethality of mouse embryos at mid-gestation from a 
severe defect in angiogenesis. Furthermore, endothelial cells from the mutant mice with no 
obvious alteration in proliferation or survival show strong migration defect, which 
interestingly could be rescued by overexpression of the small GTPase RhoA (Ras homolog 
gene family: member A), but not RhoB (Ras homolog gene family: member B) or Rac1 
(Graupera et al., 2008).  
Focal-adhesion kinase (FAK) was also reported to bind to Shb (Holmqvist et al., 
2003). A signaling pathway involving VEGF-induced FAK phosphorylation and the 
recruitment of its substrate the actin anchoring protein paxillin might also be involved in 
VEGFR2 mediated cell migration (Holmqvist et al., 2003). 
 Two other phosphorylation sites, Tyr951 and Tyr1214, might also be involved in 
VEGF-mediated cell migration (Fig. 5-9). Tyr951 serves as a binding site for VEGF receptor-
associated protein (VRAP, also known as Tsad, T-cell specific adaptor) (Matsumoto et al., 
2005). VRAP knockout mice exhibit decreased tumor-induced angiogenesis and SiRNA-
mediated VRAP knockdown cells show defective migratory response upon VEGF 
stimulation (Matsumoto et al., 2005). Phosphorylated Tyr1214 was reported to associate 
with the adaptor protein Nck (non-catalytic region of tyrosine kinase adaptor protein), which 
might facilitate actin remodeling through recruitment of the Src family protein Fyn to the site 
to activate cdc42 and MAPK (Lamalice et al., 2006).  
 
Vascular permeability Although the first identified function of VEGF was the induction of 
vascular permeability (Senger et al., 1983), the precise mechanism is still elusive. 
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Generation of nitric oxide (NO) by endothelial nitric oxide synthase (eNOS) has been shown 
to be essential for VEGF induction of vascular permeability (Fukumura et al., 2001). 
Activation of eNOS requires Akt-dependent phosphorylation (Fig. 5-9) (Dimmeler et al., 
1999; Fulton et al., 1999). The endothelial cell specific adhesion molecule VE-Cadherin is 
the key component of endothelium adherens junction that plays a main role in the control of 
vascular integrity and permeability (Carmeliet et al., 1999; Fukuhara et al., 2005). The 
tyrosine kinase Src recruited to VEGFR2 possibly via VRAP (Matsumoto et al., 2005) 
appears to be responsible for the disruption of VEGFR2/VE-Cadherin complex and 
increased vascular permeability upon VEGF stimulation (Eliceiri et al., 1999; Weis et al., 
2004). The signaling cascade initiated by VEGFR2 activation involving Src-dependent 
phosphorylation of a Guanine nucleotide exchange factor (GEF) Vav2 and subsequent 
activation of Rac1 and its downstream effector the serine-threonine kinase PAK (p21-
activated kinase), has been proposed. In this pathway serine phosphorylation of VE-
Cadherin by PAK promotes its internalization into clathrin-coated vesicles and thereby 
triggers the disruption of intercellular junctions (Gavard and Gutkind, 2006) (Fig. 5-9). 
Alternatively, it has been proposed that phosphorylation of VE-Cadherin by VEGFR2 might 
recruit the phosphatase SHP-2 to dephosphorylate the VE-Cadherin-bound Src at its Tyr527 
(Src internal regulatory phosphorylation site). Active Src could stimulate downstream 
Akt/eNOS signaling which results in endothelial cell junction disassembly (Ha et al., 2008).    
 
Survival Akt signaling downstream of PI3K has been shown to be essential for           
endothelial cell survival (Fujio and Walsh, 1999). This might involve Akt-mediated 
phosphorylation of apoptotic proteins B-cell lymphoma 2 (Bcl-2)-associated death promoter 
(BAD) and caspase 9, which inhibits their apoptotic activities and thereby promotes cell 
survival (Brunet et al., 1999; Cardone et al., 1998). 
 
5.4 Eph receptors and Ephrin ligands 
5.4.1 General characteristic of Eph receptors and ephrin ligands 
Structures and interactions Eph receptors (derived from erythropoietin-producing 
hepatocellular carcinoma cells from which their cDNAs was first cloned) represent the 
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Figure 5-10 Eph receptors and ephrin ligands. Schemetic 
representation of structural organization of Ephs and 
ephrins. Yellow circles marked with P show region containing 
tyrosine phosphorylation sites. 
largest family of RTKs. They are classified into two subclasses based on their extracellular 
sequence similarities and their binding affinities to thev two subclasses of their ligands. Thus 
far, ten A-class (EphA1-EphA10) and six B-class (EphB1-EphB6) of the receptors have 
been identified in vertebrates. The extracellular region of the Eph receptors consists of the 
ligand-binding globular domain, a 
cystein-rich region, and two 
fibronectin type-III repeats. The 
cytoplasmic part, containing the 
juxtamembrane region with two 
conserved tyrosine residues, a 
tyrosine-kinase domain, a sterile -
motif, and a PDZ (Postsynaptic 
density-95/discs large/zonula 
occludens-1)-binding motif, follows a 
single membrane spanning segment 
(Fig. 5-10). Their ligands, the ephrins 
(Eph receptor interacting proteins), 
are also divided into two subclasses. 
In vertebrates, six A-class  
(ephrinA1-ephrinA6) and three B-
class Ephrins (ephrinB1-ephrinB3) 
are known to date. The two classes 
of ephrin ligands only share a similar 
extracellular Eph-receptor-binding 
domain. EphrinAs are tethered to the cell membrane by a glycosylphosphatidylinositol (GPI)-
anchor. EphrinBs, on the other hand, are transmembrane proteins with a short cytoplasmic 
tail containing conserved tyrosine phosphorylation sites and a carboxy (C)-terminal PDZ-
binding motif (Fig. 5-10) (Kullander and Klein, 2002; Pasquale, 2005). 
Interactions between Eph receptors and ephrin ligands are promiscuous within each 
class. Although the binding affinities are varied among each couple, EphAs bind all ephrinAs 
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and EphB bind all ephrinBs. The exceptions to this class discrimination rule are ephrinA5, 
which can bind to EphB2 (Himanen et al., 2004) and EphA4, which binds to both classes of 
ephrins (Pasquale, 2004). Apart from the high affinity binding-interfaces, which is essential 
for initiation of receptor-ligand dimerization, regions that can mediate low-affinity homophilic 
binding have been identified in both Ephs and ephrins (Himanen and Nikolov, 2003; 
Pasquale, 2005). Aggregation of the Eph-ephrin complexes into high-order clusters is 
indeed a prerequisite for the induction of a robust signal transduction upon Eph-ephrin 
interactions (Pasquale, 2005). Signal strengths and outcomes of those signals are thought 
to rely heavily on the degree of clustering (Pasquale, 2008; Poliakov et al., 2004).     
In addition to the formation of the “signaling cluster”, another unique characteristic of 
Eph-ephrin system that makes it standouts of all the RTKs is the ability to transduce the 
signal bidirectionally. Eph receptor “forward signaling” is mediated by either phosphorylation 
or association with various effector proteins. Ephrins, on the other hand, lack an intrinsic 
kinase activity and mediate their “reverse signaling” by recruitment of other kinases to the 
tyrosine phosphorylation sites as well as association of several effector molecules to the C-
terminal PDZ-binding domain (Kullander and Klein, 2002).   
 
Cis- vs trans-interaction Stimulation of the downstream signaling is best known to occur 
upon interaction of the Eph receptors and ephrin ligands on adjacent cells. Although there 
are some evidences of Ephs and ephrins interact in cis on the same cell surface, the 
functional relevance of cis-inteactions remains to be established. It has been reported that 
EphA3 and ephrinA5 co-expressed in axonal growth cone of retinal ganglion cells could 
interact in cis. Such interaction might prevent intercellular (trans) interaction and reduces 
Eph-mediated cellular responsiveness to ligands presented in trans (Carvalho et al., 2006; 
Egea and Klein, 2007). Ephs and their cognate ephrin ligands expressed in the same cells 
might not be able to interect in cis due their partitioning into separated membrane domains 
as demonstrated in the spinal cord motor neurons. EphA4 and ephrinA5 localized in different 
membrane domains of axonal growth cone do not interect and interestingly seem to mediate 
the opposite cellular response whereby EphA forward signaling induces repulsion and 
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Figure 5-11 Eph receptor forward signaling. Schemetic 
representation of some of the signaling pathways triggered by Eph 
receptor activation. Blue cylinder, kinase domain; green circle, 
SAM domain; purple oval, PDZ-binding motif. Yellow circles 
marked with P represent phosphorylated tyrosines. 
ephrinA reverse signaling mediates attraction (Egea and Klein, 2007; Marquardt et al., 
2005).  
 
5.4.2 Eph forward signaling 
 Upon ligand engagement and subsequent formation of signaling clusters, each 
receptor undergoes trans-autophosphorylation by a partner receptor in the cluster (Kalo and 
Pasquale, 1999). It has been suggested that Eph receptors might as well be phosphorylated 
by Src-family kinases (Knoll and Drescher, 2004; Matsuoka et al., 2005; Pasquale, 2005). 
Phosphorylation of the two 
tyrosine residues within the 
juxtamembrane domain 
disrupts the intermolecular 
inhibitory interaction between 
the non-phosphorylated 
juxtamembrane domain and the 
kinase domain and thereby 
allows the kinase domain to 
convert into its fully active 
conformation (Wybenga-Groot 
et al., 2001; Zisch et al., 2000). 
Once activated, the receptors 
are able to interact with various 
adaptor molecules containing 
SH2 domains that often lack 
enzymatic activity and function 
as linkers that connect the receptors to further downstream signaling molecules (Kullander 
and Klein, 2002; Pawson and Scott, 1997). In addition, several interaction partners are 
recruited to the receptors independent of this autophosphorylation. These include several 
PDZ-domain-containing proteins as well as Rho-family guanine nucleotide-exchange factors 
(Rho-GEF) (fig. 5-11) (Noren and Pasquale, 2004).  
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 Among the broad ranges of diverse cellular activities mediated by signaling 
mechanisms downstream of Eph receptors, regulation of cell movements is probably the 
best characterized. Eph receptors are known to regulate cell movements by controlling the 
active state of Rho family GTPases that act directly at the actin rearrangement process 
(Noren and Pasquale, 2004). Activation of Rho GTPases is mediated by guanine nucleotide-
exchange factors (GEFs) that promote the exchange of GDP for GTP. GTPase-activating 
proteins (GAPs), on the contrary, enhance the intrinsic GTPase activity of Rho proteins and 
thereby regulate their conversion to an inactive state (Heasman and Ridley, 2008; Rossman 
et al., 2005). Association of the Rho GEF ephexin 1  to unclustered (and thus non-
phosphorylated) EphA is thought to activate Rac1, cdc42, and RhoA in parallel, leading to a 
balance of their GTPase activities required for axon outgrowth (Egea and Klein, 2007). Once 
Eph receptor is transphosphorylated, ephexin 1 recruited to the receptor is also 
phosphorylated, probably by Src (Knoll and Drescher, 2004), which shifts its preference 
toward RhoA leading to actin depolymerization and thereby growth cone retraction (Egea 
and Klein, 2007; Sahin et al., 2005). In addition to ephexin, the Rho GEF Vav2 has also 
been shown to play an important role in Eph-mediated growth cone retraction (Cowan et al., 
2005). Vav2 seems to have a different mode of action as compared to ephexin 1. Firstly, 
Vav2 binds ephrin-activated Eph receptors of both classes in a phosphorylation-dependent 
manner. The tyrosine phosphorylation site at the juxtamembrane domain of Ephs and SH2 
domain in Vav2 are required for this interaction. Once associated with Ephs, Vav2 becomes 
transiently phosphorylated to promote Rac1- dependent endocytosis of the Eph-ephrin 
complexes which leads the conversion of initial adhesion to repulsion during growth cone 
collapse (Cowan et al., 2005; Egea and Klein, 2007). Recently, a GAP specific for Rac1, 2-
chimearin, has been identified as an EphA4 effector in the regulation of growth cone 
collapse and therefore essential for correct neuronal circuit formation (Beg et al., 2007; 
Iwasato et al., 2007; Shi et al., 2007; Wegmeyer et al., 2007). The adaptor protein Nck has 
been implicated as a linker for EphA4 and 2-chimearin interaction (Wegmeyer et al., 2007). 
 Other important molecular effectors such as PI3K and RasGAP are known to 
associate with Eph receptors and mediate a wide variety of cellular processes downstream 
                                                                                          5. Introduction 
 
40 
 
of the receptors including cell-matrix adhesion and mitogenesis (Kullander and Klein, 2002; 
Pasquale, 2008).  
     
5.4.3 Ephrin reverse signaling 
5.4.3.1 EphrinA reverse signaling  
Although ephrinA-mediated signaling events have been implicated in several cellular 
activities, the mechanism by which these GPI-anchored proteins transduce their signals 
across the plasma membrane is poorly understood (Knoll and Drescher, 2002). EphrinAs 
have been proposed to interact in cis with other transmembrane proteins which therefore act 
as coreceptors to fulfill their signal transduction. There are increasing evidences in favor of 
this model including the ephrinA-mediated RGC axon repulsion during the development of 
thev retinotopic map through the p75 low-affinity nerve growth factor receptor (Lim et al., 
2008). During the branching and synaptogenesis of these RGC axons the association of 
ephrinA and TrkB (Tropomycin-related kinase) B is required (Marler et al., 2008). 
Alternatively, Eph-stimulated ephrinA clusterings may possibly lead to changes in physical 
properties of lipid rafts in which ephrinAs are located and thereby cause the recruitment and 
activation of transmembrane proteins within the rafts (Davy et al., 1999).   
 
5.4.3.2 EphrinB reverse signaling  
EphrinBs can transduce their signals via their conserved tyrosine phosphorylation 
sites and the PDZ-binding motif on their cytoplasmic tails (fig. 5-12). EphB receptor binding 
and formation of the receptor-ligand clusters are likely to alter the ephrinB conformation in 
favor of the recruitment and phosphorylation of their tyrosine residues by Src family kinases 
(Palmer et al., 2002). Consequently, phosphorylated tyrosines of ephrinBs serve as docking 
sites for SH2-containing adaptor proteins. An example to this mode of action is the 
recruitment of Nck2 (also known as Grb4) to the EphB-stimulated phosphorylated ephrinB1 
and activation of the signaling pathway that ultimately leads to changes in focal adhesion 
kinase (FAK) and the actin cytoskeleton (Cowan and Henkemeyer, 2001). Binding of Nck2 
to ephrinBs, however, could potentially be mediated by the SH3 domain presented in Nck2 
and its proline-rich binding site within the intracellular domain of ephrinBs. SH3-mediated 
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Figure 5-12 EphrinB reverse signaling. Schemetic 
representation of some signaling pathways mediated by 
recruitment of Src kinase to phosphorylate ephrinBs at 
specific tyrosines (yellow circle marked with P, one out of five 
conserved tyrosine phosphorylation sites is depicted here)  
and interactions of ephrinBs with PDZ proteins via the PDZ-
binding site (green oval) at the end of their cytoplasmic tail.   
interaction of Nck2 to ephrinBs might allow the SH2 domain of Nck2 to recruit the G protein-
coupled receptor kinase-interacting protein 1 (GIT1) to the signaling complex to promote 
spine maturation and synapse formation through the activation of the Rac GEF protein β-
PIX (fig. 5-12) (Segura et al., 2007; Zhang et al., 2005). Protein tyrosine phosphatase BAS-
like (PTP-BL), previously shown to bind to ephrinB by its PDZ motif (Lin et al., 1999), has 
been identified as a negative regulator of ephrinB tyrosine phosphorylation. PTP-BL is 
recruited to EphB-activated ephrins, with delayed kinetics as compared to their 
phosphorylation by Src, and dephosphorylates the tyrosine residues of ephrins (Palmer et 
al., 2002).    
     Several other PDZ motif-containing proteins have been shown to interact with 
ephrinBs. These include adaptor proteins that will recruit additional partners to the signaling 
complexes such as glutamate-receptor-interacting-proteins (GRIP) 1 and 2, and syntenin 
(Bruckner et al., 1999; Lin et al., 1999; Torres et al., 1998), or PDZ proteins with functional 
units like protein kinase C-interacting protein (Pick1), partitioning-defective protein 6 (PAR6), 
and PDZ-RGS3 (Lee et al., 2008; 
Lin et al., 1999; Lu et al., 2001; 
Torres et al., 1998). These 
interactions are essential for a 
wide variety of signal cascades 
involved in the modulation of cell-
cell contacts (Lee et al., 2008), 
regulation of migratory signal of 
other receptors (Lu et al., 2001) as 
well as stabilization of other 
membrane proteins on the cell 
surface (Essmann et al., 2008). 
Association of ephrinB3 to PAR6 
disrupts the binding of cdc42 to the 
ternary polarity complex of PAR6, 
PAR3, and atypical protein kinase 
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C (aPKC) (Joberty et al., 2000; Lin et al., 2000) and thereby leads to inhibition of tight 
junction formation. Interestingly, phosphorylation of a certain tyrosine residue of ephrin 
results in loss of the ligand ability to interact with PAR6 (fig. 5-12) (Lee et al., 2008). 
Activation of ephrinB1 leads to recruitment of PDZ-RGS3 whose RGS domain acts as 
activator of intrinsic GTPase activity of the G protein  subunit (G) and therefore 
inactivates the GTP-bound form of the G and subsequent downstream signaling. This 
mode of action of ephrins has been shown to neutralize the G-protein coupled receptor 
CXCR4 attraction to the chemokine SDF1 during chemotactic cell migration in cerebral 
granular cells (fig. 5-12) (Lu et al., 2001).           
 
5.4.4 Regulation of adhesion and repulsion 
 The complexity of the the Eph-ephrin signaling network is mirrored by a vast array of 
cellular effects. Regulation of cytoskeletal dynamics by both forward and reverse signal 
transduction through several downstream partners can lead to various outcomes ranging 
from repulsion to adhesion and attraction (Cowan and Henkemeyer, 2002; Pasquale, 2005). 
An apparent explanation to these diverse cellular responses is the distinct expression 
profiles of the receptors and ligands themselves as well as their downstream effectors in 
different cellular contexts. In certain settings, however, the same receptor and ligand couple 
could mediate both attractive and repulsive responses as demonstrated in the process of 
neural crest migration and axon outgrowth (Hansen et al., 2004; McLaughlin et al., 2003; 
Santiago and Erickson, 2002). Signaling strength, depending on levels of receptor and 
ligand expression and possibly degrees of their clustering, may contribute to these variable 
signaling outcomes (Pasquale, 2005; Poliakov et al., 2004; Stein et al., 1998). 
 Cleavage of ephrin ectodomain by the A-Disintegrin-And-Metalloprotease (ADAM) 
10, the mammalian homolog of Drosophila Kuzbanian (KUZ), has been proposed as a 
possible molecular switch between adhesion and repulsion. KUZ was shown to associate 
with ephrinA2 and, upon complex formation with EphA3, mediate ephrin cleavage in cis to 
release the ligand from the cell surface and permit segregation of contacted cells. (Hattori et 
al., 2000). More recently, a different model whereby ADAM10 constitutively associated with 
EphA3 mediates trans cleavage of ephrinA5 presented on the surface of opposing cells 
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(Janes et al., 2005) has been proposed. Nonetheless, evidence supporting the existence of 
this non-cell-autonomous operation of ADAM10 in physiological setting is still missing.  
 Endocytosis of Eph-ephrin complexes might be an alternative mechanism for 
conversion of adhesive interaction to a repulsive signal. Interestingly, the endocytosed 
vesicles observed in both EphB and ephrinB expressing cells upon cell-cell interaction 
contain intact receptor-ligand complexes and plasma membrane fragments from both cells 
(Marston et al., 2003; Zimmer et al., 2003). This unusual mechanism is thought to imply a 
functional relevance in the exchange of Eph receptors, ephrin ligands, and possibly their 
associated proteins between cells for continued signaling in the intracellular compartments 
(Pasquale, 2008).     
   
5.4.5 Eph-ephrin in vascular morphogenesis 
Arterial-venous segregation Several Ephs and ephrins are expressed in the vascular 
system. Interestingly, EphB4 and its most preferred ligand ephrinB2 are differentially 
expressed in venous and arterial ECs, respectively. A Number of molecular regulators in the 
Notch and VEGFR signaling pathways, as well as hemodynamic factors have been shown 
to mediate this distinct expression pattern (see 5.1.4). Functional relevance of this 
arteriovenous-specific expression pattern has started to be revealed. In zebrafish, dorsal 
aorta and cardinal vein has recently been demonstrated to arise from a common precursor 
vessel rather than direct assembly of endothelial precursor cells into two independent 
vessels by vasculogenesis as previously thought. Venous-fated progenitors preferentially 
expressing EphB4 migrate ventrally from the common precursor vessel to form the cardinal 
vein, whereas ephrinB2 prominently expressed in the arterial-fated cells mediates repulsion 
of these cells from the ventral route to establish the dorsal aorta. EphrinB2C (signaling 
deficient form) overexpressing cells transplanted into wild type zebrafish hosts show 
significant increased contribution to the cardinal vein, indicating that reverse signaling 
downstream of ephrinB2 is required for cellular repulsion during the ventral migration. 
Conversely, cells overexpressing ephrinB2 largely contributed to intersomitic vessels that 
sprout dorsally from the dorsal aorta, suggesting an increased repulsion of arterial 
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progenitors from the EphB4-presenting venous cells by elevated ephrinB2 signaling (Herbert 
et al., 2009).      
 
Angiogenic remodeling Target deletion of the gene encoding ephrinB2 or EphB4 in mice 
clearly demonstrates the crucial requirement of these proteins in angiogenic remodeling. 
While the formation of primary plexus and dorsal aorta, occurred via vasculogenic assembly 
of endothelial precursor cells, appears to be normal, further development of these uniformed 
primitive vessels into the hierarchically organized network of functional vascular system 
through angiogenesis is severely defected. These defects lead to embryonic lethality in mice 
lacking either ephrinB2 or EphB4 (Adams et al., 1999; Gerety et al., 1999; Wang et al., 
1998). Endothelial-cell-specific knockout (Gerety and Anderson, 2002) as well as a mutant 
lacking the cytoplasmic domain of ephrinB2 (ephrinB2C) (Adams et al., 2001) recapitulate 
the vascular phenotypes of the ephrinB2 global knockout, suggesting the essential function 
of ephrinB2 reverse signaling in ECs.  
 Despite strong evidences that verify the essential functions of both ephrinB2 and 
EphB4 in blood vessel development, little is known about their molecular mechanisms. 
Stimulation of ECs with soluble pre-clustered ephrinB ligands or EphB receptors shows that 
both forward and reverse signaling promote in vitro angiogenic sprouting (Adams et al., 
1999; Palmer et al., 2002). Activation of ephrinB1 reverse signaling has been shown to 
promote integrin-mediated EC attachment and migration and induce mouse corneal 
neovascularization (Huynh-Do et al., 2002). However, contradictory results on the inhibitory 
effects of EphB4 forward signaling in EC migration and proliferation have also been reported 
(Fuller et al., 2003; Hamada et al., 2003; Kim et al., 2002). A possible explanation for this 
might be the difference in concentration or clustering of soluble Ephs and ephrins (Kuijper et 
al., 2007). It has been shown that non-clustered forms of soluble Eph and ephrins are rather 
inhibitory than activating (Segura et al., 2007).        
 
Mural cell recruitment Beside the vascular endothelium, ephrinB2 is expressed also in 
perivascular cells such as pericytes and vascular smooth muscle cells (Gale et al., 2001; 
Shin et al., 2001). Its functional relevance in these mural cells that provide structural stability 
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and elasticity to the vessel wall has been revealed through the conditional gene targeting 
approach to disrupt its expression selectively in these cells. Mural-cell-specific ephrinB2 
knockout mice display perinatal lethality, edema, and extensive skin hemorrhage due to the 
inability of mural cells to appropriately incorporate into the blood vessel wall (Foo et al., 
2006). In vitro, loss of ephrinB2 causes defective focal adhesion formation and cell 
spreading, and increased unpolarized motility of vascular smooth muscle cells. These 
effects have been proposed to be mediated by the Crk-family adaptor proteins and p130 
Crk-associated substrate (CAS). Crk and CAS form complexes upon integrin activation and 
recruit several effector molecules to their SH2 domains to modulate actin dynamics through 
Rac1 activation (Chodniewicz and Klemke, 2004). EphrinB2 seems to be required for the 
tyrosine phosphorylation of CAS and thereby enable Crk-CAS binding (Foo et al., 2006).   
 
Lymphatic development In newborn mice, the primitive plexus of the dermal lymphatic 
vessels expressing both ephrinB2 and EphB4 are actively remodeled by angiogenic 
sprouting that invade upper dermal layer to form a superficial capillary plexus. After the 
formation of the two vessel layers, the expression of ephrinB2 is only maintained in the 
valve-containing collecting lymphatic vessels, whereas EphB4 is detected throughout the 
lymphatic network (Makinen et al., 2005). The generation of two ephrinB2 signaling mutant 
mice lacking either the PDZ-binding motif (ephrinB2V) or all the five conserved tyrosine 
residues (ephrinB25Y) has uncovered the critical role of the ligand in lymphatic vasculature 
remodeling. Homozygous ephrinB2∆V mice die during the first postnatal week. While the 
initial formation of primitive plexus is unaffected, loss of PDZ-binding motif disturbs sprouting 
of lymphatic ECs and thus subsequent formation of superficial capillary networks. Collective 
lymphatic vessels of this mutant are devoid of valves. By contrast, ephrinB25Y mice display 
normal to very mild lymphatic phenotype, suggesting the requirement of PDZ interaction 
independent of tyrosine phosphorylation of ephrinB2 for the normal development of 
lymphatic vasculatures (Makinen et al., 2005).   
 
Tumor angiogenesis  Several Ephs and ephrins have been reported to be upregulated 
during tumor progression. Elevated levels of EphA2 expressed in active angiogenic tumor 
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vessels and its ligand ephrinA1 present in tumor cells as well as tumor endothelium has 
been linked to growth of many cancers (Brantley-Sieders and Chen, 2004; Ozawa et al., 
2005; Pasquale, 2008). Knockout of EphA2 in mice or blocking EphA receptor activation 
with soluble recombinant proteins reduce tumor vascularization and thereby inhibit xenograft 
tumor growth (Brantley-Sieders and Chen, 2004; Fang et al., 2005; Kuijper et al., 2007). 
Truncated form of EphB4 lacking the cytoplasmic domain (EphB4C) overexpressed in a 
breast cancer cell line could promote tumor growth associated with increased tumor 
vascularization, most likely via the activation of endothelium ephrinB2, in a xenograft model 
(Noren et al., 2004).  However, it has also been reported that EphB4 might suppress 
angiogenic sprouting and therefore reduce branching, but enhance circumferential growth of 
blood vessels in brain tumors (Erber et al., 2006). These evidences together provide 
credible implication on the importance of Eph-ephrin signaling in tumor-induced 
neovascularization and tumor growth. Nevertheless, the exact biological role of Ephs and 
ephrins in tumors is unclear. The relevance of their interactions in the communication 
between tumor cells and ECs, the molecular mechanisms of their downstream signaling 
pathways, and the distinct cellular behaviors induced upon their signaling in specific cell 
types, all remain to be clarified to give access to therapeutic opportunities based on Ephs 
and ephrins targeting.     
     
5.5 Receptor endocytosis  
 Diverse array of molecules are internalized from the cell surface and sorted into 
various internal membrane compartments via different endocytic pathways. Distinct 
molecular machineries are employed to mediate the common process of cargo selection, 
membrane budding and pinching off to form vesicular carriers, and subsequent trafficking of 
these vesicles to their targets. The best-characterized pathway is clathrin-mediated 
endocytosis (Fig. 5-13), which is responsible for internalization of virtually every signaling 
receptor and their associated ligands (Sorkin and von Zastrow, 2009). The key component 
of this pathway is the triskelion molecule clathrin which is able to assemble into a polyhedral 
lattice at the plasma membrane and function as a scaffold for membrane invagination 
(Conner and Schmid, 2003). Molecules destined to be endocytosed are recruited to the 
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Figure 5-13 Endocytosis pathways. Surface receptors and other 
extracellular molecules are internalized intracellularly via several routes 
into early endosomes. Cargo can be rapidly recycled back to the plasma 
membrane in a Rab11-comtaining endosomal compartment or remained 
in the early endosomes  that matured into late endosome and 
multivesicular body (MVB). Cargo destined for degration is sorted into 
intraluminal vesicle of MVB in a process that required ubiquitilation (Ub, 
Ubiquitin) and endosomal sorting complex required for transport 
(ESCRT). Further fusion of lysosome to MVB and late endosome results 
in protelytic degration of cargo. Model is reproduced from Gould and 
Lippincott-Schwartz, 2009. 
clathrin-coated pits by interacting with adaptor molecules such as adaptor protein-2 (AP2) 
that binds directly to cargo proteins containing tyrosine or di-leucine-based motifs (Le Roy 
and Wrana, 2005). Other adaptors such as Epsin, its partner protein Epidermal growth factor 
receptor (EGFR)-pathway 
substrate-15 (EPS15), 
and Dishevelled (Dvl) 
have also been shown to 
facilitate endocytic 
complex assembly (Brett 
and Traub, 2006; Marmor 
and Yarden, 2004; Sorkin 
and von Zastrow, 2009; 
Yu et al., 2007). 
Ubiquitylation has been 
proposed to serve as 
targeting signal that 
directs ubiquitylated 
cargos into clathrin-
coated pits as shown in 
the endocytosis process 
of several signaling 
receptors (Arevalo et al., 
2006; Gupta-Rossi et al., 
2004; Kazazic et al., 
2009). Ubiquitin 
interaction motifs (UIM) 
that are presented in 
Epsin and EPS15 might 
mediate the binding of these adaptor proteins to ubiquitylated cargos (Sorkin and von 
Zastrow, 2009; Traub and Lukacs, 2007). In addition, interaction of epsin with phospholipids 
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such as phosphatidylinositol (PtdIns)-4,5-bisphosphate may also contribute to vesicle 
formation (Legendre-Guillemin et al., 2004). Once cargos are captured inside, the GTPase 
dynamin mediates the scission of the clathrin-coated pits from the cell membrane to form 
clathrin-coated vesicles (Sorkin and von Zastrow, 2009).  
 Although alternative routes of endocytosis that does not depend on clathrin have 
been shown to play an important role in the uptake of GPI-anchored proteins, toxins, 
pathogens, as well as some transmembrane proteins, the molecular nature of these 
pathway is largely unknown (Mayor and Pagano, 2007; Sigismund et al., 2008). These 
clathrin-independent endocytic routes are sensitive to cholesterol depletion. The enrichment 
of cholesterol in membrane rafts together with the observations that lipid rafts are depleted 
within clathrin-coated pits lead to the idea that these pathways are raft-dependent (Le Roy 
and Wrana, 2005; Nichols, 2003a; Nichols, 2003b). One of the clathrin-independent 
endocytosis pathways is characterized by the presence of caveolae, the plasma membrane 
invagination enriched in raft lipids (Fig. 5-13) (Rothberg et al., 1992). The raft-resident 
protein caveolin seems to be important for the formation of caveolae (Drab et al., 2001). A 
distinct mechanism which does not required clathrin, caveolin, or dynamin, but probably 
involve activities of the GTPase ARF6, a mediator of actin remodelling and 
phosphatidylinositol 4,5-bisphosphate formation, has also been described (Fig. 5-13) 
(D'Souza-Schorey and Chavrier, 2006; Naslavsky et al., 2004).             
 Endocytic vesicles derived from clathrin-dependent and clathrin-independent 
pathways are transported to early endosomes from where endocytosed proteins are further 
sorted into lysosomes for degradation or recycled back to the plasma membrane. Several 
GTPases of the Ras superfamily, Rab proteins, localized in distinct compartments of 
endosomes are known regulator of endosomal trafficking. Internalized proteins in Rab5-
positive early endosomes can be directed to Rab11-positive recycling endosomes in a 
Rab4-dependent mechanism (Sorkin and von Zastrow, 2009). Proteins destined for 
degradation in lysosomes are kept in the endosomes that subsequently will mature to 
multivesicular bodies, where the endosomal sorting complex required for transport (ESCRT) 
mediates their sorting into intraluminal vesicles (Fig. 5-13) (Hurley and Emr, 2006; Le Roy 
and Wrana, 2005). 
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5.5.1 Endocytosis in control of signaling 
 It has become increasingly evident that endocytosis is not only a signal attenuation 
mechanism used by cells to remove signaling receptors from cell surface, but also an 
integral part of signaling that permits spatial and temporal regulation of signaling events. A 
cellular process that critically relies on strictly-regulated signal polarization is guided 
migration of cells or cellular extensions in response to extracellular cues. During Drosophila 
oogenesis border cells are guided by two RTKs, EGFR (Epidermal growth factor receptor) 
and PVR (PDGF/VEGF receptor) and migrate toward oocytes where their ligands are 
produced (Duchek and Rorth, 2001; Duchek et al., 2001). Endocytosis and recycling of 
these RTKs to the cell membrane are essential for spatial restriction of their downstream 
signaling and thereby ensure a localized cellular response required for directional migration 
of these cells (Jekely et al., 2005). In line with this finding, activation by RTKs of the pivotal 
regulator of actin remodeling and cell migration Rac requires Rab5-mediated clathrin-
dependent endocytosis of Rac. Induced by mitogenic stimuli, Rac is endocytosed and 
transported to early endosomes where it becomes activated by the RacGEF Tiam1 (T-cell 
lymphoma invasion and metastasis 1). Subsequent recycling of activated Rac to specific 
regions of the plasma membrane ensures localized signaling which is required for the 
formation of polarized actin-based cellular protrusions that direct cell motility (Gould and 
Lippincott-Schwartz, 2009; Palamidessi et al., 2008). Similarly, regulation of melanoma cell 
polarity and directional movement by Wnt signaling requires internalization and intracellular 
translocation of the melanoma cell adhesion molecule (MCAM). In the presence of 
chemokine gradient, Wnt5A mediates intracellular assembly of membrane receptors MCAM 
and frizzled 3 (a Wnt receptor) with cytoskeletal proteins actin and myosin at the cell 
periphery in a polarized manner. This process is dependent on the endosomal recycling 
protein Rab4 and functions to trigger membrane retraction, thus influence direction of cell 
movement (Gould and Lippincott-Schwartz, 2009; Witze et al., 2008).    
 The mitogenic and survival signals mediated via MAPK/ERK downstream of different 
RTKs have been shown to depend on functional receptor endocytosis. Clathrin-mediated 
endocytosis of VEGFR2 is important for the activation of p44/42 MAPK and proliferation of 
ECs. Contact-mediated inhibition of the receptor internalization by the adheren junction 
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protein VE-Cadherin might allows dephosphorylation of the receptor by the junction-
accociated phosphatase DEP-1 (density-enhanced phosphatase-1) and limit the receptor 
signaling (Lampugnani et al., 2006). Correspondingly, compelling evidences indicate the 
important role of clathrin-dependent endocytosis of EGFR to ensure the sufficient duration 
and signaling intensity of MAPK/ERK activation (Sigismund et al., 2008; Sorkin and von 
Zastrow, 2009; Vieira et al., 1996). In neurons, neurotrophins produced by post-synaptic 
cells activate the receptor TrkA expressed in the pre-synaptic axonal termini which results in 
endocytosis and transport of the activated TrkA along axonal microtubule network to the cell 
bodies where ERK5 activated by the receptor translocates into the nucleus to promote cell 
survival (Deinhardt et al., 2006; Howe et al., 2001; Watson et al., 2001; Wu et al., 2007). In 
addition to the signaling pathways mentioned here, endocytosis has also been shown to 
regulate different signaling cascades downstream of RTKs such as PI3K/Akt as well as 
several other receptor systems including transforming growth factor  receptors (TGF), G 
protein-coupled receptors (GPCR), and tumor necrosis factor receptor (TNFR) (Sorkin and 
von Zastrow, 2009).        
 
5.6 The thesis project 
 Previous works have clearly demonstrated that ephrinB2 and its cognate receptor 
EphB4 are indispensable for appropriate development of the vascular system. Analysis of 
mutant mice lacking ephrinB2 or EphB4 showed that loss of either gene does not affect 
vasculogenesis since the formation of primitive plexus of uniformed vessels at the earlier 
stage of development appeared normal. However, further expansion and remodeling of the 
primary vessels to achieve the complex hierarchical functional vascular networks by 
angiogenesis in both mutant mice is almost completely diminished. Further molecular 
insights come from the analysis of mutant mice in which the cytoplasmic tail of ephrinB2 is 
removed (ephrinB2C). Defects in vascular development of the ephrinB2 signaling-deficient 
mice that resemble the complete knockout of ephrinB2 indicate the importance of reverse 
signaling downstream of ephrinB2 for its vascular function. Two signaling mutant mice, 
ephrinB25Y in which all five conserved tyrosine residues of ephrinB2 were mutated and 
ephrinB2V with deletion of the PDZ-binding motif at the end of its cytoplasmic tail, have 
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been generated. While defective lymphangenesis found in ephrinB2V but not ephrinB25Y 
mice suggests the importance of PDZ interaction downstream of ephrinB2 in this process, 
the implication of this pathway in the development of blood vasculature is still unclear.  
The project presented in this dissertation was therefore set out to elucidate the 
unanswered questions, namely the exact role of ephrinB2 in the multifaceted development 
of the blood vasculature and the precise molecular mechanisms underlying ephrinB2 
function. By employing the mouse retina model, this work identified the process of 
endothelial tip cell filopodial extension during guided migration of growing retinal vessels 
along the astrocyte network to be regulated by ephrinB2 through its PDZ-dependent 
signaling. The molecular linkage between ephrinB2 and the pivotal angiogenesis regulator 
VEGFR2, demonstrated for the first time in this study, provides a mechanistic insight of how 
ephrinB2 might accomplish this task. The novel finding that ephrinB2 regulates VEGFR2 
endocytosis which thereby allow sustained signaling downstream of VEGFR2 in intracellular 
compartments, implies a possible mechanism that endothelial tip cells might use to ensure 
spatial resolution of the receptor signaling required for localized control of actin dynamics 
during the directional migration of developing blood vessel. Angiogenesis is an essential 
process for tumor growth and metastasis. Another aim of this study was thus to address the 
importance of ephrinB2 in progression of tumors. This led to the finding that tumor-induced 
angiogenesis and consequently tumor growth rely on PDZ-interaction downstream of 
ephrinB2, resembling the mechanism governing developmental angiogenesis. This 
uncovered role of ephrinB2 might provide an alternative for anti-angiogenic treatment in 
tumor therapy.       
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6. Results 
6.1. EphrinB2 PDZ-signaling controls endothelial tip cell filopodial 
extension during sprouting angiogenesis  
In order to study the role of ephrinB2 reverse signaling in angiogenesis in vivo, two 
different signaling mutant mouse lines were employed. The tyrosine phosphorylation-
deficient ephrinB2
5Y/5Y 
mice bearing targeted mutation of all five conserved tyrosine 
residues, whereas the PDZ-signaling-deficient ephrinB2
V/V
 mice lacking a C-terminal 
valine residue within the PDZ-interaction site, have been generated as previously described 
(Makinen et al., 2005). The latter showed impairment of lymphatic vasculature remodeling 
(Makinen et al., 2005). The development of the vascular system of these two signaling 
mouse mutants was analyzed in the retina model where the growth of the vasculature tree 
occurs exclusively by angiogenic sprouting in a highly reproducible pattern (Dorrell and 
Friedlander, 2006).   
    
6.1.1. EphrinB2 reverse signaling through PDZ-interaction is indispensable 
for developmental angiogenesis 
 During the first postnatal week the retinal vasculature sprouts from the optic nerve 
head along the astrocytic scaffold toward the non-vascularized hypoxic area. A superficial 
vascular network forms in one plane and later on sprouts toward the deeper layers of the 
retina to form intermediate and deep vascular plexus. To visualize superficial vascular 
plexus whole-mounted retinas were stained with FITC conjugated lectin from Bandeiraea 
simplicifolia. Analysis of the retina vasculatures of newborn mice in C57Bl/6 background 
revealed that in homozygous ephrinB2
V/V
 (eB2V/V) mice the extension of the superficial 
retinal vascular plexus was severely impaired compared with wild type littermates (control) 
(Fig. 6-1). The significantly reduced migration of endothelial cells toward the retinal 
periphery, assessed by radial length of the vascular bed (Fig. 6-1a, c), as well as lateral 
branching (Fig. 6-1b), ultimately resulted in a great reduction in the retinal blood vasculature 
density of the ephrinB2
∆V/∆V
 mice
 
(Fig. 6-1d).  
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Figure 6-1 EphrinB2 PDZ interactions are required for expansion of superficial retinal vasculature in 
new born mice. Retinas from C57/BL6 wild type (control), and ephrinB2
V/V mutant (eB2 ∆V/∆V) mice 
were stained with isolectin-B4, flat-mounted and visualized by confocal microscopy. Removal of the PDZ-
interaction domain (eB2 ∆V/∆V) results in impairment of angiogenic sprouting and formation of primitive 
capillary plexus as observed in the expansion of the vascular bed shown in P1 retinas, a, and vascular 
branching as shown in the closed up image at the sprouting front of P2 retinas, b.  Scale bars: 150 µm (a) 
and 75 µm (b). c, Quantification of the extension of the capillary bed based on the radial length from the 
optic nerve to the periphery ephrinB2
V/V mutant retinas (eB2 ∆V/∆V). d, Vessel density quantified as 
percentage of retina area covered with vessels was, in average, 35.21±6.17% and 13.11±1.38% in wild type 
and mutant retinas, repectively. Error bars represent standard error of the means (SEM). Statistical analysis 
was performed by two-tailed t-test, n=4 wild type and 4 ephrinB2
V/V mice, * P< 0.05, ** P < 0.01. 
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Due to early postnatal lethality of ephrinB2
V/V
 mice in the C57Bl/6 background, 
detailed analysis of retina vessels at later developmental stages was done in CD1 mice that 
survived the requirement of ephrinB2 PDZ-dependent signaling during development and 
showed normal fertility. At postnatal day (P) 7 when the leading front of the vascular bed is 
about to reach the retinal periphery and the morphology of arteries and veins is clearly 
distinguishable, analysis of the vasculature in arterial zones revealed 25-27% decrease in 
branching and density of the vascular bed in ephrinB2
∆V/∆V 
mice compared with wild type 
littermates (Fig. 6-2a, b, c). Likewise, formation of vascular sprouts quantified by the number 
of filopodia bursts within the developing vascular plexus was significantly reduced in the 
ephrinB2
∆V/∆V 
mutant mice (Fig. 6-2d).  
 
Figure 6-2 Vascular branching and formation of vascular sprouts are impaired in absence of 
ephrinB2 PDZ-dependent signaling. a, Decreased vessel branching and tip cell sprouting (tip cells are 
indicated by red asterisks) in ephrinB2
∆V/∆V
 mice (eB2 ΔV/ΔV) compared with wild type littermates (control) 
in CD1 background was observed in P7 retinas. Scale bar is 75 µm. b, Quantification of vessel branching 
showed a significant decrease from an average of 92.84±4.36 to 69.39±3.60 branch points per 0.1 mm
2
 
microscopic field in wild type and ephrinB2
V/V retinas, respectively. c, Vessel density measured as 
percentage of retina area covered with vessels in wild type retinas was 26.03±0.36% in average as 
compared with 19.92±1.05% in the mutant retinas. d, Defective vascular sprouting activity of ephrinB2
V/V 
mice was evidenced from the reduction in number of filopodial bursts counted at 193.41±5.20 and 
155.03±5.5 per 0.1 mm
2
 microscopic field on average in wild type and ephrinB2
V/V mutant retinas, 
respectively. Error bars represent SEM. Two-tailed t-test, n=4 wild type and 4 ephrinB2
V/V mice, * P< 0.05, 
** P < 0.01, *** P < 0.001. 
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To further verify that the vascular phenotypes observed in ephrinB2
∆V/∆V 
mice are not 
transient and could be caught up during later stages of development, retinal vasculature in 
adult mice (12-15 weeks old) was analyzed. Vessels were labeled with cardiac injection of 
high-molecular weight FITC-dextran and vascular density was assessed in the deep retinal 
layer. Similar reduction in the density of the vasculature in the deep plexus of adult 
ephrinB2
∆V/∆V 
mice compared with wild type littermates (Fig. 6-3) confirmed that the 
phenotypes observed in these mice during the first postnatal week are not due to a delay in 
vascular development.  
 
 
 
 
Figure 6-3 The vascular phenotypes caused by loss of ephrinB2 PDZ-interactions are persisted in 
adult mice. a, Following perfusion with FITC-dextran, retinas from adult ephrinB2
∆V/∆V
 (eB2 ∆V/∆V) mice 
and wild type littermates (control) were flat-mounted and vascularization in the deep retinal plexus was 
analyzed by confocal microscopy. Scale bar is 150 µm. b, Vascular density based on percentage of retina 
area covered with vessels was measured 13.78±0.68% in ephrinB2
V/V retinas and 19.02±0.61% in wild 
type retinas. Error bar represents SEM, Two-tailed t-test, n=3 wild type and 3 ephrinB2
V/V mice, ** P< 
0.01.   
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6.1.2. Angiogenic growth of blood vessels is unaffected in the absence of 
ephrinB2 tyrosine phosphorylation  
 In contrast to the disruption of PDZ-dependent signaling downstream of ephrinB2, 
impairment of ephrinB2 tysosine phosphorylation has no apparent effect on retinal 
vasculature development. Expansion of the superficial vascular plexus observed in newborn 
ephrinB2
5Y/5Y
 homozygous mutant mice in C57Bl/6 background appeared normal compared 
with control wild type littermates (Fig. 6-4a). These mice are also viable and fertile. Detailed 
analysis of the developing vessels at the age of P7 in CD1 background showed the 
undistinguished vessel branching, density of vascular bed, as well as formation of new 
vessel sprouts in homologous ephrinB2
5Y/5Y 
mice compared with wild type littermates (Fig. 6-
4b, c, d, e).     
 
                                                                                                     6. Results 
 
57 
 
Figure 6-4 EphrinB2 phosphotyrosine dependent signaling is dispensable for in vivo retinal 
angiogenesis. a, Extension of superficial retinal vascular network of P2 ephrinB2
5Y/5Y
 mice (eB2 5Y/5Y) in 
C57Bl/6 background was indistinguishable from wild type littermates (control).
 
b, Vessel branching and tip 
cell sprouting (tip cells are indicated by red asterisks) in the developing retinal vasculatures of P7 
ephrinB2
5Y/5Y
 mutants in CD1 background were unaffected. Scale bar is 75 µm in both a and c. c, Vessel 
branching quantified by number of branch points per 0.1 mm
2
 microscopic field was not significantly 
different between wild type (95.08±4.10) and ephrinB2
5Y/5Y
 (92.84±4.36) mutant retinas. d, Similar vessel 
density, assessed by percentage of retina area covered with vessels, was observed in wild type 
(25.67±0.27%) and ephrinB2
5Y/5Y
 mice (25.26±0.34%). e, Number of filopodia bursts within the vascular bed 
was counted, on average, 160.44±26.83 and 154.17±15.91 per 0.1 mm
2
 microscopic field in wild type and 
ephrinB2
5Y/5Y
 mice, respectively, reflecting unaltered sprouting activity of the mutant vessels. Two-tailed t-
test, n=3 wild type mice and 3 ephrinB2
5Y/5Y 
mice, n.s. not significant.  
 
 
Together, these results indicate the crucial role of ephrinB2 reverse signaling 
through PDZ-interactions, which is independent of its tysosine phosphorylation, in 
angiogenic sprouting of the retinal blood vasculature.  
 
 
6.1.3. The requirement of ephrinB2 PDZ-signaling in angiogenic growth of 
blood vessels is widespread throughout the central nervous system 
During development, the vasculature of the central nervous system develops 
exclusively via angiogenesis as opposed to de novo vasculogenesis taking place in several 
other tissues. In addition to the retinas, different vascular beds within several regions of the 
ephrinB2∆V/∆V mutant brains were examined. In agreement with the importance of 
ephrinB2 PDZ-dependent signaling in angiogenic sprouting of the retinal vasculatures, 
pronounced vascularization defects were observed in the cortex, thalamus, and striatum of 
adult ephrinB2∆V/∆V mutants with a general reduction in vessel density of 20-30% 
compared with wild type littermates (Fig. 6-5). This observation implies that ephrinB2 via its 
PDZ signaling may represent a general regulator of sprouting angiogenesis. 
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Figure 6-5 EphrinB2
∆V/∆V
 mice show vascular defects throughout the central nervous system. a, Adult 
(12-15 weeks old) CD1 ephrinB2
∆V/∆V
  mice (eB2 ∆V/∆V) and wild type littermates (control) were injected 
with high molecular weight FITC-dextran. Blood vessels in the cortex, thalamus and striatum were 
visualized by confocal microscopy. Scale bar: 150 µm. b, Similar reduction in the vascularization of 
ephrinB2
∆V/∆V
 mutant brains was observed in different regions. Vascular density of wild type as compared 
with ephrinB2
∆V/∆V
 mice was, in average, 18.63±0.60% versus 14.92±0.99%, 21.01±1.54% versus 
14.95±0.80%, and 18.34±0.44% versus 13.52±0.77%, in the cortex, thalamus, and striatum, respectively. 
Error bars represent SEM. Two-tailed t-test, n=3 wild type and 3 ephrinB2
V/V mice, * P < 0.05. 
 
 
 6.1.4. Lack of ephrinB2 PDZ-signaling specifically affects filopodial 
extension in endothelial tip cells, without alteration of cell proliferation  
Bidirectional signaling of Eph receptors and their ephrin ligands represents one of 
the most important guidance cues that directs the axonal growth cones at the distal end of 
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growing axons to their appropriated targets. Emerging evidences suggest that axonal growth 
cones and capillary tip cells share several repulsive and attractive cues in their environment 
that ultimately determine their directional migration. To address the question whether the 
exact cellular mechanism regulated by ephrinB2 during sprouting angiogenesis would be the 
guidance of vascular sprouts, endothelial tip cells at the leading front of the growing vascular 
network were investigated. Extension of filopodial processes, a hallmark of endothelial tip 
cells that reflects their highly explorative and invasive behavior, was found to be clearly 
affected by the lack of ephrinB2 PDZ target site. A striking reduction of up to 56.7% of 
filopodial density was observed in ephrinB2
∆V/∆V
 mice compared with wild type littermates 
(Fig. 6-6) and implicated the importance of ephrinB2 PDZ-signaling in the formation or 
stabilization of the filopodia structure required for guided migration of sprouting endothelial 
tip cells. 
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Figure 6-6 Disruption of ephrinB2 PDZ-dependent signaling causes severe defect in endothelial tip 
cell filopodia extension. a, Developing retinal vasculatures of CD1 P7 EphrinB2
∆V/∆V
 mice (eB2 ∆V/∆V) 
and wild type littermates (control) were visualized by isolectin-B4. Lower panel are closed up images of the 
vascular front areas as indicated by the red box. Filopodial extensions (green dots) were quantified along 
the length of the vessel front (red line). Scale bars represent 25 µm. b, ephrinB2
∆V/∆V
 mutant retina vessels 
exhibited a drastic decrease in filopodia extension at the sprouting front counted 12.48±0.88 as compared 
with 28.84±1.71 filopodia per 100 µm vessel length (in average) in wild type retinas. Error bar represent 
SEM. Two-tailed t-test, n=6 wild type and 5 ephrinB2
V/V mice, *** P<0.001. 
 
 
 Reduction in vessel coverage could also be attributed to a decreased endothelial cell 
proliferation. To examine this possibility, proliferating cells in the developing mouse retina 
were labeled with Bromodioxyuridine (BrdU) and number of BrdU positive cells per vascular 
area was quantified. EphrinB2
∆V/∆V
 mutants and wild types littermates showed no difference 
in the proliferation of endothelial cells at the vascular front (Fig. 6-7), suggesting that 
reduced sprouting activity rather than endothelial proliferation account for the decreased 
vessel density caused by loss of ephrinB2 PDZ-signaling.  
 
 
Figure 6-7 Endothelial cell proliferation is not affected in ephrinB2
∆V/∆V
 mutant retinas. a, Isolectin B4 
(red) and BrdU (green) staining of whole-mounted wild type (control) and ephrinB2
∆V/∆V 
(eB2 ∆V/∆V) mouse 
retinas at the age of P7 showed indistinguishable endothelial cell proliferative activity at the vascular front. 
Scale bar is 50 µm. b, Quantification of BrdU positive cells per isolectin-B4-positive vessel area confirmed 
indifferent number of proliferating endothelial cells between wild type (1806.92±83.87 cells per mm
2
) and 
ephrinB2
∆V/∆V 
(1854.56±87.58 cells per mm
2
). Error bar represent SEM. Two-tailed t-test, n=3 wild type and 
3 ephrinB2
V/V mice, n.s. not significant.  
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6.1.5. Complementary expression of ephrinB2 in sprouting retinal vessels 
and EphB receptors in the scaffolding astrocytic network 
 For the detection of ephrinB2 whole-mounted retinas were stained with the 
recombinant protein consisting of EphB4 ectodomain and the Fc fraction of the human 
immunoglobulin G (EphB4-Fc). EphB4-Fc preferentially binds to ephrinB2 and thereby 
allows the detection of ephrinB2 localization by fluorochrome-conjugated anti-Fc. In the 
actively sprouting retinal vascular network, ephrinB2 was found to be expressed in all 
microvessels and arteries as well as mural cells sparsely covering the entire vascular bed, 
but largely absent in matured veins (fig. 6-8a-c). At the sprouting fronts, both endothelial tip 
cells and stalk cells were positive for ephrinB2 (Fig. 6-8d). In agreement with the function of 
ephrinB2 at the tip cells, clusters of ephrinB2 were also present in the filopodia structures of 
the tip cells (Fig.6-8e-f). During retinal vasculature development astrocytes secrete VEGF 
that, though the signaling of its receptor VEGFR2 predominantly expressed in tip cells and 
localized to filopodia, guides the extension of tip cell filopodia and subsequent migration of 
endothelial sprouts along the astrocytic scaffold. Interestingly, staining of whole-mounted 
retinas with ephrinB2 extracellular domain fused with human Fc (ephrinB2-Fc) revealed the 
high expression of EphB receptors in the astrocytic meshwork (Fig. 6-8g-i), suggesting the 
potential role of astrocytes to provide a source of ephrinB2 activation in vascular 
endothelium. 
 
 
 
Figure 6-8 EphrinB2 is expressed throughout the developing retinal vascular network and its 
receptors EphB are abundant in the astrocytic scaffold. a-c, Double staining of whole-mounted P4 
retinas with isolectin-B4 to mark the entire vascular bed (green) and EphB4-Fc that  labeled ephrinB2 (red) 
showed the expression of ephrinB2 all over the actively sprouting vascular network including arteries (white 
circles) and all microvessels with the exception of veins (white asterisks). Perivascular cells including 
pericytes and smooth muscle cells are also positive for ephrinB2. d, At the vascular front the expression of 
ephrinB2 was detected in both tip and stalk cells. e and f, high magnification images which focus on an 
endothelial tip cell as indicated by the white box in d showed clusters of ephrinB2 localized at the tip cell 
filopodia (white arrowheads in e). g-i, Whole-mounted retina staining with an antibody specific for the 
astrocyte marker GFAP and  ephrinB2-Fc fusion protein showed the expression of EphB receptors (green) 
in astrocytic network (red). h and i are high magnification images of the area indicated by the white box in g. 
Scale bars: a, 150 µm,  d and g, 25 µm, e and h, 10 µm.        
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6.1.6. EphrinB2 gain-of-function promotes filopodial protrusion in cultured 
endothelial cells 
 To further confirm the direct effect of ephrinB2 on filopodial dynamics in endothelial 
cells, YFP-ephrinB2 fusion gene or only YFP were introduced into primary mouse lung 
endothelial cells (MECs) by electroporation. Eletroporated cells were seeded onto 2-
dimentional matrix consisting of fibronectin and gelatin. Numbers and cumulative lengths of 
filopodial protrusions in these cells were quantified. In comparison to MECs overexpressing 
only YFP, cells overexpressing YFP-ephrinB2 showed excessive extension of filopodia 
during their spreading on the 2-dimensional matrix (Fig. 6-9a, b). In consistence with this 
observation, MECs overexpressing YFP-ephrinB2 exhibited highly dynamic extension and 
retraction of filopodia that facilitated cell movement in 3-dimentional matrigel (Fig. 6-9c, 
movie S1).   
 
Figure 6-9 Overexpression of ephrinB2 induces filopodial dynamics in endothelial cells. Primary 
mouse endothelial cells overexpressing YFP-ephrinB2 showed numerous filopodial extensions after 6h of 
cell spreading on 2-dimensional matrix (a), counted up to 5.81±0.95 filopodia per 100 µm of cell surface 
length (in average) as compared with 1.74±0.21 per 100 µm of cell surface length in cells overexpressing 
only YFP (b). Increase in cumulative filopodial lengths was also evident comparing 17.23±3.23 and 
106.36±24.85 µm per 100 µm of cell surface length (in average) in the YFP and the YFP-ephrinB2 
overexpressing cells, respectively. (b). c, Six consecutive time points from the supplementary time lapse 
movie 1 showed active sprouting activity of YFP-ephrinB2 overexpressing cells seeded in 3-dimensional 
matrigel. Scale bars: a, 100 µm, c, 25 µm. Error bar represent SEM. Two-tailed t-test, n=14 cells per 
condition, * P<0.05, ** P<0.01. 
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6.1.7. EphrinB2 PDZ-interaction confers contact-mediated repulsive activity 
to endothelial cells 
 Matrigel, the mixture of basement membrane proteins and growth factors secreted 
from a mouse sarcoma cell line that resembles the complex extracellular environments of 
several tissues, has been used extensively to study endothelial cell behavior during their 
organization into a three-dimensional branching network. Once seeded onto matrigel, 
endothelial cells extend cellular processes and migrate toward nearby cells to establish cell-
cell contacts. The cellular assembly and elongation subsequently give rise to the capillary-
like structures containing intercellular or lumen-like spaces. In agreement with ephrinB2 
gain-of-function that resulted in excessive filopodia extensions (Fig. 6-9), overexpression of 
YFP-ephrinB2 in endothelial cells whose endogenous ephrinB2 has been knocked out (Fig. 
6-10) conferred highly invasive behavior as well as cell-cell contact-mediated repulsive 
activity to these cells. This consequently prevented their inclusion into the tubular endothelial 
network formed on matrigel (Fig. 6-11a and movie S2).  
 
 
 
Figure 6-10 Characterization of ephrinB2 knockout endothelial cells. a-c, Loss of ephrinB2 expression 
was confirmed by an immunofluorescence assay in which ephrinB2-clustering was induced by stimulation 
with the extracellular domain of the ephrinB2-preferential receptor EphB4 fused with human Fc (EphB4-fc), 
previously pre-clustered by coupling with anti-Fc antibody. Non-stimulated cells (treated with pre-clustered 
Fc) showed no ephrinB2 staining (a). EphrinB2 clusters were observed in control ephrinB2
lox/lox 
endothelial 
cells (b) but absent in ephrinB2 knockout cells (eB2KO) derived from ephrinB2
lox/lox 
cells after Cre 
recombination (c). Scale bar is 25 µm.  
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This repulsive phenotype was in an evident contrast to the ephrinB2 knockout cells 
that have lost the contact-dependent repulsion and tightly integrated into the tubular 
structures (Fig. 6-11b and movie S3). The induction of cellular repulsion in endothelial cells 
by ephrinB2 depends on its PDZ signaling. Re-introduction of the ephrinB2 expression 
construct in which all the tyrtosine phosphorylation sites are mutated while the PDZ-binding 
motif still present (ephrinB25Y), but not the construct with a targeted deletion of the PDZ-
interaction site (ephrinB2V), could rescue the repulsive phenotype in ephrinB2 knockout 
cells  (Fig. 6-11c-e, Fig. 6-12, and movie S4-6).  
These observations are consistent with an intercellular repulsive activity regulated by 
Eph-ephrin contacts observed in other cell types (Mellitzer et al., 1999; Zimmer et al., 2003) 
that might be involved in initial destabilizing forces possibly required for the budding of the 
selected sprouting endothelial cells (tip cells) from a tightly-arranged endothelial cell layer 
lining the vascular wall.  
 
 
Figure 6-11 EphrinB2 reverse signaling mediates repulsive activity in endothelial cells. a, MECs 
whose endogenous ephrinB2 had been knocked out were electroporated with YFP-ephrinB2 (green cells) 
and seeded on matrigel. Overexpression of YFP-ephrinB2 induced contact-mediated cellular repulsion and 
subsequent exclusion of the endothelial cells from the cord-like structures. Three different time points of the 
supplementary time-lapse movie 2 are shown. b, endothelial cells lacking ephrinB2 stably integrated in 
endothelial tubes. EphrinB2KO endothelial cells (green cells) were infected with adenovirus encoding GFP 
and seeded on matrigel. Three consecutive time points of the supplementary time-lapse movie 3 are shown. 
c, The repulsive phenotype conferred by ephrinB2 is reverse signaling dependent. Overexpression of YFP-
ephrinB2ΔC in MECs lacking endogenous ephrinB2 (green cells) resulted in stable integration of these cells 
into the tubular structures. Three different time points of the supplementary time-lapse movie 4 are shown. 
d, PDZ-interactions are required to trigger the repulsive behavior in endothelial cells. EphrinB2KO MECs 
overexpressing YFP-ephrinB2ΔV (green cells) were stably integrated in the tubular network when seeded in 
matrigel. Three different time points of the supplementary time-lapse movie 5 are shown. e, Tyrosine-
dependent signaling is dispensable for the repulsive action of ephrinB2 in endothelial cells. EphrinB2KO 
MECs overexpressing YFP-ephrinB25Y (green cells) were repulsed from other cells that assembled to form 
tubular structures in matrigel, similar to the behavior observed in the overexpression of full-length ephrinB2. 
Three different time points of the supplementary time-lapse movie 6 are shown. Red arrows indicate some 
of the cells that were integrated (b,c, and d) or non-integrated (a and e) in the capillary-like structures. Scale 
bar is 50 µm.   
                                                                                                     6. Results 
 
66 
 
 
 
 
 
                                                                                                     6. Results 
 
67 
 
 
 
Figure 6-12 Contact-mediated repulsion of endothelial cells requires ephrinB2 PDZ-interaction, but 
not tyrosine phosphorylation. a, High magnification pictures of the tubular structures formed in matrigel 
by endothelial cells lacking ephrinB2 some of which were  expressing YFP-ephrinB2, YFP-ephrinB2ΔC, 
YFP-ephrinB2ΔV or YFP-ephrinB25Y (all in green). Introduction of ephrinB2 wild type and ephrinB25Y, but 
not ephrinB2ΔC and ephrinB2ΔV, was sufficient to restore the repulsive phenotype in endothelial cells. b, 
Quantification of green cells that were excluded from the tubes is shown as percentage of all green cells in 
each condition. 83.33±9.62%, 22.51±6.34%, 34.26±4.90%, and 70.36±3.55% of all cells overexpressing 
YFP-ephrinB2 (eb2), YFP-ephrinB2∆C (eb2∆C), YFP-ephrinB2∆V (eb2∆V), and YFP-ephrinB25Y (eb25Y), 
respectively, were unable to integrated into the endothelial tubes. Scale bar is 25 µm. Error bars represent 
SEM. Two-tailed t-test, n=3 movies of YFP-ephrinB2, 3 movies of YFP-ephrinB2ΔV, 4 movies of YFP-
ephrinB2ΔC, and 4 movies of YFP-ephrinB25Y, * P<0.05, ** P < 0.01, n.s. not significant).  
 
6.1.8. Supplementary information on CD-Rom 
Movie 1. Endothelial cells overexpressing YFP-ephrinB2 extended numerous dynamic 
filopodia which facilitated cell migration in the extracellular matrix. The movie is 8 h long with 
96 frames at 5 min intervals.  
Movie 2. EphrinB2 confers a repulsive phenotype in endothelial cells. Dynamic filopodial 
processes protruded from YFP-ephrinB2 overexpressing cells (green) were, upon contact 
with neighboring cells, rapidly retracted which consequently led to the exclusion of these 
cells from the capillary-like structures. The movie is 7 h long with 84 frames at 5 min 
intervals. 
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 Movie 3. Endothelial cells lacking ephrinB2 (green) lost their contact-dependent repulsion 
and invasive migratory behavior. These cells tightly assembled into capillary-like structures. 
The movie is 7 h long with 84 frames at 5 min intervals. 
Movie 4. Deletion of the cytoplasmic tail results in the loss of function of ephrinB2. EphrinB2 
knockout endothelial cells in which YFP-ephrinB2∆C was re-introduced (green) behaved 
indifferent from other knockout cells. These cells lost the repulsive phenotype and integrated 
into the tubular network, suggesting the significance of reverse signaling downstream of 
ephrinB2 in the regulation of endothelial cell contact-mediated repulsion. The movie is 8 h 
long with 96 frames at 5 min intervals. 
Movie 5. PDZ-interactions are necessary for the repulsive activity conferred by ephrinB2. 
Expression of YFP-ephrinB2∆V (green) in the ephrinB2 deficient cells was unable to rescue 
the repulsive and invasive behavior observed upon the expression of wild type ephrinB2. 
These YFP-ephrinB2∆V expressing cells were readily integrated into the tubular network. 
The movie is 8 h long with 96 frames at 5 min intervals. 
Movie 6. Tyrosine phosphorylation is dispensable for the repulsive phenotype. EphrinB2 
knockout endothelial cells in which YFP-ephrinB25Y was re-introduced (green) behaved 
similar to those expressing wild type ephrinB2. These cells exhibited high motility and were 
excluded from the endothelial tubes. The movie is 8 h long with 96 frames at 5 min intervals. 
 
Together, these results indicate that ephrinB2 reverse signaling through PDZ-
interactions controls vascular sprouting by promoting tip cell filopodial extension during 
developmental angiogenesis. EphrinB2 might also be important in the modulation of 
endothelial cell invasive behavior which could be involved in the regulation of cellular contact 
between endothelial cells.  
 
6.2. EphrinB2 PDZ-interaction is crucial for VEGFR2 internalization and 
signal transduction  
Interaction between VEGF secreted from astrocytes and localized in the extracellular 
matrix within the close proximity to the astrocyte surface, and its receptor VEGFR2 located 
on the endothelial tip cell filopodia has been suggested to provide the initial establishment of 
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astrocyte-endothelial contacts that mediate endothelial cell guidance along the pre-existing 
astrocytic scaffold during the vascularization of the retina (Gerhardt et al., 2003). Therefore, 
the next question to be addressed is if the impairment of filopodial extensions in 
ephrinB2
∆V/∆V
 mutant tip cells could be a result of misregulated VEGFR2 function indicating 
a molecular crosstalk between ephrinB2 reverse and VEGFR2 signaling.  
 
6.2.1. VEGF-induced endocytosis of VEGFR2 requires PDZ interactions 
downstream of ephrinB2 
Intracellular compartmentalization of signaling receptors has been supported by 
several compelling evidences to represent a critical mechanism that cells use to strictly 
regulate signal transduction temporally and spatially. Rather than being removed from the 
cell surface and en route directly to the proteolytic degradation machinery only to dampen 
cellular response to extracellular signals as previously thought, several receptors 
endocytosed and sorted into different endosomal compartments are now recognized to 
continue their signaling as is the case for EGF and NGF receptors. Indeed, activation of 
some signaling pathways downstream of these receptors has been clearly demonstrated to 
rely on receptor endocytosis (Howe et al., 2001; Sigismund et al., 2008). Internalization of 
VEGFR2 has also been shown to promote its phosphorylation and mitogenic signaling 
(Lampugnani et al., 2006). Conversely, at the cellular surface VEGFR2 is dephosphorylated 
and inactivated by membrane-associated phosphatases such as CD148 (Lampugnani et al., 
2006) or VE-PTP (Mellberg et al., 2009).   
To test whether ephrinB2 might have a role in the VEGFR2 trafficking, endocytosis 
of VEGFR2 in primary endothelial cells isolated from ephrinB2 signaling mutant mice was 
assessed by using the immunofluorescence-based, antibody feeding assay. Briefly, cell 
surface VEGFR2 was labeled with an antibody raised against its ectodomain prior to 
stimulation of the receptor internalization. VEGFR2 internalization was activated by 
stimulation with VEGF. After cell fixation, remaining surface receptor was firstly detected 
with a fluorochrome-conjugated secondary antibody. Then cells were permeabilized and 
internalized receptor was detected with another secondary antibody conjugated with 
different fluorochrome. EphrinB2
lox/lox 
MECs (control) robustly internalized surface VEGFR2 
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in response to stimulation with VEGF, whereas ephrinB2 knockout (eB2KO) as well as PDZ-
signaling-deficient (eB2V) MECs failed to do so. Disruption of ephrinB2 tyrosine 
phosphorylation does not seem to affect VEGFR2 internalization. Phosphotyrosine-deficient 
cells (eB25Y) exhibited comparable level of internalized VEGFR2 to control cells (Fig. 6-13).     
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Figure 6-13. EphrinB2 PDZ-signaling is necessary for VEGFR2 internalization. a, Endocytosis of 
VEGFR2 was visualized by the antibody feeding assay. EphrinB2
lox/lox 
primary endothelial cells (control), 
ephrinB2-deficient cells derived from these cells by viral-transduction of Cre-recombinase (ephrinB2
lox/lox
;
 
Cre
+
, eB2 KO), ephrinB2 PDZ signaling-deficient cells (ephrinB2
ΔV/ΔV
,
 
eB2ΔV), and ephrinB2 
phosphotyrosine-signaling deficient cells (ephrinB2
5Y/5Y
, eB25Y) were stimulated for 30 min with VEGF. 
VEGFR2 that remained at the plasma membrane was labeled in green, while internalized receptor was 
marked in red. Scale bar is 25 µm. b, Quantification of VEGFR2 internalization based on fluorescence 
intensities, shown as average percentage of internalized VEGFR2 (red) versus total VEGFR2 (red + green). 
In control cells the basal level of VEGFR2 internalization measured 28.67±7.75% (grey bar) increased up to 
66.67±3.67% after VEGF-stimulation. EphrinB2 knockout and ephrinB2
ΔV/ΔV
 MECs were unable to respond 
to VEGF-stimulation as only 17.80±7.04% and 19.67±4.29% of VEGFR2, respectively, were internalized. 
On the contrary, up to 68.83±5.44% of VEGFR2 internalization was observed in EphrinB2
5Y/5Y 
mutant cells. 
Error bars represent SEM. Two-tailed t-test, n=4 independent experiments, *** P<0.001.  
 
 
 
6.2.2. Expression levels of ephrinB2, VEGFRs, and NICD are unaltered in 
ephrinB2∆V/∆V mutant mice and endothelial cells 
 To verify that the vascular defects and the impairment of VEGFR2 internalization 
observed in ephrinB2
∆V/∆V
 mice and primary endothelial cells are not the consequence of a 
reduction in the expression levels of ephrinB2 or VEGF receptors, ephrinB2
∆V/∆V
 and wild 
type MECS were subjected to western blot analysis. In comparison to wild type cells, no 
significant change in the expression levels of EphrinB2, VEGFR2 and VEGFR3 (another 
receptor in VEGF family that is essential for lymphangiogenesis and also plays an important 
role in angiogenic growth of blood vessels during development) could be detected in the 
ephrinB2
∆V/∆V
 cells (Fig. 6-14a).  
 Notch signaling is a known modulator of ephrinB2 expression and therefore of the 
acquisition of arterial identity of endothelial cells (Roca and Adams, 2007). Signaling 
pathways activated downstream of Notch and VEGFR2 are intertwined within a negative 
feedback loop that permits a strict regulation of their signal outcomes. VEGF functions 
upstream of Notch signaling by acting as an inducer of the Notch ligand DLL4 expression 
that consequently leads to trans-activation of Notch. On the other hand, VEGFR2 has also 
been shown to be downregulated once Notch downstream signal is activated (Suchting et 
al., 2007). Moreover, deregulated VEGFR2 has been suggested to be responsible for 
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excessive filopodial sprouting in developing mouse retinal vessels following disruption of 
Notch signaling (Hellstrom et al., 2007; Suchting et al., 2007). To examine the possibility that 
Notch signaling might be involved in the vascular function of ephrinB2, the levels of 
activated Notch1 (NICD, Notch intracellular domain) in ephrinB2
∆V/∆V
 mutant mice and 
control wild type littermates were assessed by western blot analysis. Comparable levels of 
NICD detected in the mutant and the control brain tissues (Fig. 6-14b) suggest that the 
vascular defects as well as impaired VEGFR2 endocytosis caused by disruption of ephrinB2 
PDZ-signaling are not a consequence of deregulated Notch signaling.      
 
Figure 6-14 Characterization of ephrinB2
ΔV/ΔV 
mutant mice and endothelial cells. a, Endothelial cells 
isolated from ephrinB2
V/∆V
 (eB2∆V/∆V) and wild type mice (control) were characterized with respect to the 
expression of ephrinB2, VEGFR2 and VEGFR3. Level of MAPK was used as loading control. All protein 
levels were equal in mutant and wild type cells. b, Notch signaling is not affected in ephrinB2 PDZ-mutant 
mice. EphrinB2
V/∆V
 mutants and control wild type littermates show equal levels of activated Notch1 
assessed by the levels of Notch1 intracellular domain (NICD). Tubulin protein level was used as loading 
control. Data shown in a was generated by Essmann C.L. 
 
 
6.2.3. Activation of ephrinB2 induces VEGFR2 internalization 
 To functionally corroborate the control of VEGFR2 endocytosis by ephrinB2 reverse 
signaling, MECs were treated with soluble EphB4-Fc fusion protein pre-clustered with anti-
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hFc. The treatment of pre-clustered EphB-Fc has been previously shown to activate tyrosine 
phosphorylation as well as the recruitment of PDZ containing proteins to the cytoplasmic 
tails of ephrinB ligands (Palmer et al., 2002). Internalization of VEGFR2 upon EphB4-Fc 
stimulation in different ephrinB2 signaling mutant endothelial cells was assessed by the 
antibody feeding assay. Similar to VEGF-stimulation, MECs isolated from ephrinB2
lox/lox 
mice 
without Cre recombination that were used as control showed significantly increased 
internalization of VEGFR2 following EphB4-Fc stimulation (Fig. 6-15). Loss of ephrinB2 as 
well as absence of ephrinB2 PDZ-dependent signaling resulted in severe impairment in 
VEGFR2 trafficking upon EphB4-Fc treatment as evident in the low levels of internalized 
VEGFR2 nearly at the baseline level of non-stimulated control cells in the ephrinB2
lox/lox
; 
Cre
+
 and ephrinB2
∆V/∆V
 MECs, respectively. By contrast, lack of ephrinB2 tysosine-
phosphorylation has no apparent effect on the ability of endothelial cells to internalize 
VEGFR2. EphrinB2
5Y/5Y
 cells exhibited robust internalization of VEGFR2 upon EphB4-Fc 
stimulation to the level similar to that observed in control cells (Fig. 6-15). 
 
 
 
 
 
Figure 6-15. Stimulation of ephrinB2 reverse signaling by EphB4-Fc is sufficient to induce VEGFR2 
internalization. a, EphrinB2
lox/lox
 (control), ephrinB2 knockout (ephrinB2
lox/lox
; Cre
+
, eB2KO), ephrinB2
∆V/∆V 
(eB2∆V), or ephrinB2
5Y/5Y 
(eB25Y) primary endothelial cells were stimulated with the pre-clustered soluble 
EphB4 receptor (EphB4-Fc) for 30 min. VEGFR2 internalization was analyzed by antibody feeding assay. 
Remaining surface VEGFR2 was labeled in green and internalized receptor was marked in red. Scale bar is 
25 µm. b, Quantification of VEGFR2 internalization based on fluorescence intensities, shown as average 
percentages of internalized VEGFR2 (red) from total VEGFR2 (red + green). Activation of ephrinB2 
signaling upon EphB4-Fc treatment in control cells resulted in a robust internalization up to 73.46±4.18% of 
total VEGFR2, whereas in the ephrinB2-deficient cells only 18.13±7.83% of the receptor was internalized. In 
comparison to the control cells, significant reduction in the level of internalized VEGFR2 reaching only 
33.35±5.43% upon EphB4-Fc treatment was observed in ephrinB2
∆V/∆V
 mutant cells. On the contrary, in the 
EphB4-Fc stimulated ephrinB2
5Y/5Y 
mutant cells up to 66.64±4.75% of VEGFR2 was internalized following 
EphB4-Fc treatment. Error bars represent SEM. Two-tailed t-test, n=4 independent experiments, ** P<0.01, 
*** P<0.001).        
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 Induction of VEGFR2 internalization by EphB4-Fc-mediated ephrinB2 activation was 
further confirmed using surface biotinylation assay developed to assess internalization of 
surface receptors in live tissues. Briefly, mouse cortical slices were kept alive in artificial 
cerebro-spinal fluid buffer and surface proteins were labeled with biotin prior to stimulation 
with pre-clustered EphB4-Fc or hFc as a control. Remaining cell surface-bound biotin was 
stripped off before preparation of tissue lysates. Biotinylated proteins endocytosed 
intracellularly were pulled down with Neutravidin sepharose and levels of internalized 
VEGFR2 were detected with immunoblot analysis. Following EphB4-Fc stimulation a 
substantial increase in the amount of internalized VEGFR2, as compared with only hFc 
treatment, was observed in wild type control tissues. The effect of ephrinB2 activation on 
VEGFR2 internalization was completely inhibited in ephrinB2
∆V/∆V
 mutant (Fig. 6-16). 
Unaltered level of Tie2, a receptor tyrosine kinase that is also important for vascular 
development, upon EphB4-Fc stimulation in both wild type and ephrinB2
∆V/∆V
 mutant (Fig. 6-
16) suggests that ephrinB2 specifically induces internalization of VEGFR2 but not of other 
angiogenic receptors.   
    
 
Figure 6-16. The effect of ephrinB2 activation on VEGFR2 trafficking was confirmed in live tissue. An 
ex vivo surface biotinylation assay was employed to examine the capability of activated ephrinB2 to trigger 
internalization of VEGFR2 in lived tissues. Biotinylated internalized receptors from ephrinB2
V/V (eB2∆V) 
and wild type littermate (ctrl) cortical slices, prepared from newborn (P7-9) pups, were pulled down with 
Neutravidin beads following EphB4-Fc or only Fc stimulation. Levels of internalized VEGFR2 and Tie2 were 
assessed by western blot. VEGFR2 was not internalized in the ephrinB2
V/V mutant tissue and Tie-2 
receptor trafficking was not affected by EphB4-Fc stimulation. 
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6.2.4. Kinetics of ephrinB2-induced VEGFR2 internalization 
 Kinetics of VEGFR2 internalization following activation of ephrinB2 by EphB4-Fc 
was studied by using surface biotinylation assay in MECs. VEGFR2 was robustly 
endocytosed only after 10 min in the presence of EphB4-Fc (Fig. 6-17). Gradual reduction in 
the levels of endocytosed receptor could be observed at 30 min and 60 min after EphB4-
stimulation (Fig. 6-17). This is most likely due to receptor degradation as has previously 
been reported (Lampugnani et al., 2006). In consistence with the cortical slice biotinylation, 
internalization level of Tie2 in endothelial cells was not altered by EphB4-Fc stimulation (Fig. 
6-17). The impairment of VEGFR2 internalization previously seen in ephrinB2
∆V/∆V
 mouse 
brain tissues (Fig. 6-16) was as well consistently observed in the mutant primary endothelial 
cells. The unaltered level of internalized VEGFR2 in ephrinB2
∆V/∆V 
cells following 30 min-
treatment with EphB4-Fc, as compared with hFc treatment (Fig. 6-17), indicates that in 
absence of its PDZ target site ephrinB2 is unable to trigger endocytosis of VEGFR2.  
 
 
Figure 6-17 Kinetics of VEGFR2 internalization following ephrinB2 activation in endothelial cells. 
Internalization of VEGFR2 in primary endothelial cells after ephrinB2 activation by EphB4-Fc was assessed 
using a cell surface biotinylation assay. MECs from wild type (control) or ephrinB2
V/V (eB2∆V) mice were 
stimulated at different time points as indicated. Tie-2 receptor trafficking was not affected by ephrinB2 
activation. VEGFR2 internalization was not induced by EphB4-Fc treatment in ephrinB2
V/V endothelial 
cells. 
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6.2.5. VEGFR2 and ephrinB2 are potential interaction partners  
 In line with the direct control of VEGFR2 endocytosis by ephrinB2, clusters of 
activated ephrinB2 were largely co-localized with VEGFR2 at the plasma membrane pf 
primary endothelial cells following stimulation with VEGF (Fig. 6-18a). EphrinB2 at the cell 
surface was visualized with EphB4-Fc and fluorochrome-conjugated anti-human Fc 
antibody. Surface VEGFR2 was labeled with an antibody raised against the receptor 
extracellular domain. Furthermore, ephrinB2 and VEGFR2 in new born mouse brains were 
co-immunoprecipitated (Fig. 6-18b). Together, these results suggest that VEGFR2 and 
ephrinB2 form signaling complex to exert their collaborated function in endothelial cells. 
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Figure 6-18 EphrinB2 and VEGFR2 co-localized at the cell membrane and co-immunoprecipitated. a, 
Primary endothelial cells were stimulated with VEGF for 10 min. After fixation, cell surface ephrinB2 stained 
with EphB4-Fc is shown in green and cell surface VEGFR2 detected with VEGFR2 extracellular domain-
specific antibody is shown in red. Higher magnifications figures from the areas indicated with white box are 
shown in the lower panel. Scale bars: 25 µm in upper panels and 10 µm in lower panels. b, VEGFR2 and 
ephrinB2 form complex in vivo. P4 mouse brain lysates were immunoprecipitated with anti-VEGFR2 
antibodies or an unrelated antibody as a control and analyzed for co-immunoprecipitated ephrinB2. As a 
positive control ephrinB2 was pulled down with EphB4-Fc. Data shown in b was generated by Essmann 
C.L. 
 
Taken together the results presented indicate that ephrinB2, acting through its PDZ-
dependent signaling, is a potent regulator of VEGFR2 trafficking. The next question to be 
addressed is whether this function of ephrinB2 PDZ-interactions to trigger the internalization 
of VEGFR2 from the endothelial cell surface would be relevant for the activation and 
downstream signaling of the receptor, which might also explain the vascular phenotypes 
observed before in the ephrinB2
∆V/∆V 
mutant mice.   
 
6.2.6. VEGFR2 activation is compromised in absence of ephrinB2 PDZ-
interactions 
 Upon ligand binding, VEGFR2 is dimerized and initiate trans auto-phosphorylation. 
Several tyrosine phosphorylation sites in the intracellular domain of the receptor serve as 
docking sites for the recruitment of various effector molecules to transduce receptor 
signaling. Tyrosine 1175 is known as the focal point of VEGFR2 signaling considering 
various downstream pathways that mediate diverse cellular responses upon the receptor 
activation initiated at this site. Therefore, phosphorylation at the tyrosine 1175 of VEGFR2 in 
endothelial cells lacking ephrinB2 or those bearing different ephrinB2 signaling-deficient 
mutation was firstly examined by immunofluorescence using an antibody specific for this 
phosphorylated tyrosine residue. Stimulation of control ephrinB2
lox/lox 
MECs with VEGF 
induced a substantial increase tyrosine 1175 phosphorylation within only 10 min. Of interest, 
the phosphorylation level of tyrosine 1175 in the control cells is sustained until 30 min after 
VEGF-stimulation (Fig 6-19). EphrinB2 knockout MECs, by contrast, showed barely 
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detectable level of VEGFR2 phosphorylation at both time points observed. Phosphorylation 
at this particular tyrosine residue in the cells bearing mutation in the PDZ-target site of 
ephrinB2 was reduced to the same extent as the cells lacking ephrinB2, whereas ephrinB2 
phosphotyrosine-deficient
 
cells showed similar level of VEGFR2 phosphorylation as the 
control cells (Fig. 6-19).  
 
 
 
Figure 6-19. VEGF-stimulated phosphorylation of VEGFR2 is compromised in ephrinB2
∆V/∆V
 
endothelial cells. a, EphrinB2
lox/lox 
(control), ephrinB2 knockout (ephrinB2
lox/lox
;
 
Cre
+
, eB2 KO), 
ephrinB2
∆V/∆V 
(eB2ΔV) and ephrinB2
5Y/5Y 
(eB25Y) primary endothelial cells were stimulated for 10 and 30 
min with VEGF and the levels of VEGFR2 phosphorylation were visualized by immunofluorescence with 
specific antibodies against the phosphorylated Tyr1175 in VEGFR2. Scale bar is 25 µm. b, Quantification of 
VEGFR2 Tyr1175 phosphorylation based on fluorescence intensities is shown as percentage of 
phosphorylation in each mutant compared with control cells after 30 min of VEGF treatment. EphrinB2 
knockout and ephrinB2
∆V/∆V 
cells showed severely reduced VEGFR2 phosphorylation reaching only 
24.92±3.42% and 35.59±10.03% of control cells, respectively.  EphrinB2
5Y/5Y 
mutant cells displayed up to 
95.94±5.58% of VEGFR2 phosphorylation seen in control cells. Error bar represent SEM. Two-tailed t-test, 
n=3 independent experiments, ** P<0.01, *** P<0.001.  
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Different auto-phosphorylation sites of VEGFR2 are also involved in distinct cellular 
mechanisms regulated by the receptor (see chapter 5.3.2). To examine the importance of 
ephrinB2 on the activation of VEGFR2 and subsequent initiation of signaling cascades at 
different auto-phosphorylation sites as well as to validate the results observed in cultured 
cells in an in vivo system, phosphorylation levels of tyrosine 1054, 1175, and 1212 were 
assessed in ephrinB2
∆V/∆V
 mutant mice and wild type littermates. Whole brain lysates from 
newborn mice were immunoprecipitated with limiting amount of anti-VEGFR2 antibody to 
avoid unequal amounts of the receptor being pulled out due to less vascular density in the 
mutant mice. Levels of phosphorylation at tyrosine 1054 located within the receptor kinase 
domain (Fig. 6-20a), tyrosine 1175 (Fig. 6-20b) and 1214 (Fig. 6-20c) at its carboxy-terminus 
were assessed by antibodies specific for corresponding phosphorylated tyrosine residues. 
EphrinB2
∆V/∆V
 mice showed severe
 
reduction in the tyrosine phosphorylation of VEGFR2 at 
all the sites observed, indicating that in these mutant mice that fail to efficiently internalize 
VEGFR2, activation of the receptor is also impaired.     
 
 
 
Figure 6-20. EphrinB2
∆V/∆V
 mutant 
mice show general impairment of 
VEGFR2 phosphorylation at different 
tyrosine residues. Newborn mouse 
brain tissue lysates were 
immunoprecipitated with anti-VEGFR2 
antibody or pre-immune serum as a 
control and analyzed by western blot 
with antibodies specific for 
phosphorylated VEGFR2 on Tyr1054, 
Tyr1175 or Tyr1212 as indicated. 
Western blot using anti-VEGFR2 
antibody confirmed the equal level total 
VEGFR2 in the immunoprecipitated 
fractions. Data shown in a and c were 
generated by Essmann C.L. 
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6.2.7. Endocytosis is essential for VEGFR2 downstream signaling 
 The data obtained from both in vitro and in vivo settings shown here provide the 
proof that ephrinB2 PDZ-dependent signaling is crucial for internalization as well as 
activation of VEGFR2. The next experiments were therefore aimed to examine the possible 
functional relevance of VEGFR2 endocytosis for its signal transduction. The potent inhibitor 
of dynamin-dependent endocytosis, dynasore, was administered to primary endothelial cells 
prior to stimulation with VEGF. Activation of VEGFR2 was subsequently evaluated by the 
receptor phosphorylation levels in western blot analysis of the anti-VEGFR2 
immunoprecipitated fractions. Co-treatment of VEGF with dynasore resulted in a striking 
reduction of the VEGFR2 activation assessed at different auto-phosphorylated tyrosine 
residues as compared with treatment with VEGF alone (Fig 6-21 and Fig. 6-22). These data, 
consistent with previous report (Lampugnani et al., 2006), suggest the requirement of 
endocytosis for the activation of downstream signaling of VEGFR2. 
 
 
 
 
 
Figure 6-21. Endocytic trafficking is necessary for 
VEGF-stimulated VEGFR2 phosphorylation. MECs 
were left untreated or pre-treated for 2 h with 
dynasore and subsequently stimulated for 30 min with 
VEGF. Activation of the receptor was assessed by 
immunoprecipitation of VEGFR2 from the cell lysates 
and western blot analysis of phosphorylation on 
Tyr951 and Tyr 1212 using antibodies specific to the 
corresponding phophorylated tyrosine residue of 
VEGFR2. Western blot using anti-VEGFR2 antibody 
confirmed equal level of total VEGFR2 in the 
immunoprecipitated fractions. Data was generated by 
Essmann C.L. 
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6.2.8. VEGFR2 signaling intensity and duration depend on endocytosis of 
the receptor   
 Compartmentalization of EGF receptor into endosomes has previously been 
reported to be essential for its signal transduction by prolonging the duration of signaling 
with no apparent alteration on signal intensity (Sigismund et al., 2008). To gain more insight 
into how endocytosis influences the downstream signaling of VEGFR2, its signaling kinetics 
was examined. The prominent signaling effector of VEGFR2, Akt, is known to play important 
roles in different molecular pathways involving in proliferative and migratory signals 
downstream of VEGFR2. The role of endocytosis in the activation of Akt upon VEGF 
stimulation was therefore investigated. In primary endothelial cells, VEGFR2 
phosphorylation (assessed at the tyrosine 1175) robustly occurred within only 5 min 
following VEGF stimulation. Although phosphorylation level gradually decreased after 5 min, 
certain level could still be detected 30 min after stimulation. By contrast, in the presence of 
dynasore drastically a lower level of the receptor phosphorylation was observed 5 min after 
stimulation and the level was severely reduced until barely detectable very shortly 
afterwards (Fig 6-22a). Stimulation with VEGF resulted in elevated activation of Akt 
(assessed by an antibody specific for phosphorylated Akt) reaching its peak at 30 min during 
the 30 min observation period. In line with the VEGFR2 phosphorylation, both the level of 
Akt phosphorylation and its activation time-span were greatly reduced in the cells that had 
been treated with dynasore (Fig. 6-22a). Importantly, ephrinB2
∆V/∆V
 endothelial cells also 
showed impairment in VEGF-stimulated Akt phosphosphorylation compared with control wild 
type cells (fig. 6-22b).   
 These results strongly suggest the crucial role of endocytosis to promote the 
transition of VEGFR2 to its fully activated state as well as to facilitate sustained signaling 
downstream of the receptor over a prolonged period. EphrinB2 through its PDZ-interaction 
motif most likely works as a molecular linker that bridges VEGFR2 to the endocytic 
machinery and thereby makes possible the transduction of its signal to cellular responses.    
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Figure 6-22. Activation and prolongation of signaling downstream of VEGFR2 require receptor 
endocytosis. a, MECs were left untreated or pre-treated for 2 h with Dynasore and subsequently 
stimulated for the indicated times with VEGF. Activation of the receptor was assessed by phosphorylation 
on Tyr1175 in total cell lysates. VEGFR2 downstream signaling was assessed by level of Akt 
phosphorylation. Inhibition of endocytosis causes a drastic decrease of VEGFR2 phosphorylation and 
impairment of its signal transduction, affecting both intensity and duration of the signaling. b, VEGFR2 
signaling is defective in ephrinB2
V/V endothelial cells. MECs isolated from ephrinB2
V/V (eB2V) or control 
wild type mice were left untreated or stimulated with VEGF for the indicated times. VEGFR2 downstream 
signalling was assessed by Akt phosphorylation. Total levels of VEGFR2 and Akt in the lysates were used 
as loading control. Data generated by Essmann C.L.  
 
 
 
6.3. EphrinB2 regulates endothelial tip cell filopodial extension by 
triggering VEGFR2 internalization 
 The finding of the novel role of ephrinB2 to mediate internalization of VEGFR2 
together with the reported function of VEGFR2 in control of tip cell sprouting activity urge an 
appealing assumption that the regulation of filopodial extension by ephrinB2 might involve its 
capability to trigger VEGFR2 endocytosis and downstream signaling. To test this, a short-
term culture system of explanted retinas was developed. Briefly, retinas were dissected from 
P4-5 pups and flat-mounted onto hydrophilic membrane filter with the nerve fiber layer 
facing the membrane. Cultured medium was layered under the filter. Retina explants were 
incubated for 2-4 h for recovery. Stimulation of acute tip cell responses was carried out for 
4h by addition of exogenous stimulators and/or inhibitor into the medium. 
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6.3.1. VEGF-induced extension of endothelial tip cell filopodia requires 
receptor endocytosis 
 Explanted retinas robustly responded to stimulation with VEGF as evidenced by the 
drastic increase in number of filopodial extensions at the sprouting front of vascular bed (Fig. 
6-23). This observation confirms the cellular function of VEGFR2 as a pivotal regulator of 
actin dynamic and guided migration of endothelial tip cells. Simultaneous treatment of 
explanted retinas with VEGF and dynasore dampened the stimulatory effect of VEGF and 
caused the reduction in number of filopodial extensions to almost the basal level when no 
stimulant was presented (Fig. 6-23), demonstrating the crucial requirement of endocytosis 
for VEGFR2 function at the endothelial tip cell. 
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Figure 6-23 Acute stimulation of explanted retina with VEGF induces tip cell filopodial extension in 
an endocytosis-dependent manner. a, P4 retina explants were stimulated with VEGF or simultaneously 
treated with VEGF and Dynasore for 4 h. Vessels were stained with isolectin-B4 and filopodial extension 
along the length of the sprouting front was analyzed. In the lower panels are high magnification pictures of 
the same vascular beds shown in the upper panels. Green dots indicate filopodia and red lines show the 
length of vascular front. Scale bars represent 25 µm. b, Quantification of filopodial extension per vessel 
length revealed an average of 18.21±1.34 filopodia per 100 µm of vessel length in the untreated control 
which was increased up to 37.39±1.6334 filopodia per 100 µm of vessels after VEGF-stimulation. In the 
presence of Dynasore, VEGF-stimulation failed to promote filopodial extension. Only 20.99±2.69 filopodia 
per 100 µm vessel length (in average) was observed following the co-treatment of Dynasore and VEGF. 
Error bars represent SEM. Two-tailed t-test, n=10-12 retinas in each condition, *** P<0.001.  
  
 
6.3.2. Activation of ephrinB2 signaling is sufficient to rescue compromised 
filopodial extension caused by VEGF deprivation  
 In agreement with the evidences presented above that point out to a crucial 
requirement of ephrinB2 PDZ-interactions for VEGFR2 endocytosis and activation of its 
downstream signaling, stimulation of ephrinB2 reverse signaling in explanted retinas with 
EphB4-Fc resulted in a significant increase in the extension of filopodial structures at the 
leading front of vascular network (Fig. 6-24). The effect following EphB4-Fc stimulation was 
similar to the cellular response observed upon VEGF-stimulation (Fig. 6-23). To further 
verify the entwined relation between VEGFR2 and ephrinB2 signaling cascades and the 
dependency of the former on the latter to exert its function particularly in the endothelial tip 
cells, the ability of ephrinB2 to trigger activation of VEGFR2 signaling and consequently 
rescue the cellular outcome of inactivated VEGFR2 was examined. 
 
 
 
Figure 6-24. Activation of ephrinB2 induces tip cell filopodial extension in explanted retinas. a, P4 
retina explants were stimulated with pre-clustered EphB4-Fc or hFc for 4h. Vessels were stained with 
isolectin-B4 and filopodial extension at the sprouting front was analyzed. In the lower panel are high 
magnification pictures of the upper panel. Green dots indicate filopodia and red lines show the length of 
vascular front. Scale bars represent 25 µm. b, In the control condition in which only Fc was presented, 
retina explants exhibited 19.27±3.13 filopodia per 100 µm of vessel length (in average). Upon stimulation 
with EphB4-Fc, filopodia extension was increased up to an average of 29.83±1.81 per 100 µm of vessels. 
Error bars represent SEM. Two-tailed t-test, n=10-12 retinas in each conditions, ** P<0.001.  
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Soluble VEGFR1 extracellular domain-Fc fusion protein (sFlt1) has previously been 
shown to efficiently inhibit VEGFR2 activation. The mode of action of this inhibitor is based 
on its higher VEGF-binding affinity as compared with VEGFR2, which therefore make it an 
efficient competitor to bind and seclude VEGF from VEGFR2. Intraoccular injection of sFlt1 
has previously been reported to cause a complete retraction of endothelial tip cell filopodia 
at the sprouting front of retinal vasculature (Gerhardt et al., 2003). Similarly, deprivation of 
VEGF and thus inhibition of VEGFR2 activation by sFlt1 treatment abrogated extension of 
filopodia in explanted retina vessels (Fig. 6-25). Importantly, co-treatment of sFlt1 with 
EphB4-Fc to activate ephrinB2 reverse signaling was able to diminish the inhibitory effect of 
sFlt1 and rescue filopodial extension in the explants (Fig. 6-25), underscore the credible role 
of ephrinB2 as a prime regulator of VEGFR2 internalization and activation of its downstream 
signaling to control the active sprouting activity of endothelial tip cells.        
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Figure 6-25 EphrinB2 activation rescues tip cell filopodial dynamics following VEGF sequestering. a, 
P4 retina explants were simultaneously treated with soluble Flt-1 (sFlt1) and hFc or sFlt1 and EphB4-Fc for 
4h. Vessels were visualized by isolectin-B2 staining and filopodial extension at the sprouting front was 
analyzed. In the lower panels are high magnification pictures of the same vascular beds shown in upper 
panels. Green dots indicate filopodia and red lines show the length of vascular front. Scale bars represent 
25 µm. b, Quantification of number of filopodial processes per vessel length is shown in average values. 
Retinal explants treated with sFlt1 and hFc showed 13.01±1.33 filopodia per 100 µm of vessels. In the 
presence of EphB4-Fc number of filopodia was increased to 25.46±1.92 per 100 µm of vessels. Error bars 
represent SEM. Two-tailed t-test, n=10-12 retinas in each conditions, *** P<0.0001.  
 
 
 
6.4. EphrinB2 PDZ-signaling in endothelial cells influences tumor growth 
by regulating tumor angiogenesis 
 Tumors are long known to trigger angiogenic growth of blood vessels in host organs 
in order to attain oxygen and nutrients sufficient to supply rapid growth of tumor masses as 
well as to gain access to remote tissue by intravasation into the blood stream through these 
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abnormally developed hyperdilated vessels. Secretion of VEGF as evident in a number of 
different tumor types is the well-known mechanism by which tumors induce vessel sprouting. 
VEGF production is also dependent on oxygen levels in the microenvironments. Under 
hypoxic conditions such as the ones found when tumor masses are overgrown and oxygen 
supply from the existing vascular system cannot compensate for such rapid growth rate, 
VEGF expression is upregulated to attract vessel outgrowth toward the hypoxic areas by 
acting through VEGFR2 abundantly expressed in the vascular endothelium. Since our 
previous data has identified ephrinB2 PDZ-dependent signaling in collaboration with 
VEGFR2 to control the extension of tip cell filopodia during guided migration of developing 
vessels, it is appealing to speculate that similar signaling mechanism downstream of 
ephrinB2 might also be involved in VEGFR2 function during tumor angiogenesis.        
 
 
6.4.1. Blockade of ephrinB2 PDZ-signaling decreases brain tumor growth 
and reduces angiogenic sprouting of tumor vasculature 
 To address the role of ephrinB2 reverse signaling via PDZ-interactions on tumor 
progression, an orthotopic glioma tumor model was employed. Firstly, the high grade 
syngenic astrocytomas were generated according to a previous report where this tumor 
model has been proved to be a successful tool to reveal the functional significance of HIF 
and VEGF in tumor angiogenesis and progression (Blouw et al., 2003). In brief, astrocytes 
isolated from new born mice were immortalized by stable transfection with SV40 large T 
antigen. The immortalized astrocytes were subsequently transformed into astrocytomas by 
viral transduction of constitutively active H-ras (V-12H-ras). Colonies that grew in selective 
media were checked for expression of SV40 large T antigen and V-12H-ras by western blot 
analysis (Fig. 6-26).  
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Figure 6-26 Characterization of high grade 
astrocytomas. Expression of SV40 large T antigen 
(a) and V-12H-ras (b) in syngenic astrocytomas was 
analyzed by western blot using corresponding 
antibodies. High levels SV40 large T antigen and 
V12H-ras were detected in all the astrocytoma clones, 
but not in the primary astrocytes which were used as 
negative control.    
 
A pool of several astrocytoma clones expressing high level of SV40 large T antigen 
and V12H-ras were injected intracranially into ephrinB2
∆V/∆V 
mice and wild type littermates of 
the same crossing generation as those mice from which the cells were generated to 
preserve the same genetic background and avoid an immune rejection. Intracranial tumor 
growth in ephrinB2
∆V/∆V 
mutant mice was severely reduced reaching less than 25% of control 
tumors grown in wild type littermates (Fig. 6-27).  
Figure 6-27 Intracranial astrocytoma growth is reduced in ephrinB2
ΔV/ΔV 
mice compared with wild 
type littermates. a, Tumors grown in ephrinB2
ΔV/ΔV
 (eB2 ΔV/ΔV) mutant mice or wild type littermates 
(control) were stained with hematoxylin-eosin (HE). Scale bar represent 1 mm. b, Quantification using a 
semi-automated stereological system revealed an average tumor volume of 24.38±4.61 mm
3
 in control 
animals and 5.82±0.19 mm
3 
in ephrinB2
ΔV/ΔV
 mutants. Error bars represent SEM. Two-tailed t-test, n=7-11 
tumors from each genotype, * P<0.05. Astrocytomas injection and analysis of tumor volumes were 
performed by Siedel S.  
                                                                                                     6. Results 
 
90 
 
The stunted tumor growth in ephrinB2
∆V/∆V
 mice was associated with striking 
reduction of tumor vascularization as reflected by quantification of the vascular density from 
the endothelial marker CD34-positive areas within tumor beds (Fig. 6-28c). Similar reduction 
in the perfused vascular area (marked by intravascular lectin) revealed that functional 
vessels in tumors grown in ephrinB2
∆V/∆V
 mice were as well decreased (data not shown). 
Morphologically, the vasculature of control tumors was hyperdilated and torturous (Fig. 6-
28a), reflecting the unusual high level of pro-angiogenic stimulants that shift the balance in 
the angiogenesis program in favor of vessel expansion and therefore hinder maturation 
processes. Vascular sprouts and filopodial extensions were readily detectable on these 
tumor vessels (Fig. 6-28b). By contrast, the vasculature of tumors grown in ephrinB2
∆V/∆V
 
mice was less torturous and resembled the normal brain vessels found under physiological 
conditions (Fig. 6-28a). Importantly, similar to the angiogenic sprouting defects observed in 
ephrinB2
∆V/∆V
 mutant retinas, the filopodia-rich newly formed vascular sprouts were barely 
detectable in these tumors (Fig. 6-28b). This data points out the important role of ephrinB2 
PDZ-dependent signaling in tumor-induced angiogenic sprouting and tumor growth.  
 
 
 
 
 
 
 
 
 
 
Figure 6-28 Angiogenic sprouting of intracranial astrocytomas grown in ephrinB2
∆V/∆V mice is 
impaired. a, Vascularization of astrocytomas grown in ephrinB2
∆V/∆V
 (eB2 ∆V/∆V) mutant mice  and wild 
type littermates (control) were assessed by CD34 staining. b, Higher magnification images of tumor vessels 
show vascular sprouts. Arrows point to filopodial extensions in the tumor vessels. Note the smooth and 
normalized vessels in the ephrinB2
∆V/∆V
 mutants. Scale bars represent 100 µm in a and 25 µm in b. c, 
Quantification of vessel density is based on the area covered by vessel staining and shown in average 
percentages. Control tumors showed 12.78±0.77% vessel density, whereas ephrinB2
∆V/∆V
 mutant tumors 
had only 7.64±0.65% of vascularized area. Error bars represent SEM, Two-tailed t-test, n=7-11 tumors from 
each genotype, * P<0.05. Data generated by Siedel S. 
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6.4.2. Endothelial-specific loss of ephrinB2 is sufficient to inhibit tumor 
angiogenesis 
 Given the global expression of ephrinB2∆V protein in the mutant mice, the effects on 
tumor growth and vascularization could not yet be pinpointed to reflect a direct role of 
ephrinB2 in endothelial cells. To assess tumor growth in the context of endothelial specific 
ephrinB2 deficiency Gl261 astrocytomas were injected intracranially in the tamoxifen-
inducible endothelial specific ephrinB2 knockout mice (tamoxifen-treated ephrinB2
loxP/loxP
; 
VE-Cadherin-CreER2
+
,
 
ephrinB2
i∆EC
) and control littermates (ephrinB2
WT/loxP
;
 
VE-Cadherin-
CreER2
-
 treated with tamoxifen). The severe reduction of tumor growth in the ephrinB2
∆V/∆V
 
mutant mice was reproducible in the endothelial-specific ephrinB2 deficient mice (Fig. 6-29). 
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Figure 6-29 Endothelial-specific ephrinB2 knockout mice show arrested intracranial tumor growth. 
a, Intracranial growth of Gl261 astrocytomas was reduced in mice with an endothelial-specific tamoxifen-
inducible ephrinB2 loss-of-function (ephrinB2
i∆EC
) as compared with tumors grown in control littermates. 
Tumors were stained with hematoxylin-eosin (HE). Scale bar represent 1 mm. b, Quantification of tumor 
volumes revealed a substantial reduction from an average of 8.48±0.89 mm
3
 in control mice to 3.37±0.36 
mm
3
 in ephrinB2
i∆EC
 mice. Error bars represent SEM, Two-tailed t-test, n=8-9 tumors from each genotype, 
*** P<0.001. Tumor injection and analysis of tumor volumes were performed by Siedel S. 
 
 
Moreover, in consistent with the impairment in angiogenic sprouting of the tumor 
vasculature seen in ephrinB2
∆V/∆V
 mice, a drastic reduction in tumor vascular density (Fig. 6-
30c) as well as morphologically similar vessels which were smooth and devoid of sprouts 
(Fig. 6-30a, b) were also observed in tumors grown in endothelial-specific ephrinB2 
knockout mice. These results suggest the cell-autonomous endothelial-specific function of 
ephrinB2 in the regulation of tumor angiogenesis.   
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Figure 6-30 EphrinB2 function during pathological sprouting angiogenesis is endothelial cell 
specific. a, Vascularization of intracranial tumors grown in endothelial-specific ephrinB2 knockout mice 
(ephrinB2
i∆EC
) and control littermates was examined by immunostaining with CD34. b, High magnification 
images show detailed morphology and spouting activity of tumor vessels readily observed by the extension 
filopodial processes (indicated with black arrowheads). Scale bars represent 100 µm. c, Quantification of 
vessel density based on area of tumor masses covered by vessel staining revealed an average of 
11.61±0.60% and 5.08±0.24% of vessel coverage in control and ephrinB2
i∆EC
 tumors, respectively. Error 
bars represent SEM. Two-tailed t-test, n=5 tumors from each genotype, ** P<0.01. Data generated by 
Siedel S.  
 
6.4.3. Pathological angiogenesis in different vascular beds are commonly 
controlled by ephrinB2 
 The effect of the disruption of ephrinB2 PDZ-signaling on tumor angiogenesis was 
also observed in different vascular beds as evidenced in the analysis of a heterotopic tumor 
model. Astrocytomas subcutaneously injected in ephrinB2
∆V/∆V
 mice formed substantially 
smaller tumors as compared with tumors grown in wild type littermates (Fig. 6-31). 
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Figure 6-31 Subcutaneous tumor growth is reduced in ephrinB2
ΔV/ΔV 
mice compared with wild type 
littermates. a, Astrocytomas grown in ephrinB2
∆V/∆V
 (eB2 ∆V/∆V) mice and wild type littermates (control) 
were stained with hematoxylin-eosin (HE). Scale bar represent 100 µm. b, Quantification of tumor volume 
by a semi-automated stereological system showed that tumors in ephrinB2
∆V/∆V
 mutant mice only grew up to 
244.42±31.69 mm
3
, whereas tumors grown in control animals reached the size of 707.50±92.87 mm
3 
(in 
averages). Error bars represent SEM. Two-tailed t-test, n=15-17 tumors from each genotype, *** P<0.001. 
Tumor injection and analysis of tumor volumes were performed by Siedel S.    
 
 
 
Concurrently, analysis of tumor vascularization revealed decrease in vessel density 
in the tumors grown under the skin of ephrinB2
∆V/∆V
 mutant mice (Fig. 6-32c). Tumor vessels 
in these mutant mice were also less tortuous and lacked the filopodia-extending vascular 
sprouts (Fig. 6-32a, b).  
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Figure 6-32 Angiogenesis is impaired in tumors developed subcutaneously in ephrinB2
∆V/∆V
 mutant 
mice. a, Vasculature of subcutaneous tumors grown in ephrinB2
∆V/∆V
 (eB2 ∆V/∆V) mutant mice and wild 
type littermates (control) were labeled by CD34 staining. b, Higher magnification images showed active 
filopodial sprouting as indicated by black arrowheads, observed in control but not ephrinB2
∆V/∆V
 mutant 
tumors. Scales bars: a, 100 µm and b, 25 µm. c, Quantification of vessel density is based on area of tumor 
masses covered by vessel staining. Tumors of control animals showed an average of 15.85±0.97% 
vascular coverage, in comparison to tumors grown in ephrinB2
∆V/∆V
 mutant animals in which only 
5.45±0.52% of tumor area was vascularized. Error bars represent SEM. Two-tailed t-test, n=8 tumors from 
each genotype, *** P<0.001. Data generated by Siedel S. 
 
These data demonstrate the significant function of ephrinB2 through PDZ-dependent 
signaling as a potent regulator of active angiogenic sprouting not only in normal 
development, but also in tumor-induced pathological growth of blood vessels and thereby 
influencing tumor progression.  
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Figure 7-1 Role of ephrinB2 in endothelial tip cell. EphrinB2 
expressed at the tip cell filopodia regulates endocytosis and 
signaling to control filopodia extension and guided migration of 
vascular sprouts. Black line; plasma membrane; black circle, 
endocytic vesicle; yellow circle marked with P, phosphorylated 
tyrosines at the intracellular domain of VEGFR2.  
 7. Discussion 
Eph/ephrin bi-directional signaling has been widely appreciated as one of the most 
important guidance cue in charge of directing axonal growth cones to their appropriate 
targets during the wiring of the complex neural circuits. The work presented in this 
dissertation has identified a novel function of ephrinB2 reverse signaling via PDZ-
interactions in the control of endothelial tip cells sprouting activity during angiogenic growth 
of blood vessels in both physiological and pathological settings. Molecularly, ephrinB2 exerts 
its function in concert with the pivotal angiogenesis regulator VEGFR2 by controlling the 
receptor endocytosis and its subsequent signal transduction.  
Directional migration guided by receptors -localized at the surface of migrating cells- 
and their cognate ligands presented in the extracellular matrix or guidepost cells along the 
migration routes is tightly 
regulated by receptor 
endocytosis (Jekely et al., 2005; 
Palamidessi et al., 2008). 
Intracellular 
compartmentalization and 
recycling of surface RTKs has 
been proposed to ensure 
localized intracellular responses 
to guidance cues by spatially 
restricting signaling activation 
(Jekely et al., 2005; Palamidessi 
et al., 2008). The results 
presented here reinforce such a 
model of RTK-mediated guidance 
event during the outgrowth of 
newly formed vascular sprouts. Activation of ephrinB2 promotes VEGFR2 endocytosis which 
allows the proper spatial activation and signaling downstream of the receptor at the 
endothelial tip cell filopodia (Fig 7-1). The appropriately localized activation of VEGFR2 at 
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the tip cell filopodia might stabilize the contact to perivascular cells such as astrocytes and 
help to direct the oriented migration of endothelial cells.  
The finding of the defective angiogenesis in tumors injected in mice with disrupted 
ephrinB2 PDZ-signaling suggests a general mechanism by which ephrinB2 plays a key role 
to control VEGFR2 function during normal development as well as pathological conditions. 
In addition, the function of ephrinB2 as a regulator of VEGFR trafficking might not be 
restricted only to VEGFR2. VEGFR3, the major regulator of lymphangiogenesis whose role 
in active angiogenesis of blood vasculatures in both developmental and pathological settings 
has recently been revealed (Tammela et al., 2008), has been shown to internalized from the 
plasma membrane in an ephrinB2-dependent manner (Wang et al.). 
Blockade of ephrinB2 signaling to simultaneously interfere both with VEGFR2 and 
VEGFR3 functions might therefore represent an intriguing alternative of anti-angiogenic 
treatment for tumor therapy.       
 
7.1. VEGFR2 internalization is required for the full activation of 
downstream signaling 
 The concept that cell surface receptors could activate their downstream signaling 
intracellularly has been supported by continuously growing evidences from various 
receptor/ligand systems. Internalization of VEGFR2 was previously believed to only direct 
the surface receptor to the intracellular degradation machinery and thereby serve as a 
desensitizing mechanism to control cellular responses to VEGF stimulation. In contrast to 
this earlier dogma, Lampugnani et al. has shown that internalized VEGFR2 remained 
activated and its signaling activity, as assessed by activation of p44/42 MAPK, was 
sustained. Furthermore, association of VEGFR2 with the adherens junction protein VE-
Cadherin inhibits VEGFR2 internalization and reduces its downstream mitogenic signaling 
activity (Lampugnani et al., 2006). In accord to this study, Lee et al. reported an endogenous 
VEGF signaling pathway that is crucial for vascular homeostasis. Genetic deletion of VEGF 
specifically in endothelial cells causes increased cell death leading to catastrophic 
circulatory collapse and death of these mutant mice. Exogenous VEGF is unable to 
compensate for the absence of autocrine endothelial VEGF. In addition, phosphorylation of 
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VEGFR2 is suppressed by a small molecule antagonist that can freely enter the cell, but not 
by an extracellular VEGF inhibitor, suggesting that activation of the receptor is likely to occur 
intracellular (Lee et al., 2007). The data presented in this dissertation not only underscore 
the crucial role of endocytosis in VEGFR2 signaling, but also provide for the first time an 
evidence of the control of the receptor migratory signal by endocytosis during the angiogenic 
sprouting process. Moreover, ephrinB2 is identified here as a key player in the regulatory 
mechanism that controls VEGFR2 endocytosis. 
 The results presented here demonstrate the striking reduction of VEGFR2 
phosphorylation observed in all the major autophosphorylation sites when the receptor 
endocytosis is inhibited by the dynamin inhibitor, dynasore, as well as in mutant mice lacking 
ephrinB2 PDZ-dependent signaling. Activation of Akt, a well-known downstream effector of 
VEGFR2, is also suppressed in a similar manner. These results point out the crucial 
importance of endocytosis for the full activation of VEGFR2 and its downstream signals. It 
has previously been proposed that retaining of VEGFR2 at the cell surface makes the 
receptor accessible to protein tyrosine phosphatases and therefore leads to the 
dephosphorylation of the receptor and inhibition of its downstream signaling (Lampugnani et 
al., 2006; Mattila et al., 2008). Two tyrosine phosphatases have been implicated in the 
VEGFR2 dephosphorylation. The transmembrane phosphatase DEP-1 (Density-enhanced 
phosphatase 1, also known as CD148) is associated with VE-Cadherin and VEGFR2 
complex at the cell-cell junctions (Borges et al., 1996; Carmeliet et al., 1999).  DEP-1 
regulates VE-Cadherin-mediated contact inhibition of endothelial cell proliferation via the 
dephosphorylation of VEGFR2 (Lampugnani et al., 2002). In vivo, DEP-1 knockout mice 
exhibit early lethality due to defective vascular development associated with increased 
endothelial cell proliferation (Takahashi et al., 2003). It will be very interesting to study, using 
the conditional deletion of DEP-1, to which extent this phosphatase is regulating the function 
of VEGFR2 during sprouting angiogenesis in the retina and in tumor settings. Another 
phosphatase, T-cell protein tyrosine phosphatase (TCPTP) that, despite its name, is widely 
expressed in several cell types (Alonso et al., 2004) has also been shown to involve in 
control of VEGFR2 signaling. In response to α1β1 integrin-mediated cell adhesion to 
collagenous matrix TCPTP is translocated from the nucleus to the cytoplasm (Mattila et al., 
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2005). Overexpression of constitutively active TCPTP could bind to and dephosphorylate 
VEGFR2 and prevent its internalization in an in vitro model. Activation of TCPTP by the 
cytoplasmic tail of collagen-binding integrin α1 inhibited endothelial cell migration (Mattila et 
al., 2008). This inhibitory function of TCPTP has been proposed to be important for the 
maturation of newly developed vessels. Activation TCPTP by intergrin α1β1 upon binding to 
collagen-rich newly generated endothelium basement membrane could possibly inhibit 
VEGFR2 activation and thereby attenuate the invasive activity of endothelial cells (Mattila et 
al., 2008). TCPTP-deficient mice die shortly after birth from an inflammatory phenotype due 
to impaired immune system (You-Ten et al., 1997). The survival of these mice over the 
course of embyogenesis suggests that TCPTP is not crucial for vasculogenesis. Its 
involvement in angiogenesis is, however, have not yet been examined in vivo,  
Interestingly, DEP-1 has been shown to target specifically the tyrosine residues 
within the kinase activation loop of VEGFR2, Tyr1054/1059, but not other 
autophosphorylation sites (Chabot et al., 2009). These phosphorylation sites have also been 
reported to be substrates of TCPTP (Mattila et al., 2008). Phosphorylation at these tyrosine 
residues seems to be required for maximal level of the receptor kinase activity (Kawamura 
et al., 2008). The observations on decreased internalization of VEGFR2 in the presence of 
DEP-1 and constitutively active TCPTP as well as the previous report of the delay VEGF-
induced receptor internalization upon heterotropic expression of VEGFR2 in which tyrosine 
1054 and 1059 were mutated to phenylalanine (Dougher and Terman, 1999), suggest that 
certain level of VEGFR2 phosphorylation at least at the tyrosine residues in its kinase 
activation loop might be a prerequisite for the initiation of receptor internalization. Once 
endocytosed into the intracellular compartments, VEGFR2 is fully activated and signaling 
effectors are recruited to transducer its signal to various cellular responses.    
 
7.2. Endocytosis and spatial distribution of VEGFR2 during guided 
migration  
Growing evidences support that endocytosis provides an intracellular platform to 
control signal specificity, amplitude, and timing. Endocytosis not only  regulates  the 
intracellular signaling components availability to surface receptors (Murphy et al., 2009; 
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Figure 7-2 Possible role of endocytosis in control of 
localization and intensity of VEGFR2 signaling. VEGFR2 
localized at the cell surface are activated upon VEGF 
binding. Receptors remained at the plasma membrane are 
deactivated by phosphatases, whereas those internalized 
into intracellular compartments become fully activated. 
Recycling of activated receptors in the endocytic vesicles 
back to the cell surface might facilitate relocation of the 
receptors to specified regions as well as enhancement of 
signaling strengths. Pink circles marked with P represent 
phosphorylated tyrosines.    
Sadowski et al., 2009) but also restricts  spatially certain signaling events as evidenced for 
example in the Drosophila 
PDGF/VEGF receptor- and Rac1-
mediated cell migration (Jekely et al., 
2005; Palamidessi et al., 2008). 
These previously reported data 
together with the result presented 
here urge a model of space-restricted 
signaling of VEGFR2 and other RTKs 
that is operated by the endocytic 
machinery (Fig. 7-2). In the presence 
of its ligand along the migration 
routes, VEGFR2 is initially activated 
and internalized into endocytic 
vesicles. Remaining surface 
receptors are inactivated by 
membrane-associated 
phosphatases, whereas endocytosed 
receptors become fully activated. 
Subsequent recycling of the 
endocytic vesicles allow 
relocalization and generation of 
localized pools of active receptors to 
specific regions where signaling is 
required.  Interaction with 
downstream signaling adaptors 
specifically located in diverse 
endocytic vesicles might control the restricted spatial activation of certain signaling cascades 
which will result in diverse cellular responses. 
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7.3. EphrinB2 and VEGFR2 in control of tip cell filopodial extension 
 The long and thin plasma membrane protrusion, supported by paralleled actin 
bundles, of the filopodial process has generally been described as an antennae used by 
cells to probe their microenvironment. The best known fundamental role of filopodia is to 
direct cellular orientation during guided migration. Diverse signaling receptors for different 
extracellular matrix molecules are found in filopodia, supporting its role as a signal 
transduction site where cell surface receptors transfer signaling information from the cell 
surrounding to activate cellular responses required for migration (Mattila and Lappalainen, 
2008). Filopodial processes extended from endothelial tip cells at the sprouting front of the 
developing retinal vasculature are enriched with VEGFR2.  This has been proposed to 
function as a molecular sensor for VEGF gradients secreted from the astrocytic network into 
the surrounding matrix and lead to the migration of endothelial sprouts towards the 
avascular area (Gerhardt et al., 2003). The retina explant assay developed in this study is 
proven a very useful tool to investigate acute responses of endothelial tip cells at the 
sprouting front of the vascular bed, following exposure to different stimuli. This, of course, 
allows further insights into the molecular mechanisms involved in the filopodial sprouting 
function of VEGFR2. Numerous filopodia are sprouted out from the vascular front of 
explanted retinas upon treatment with VEGF. VEGF sequestering, by contrast, results in a 
severe impairment of filopodial extension, an effect which can be mimicked by blockade of 
dynamin-dependent endocytosis. Similar to VEGF administration, stimulation of ephrinB2 
signaling can also promote filopodial sprouting and activated ephrinB2 is able to rescue the 
sprouting activity of explanted retina vessels following VEGF blockade. These data, and 
several other evidences provided in this study, demonstrate for the first time the crucial 
importance of endocytosis in the regulation of VEGFR2-mediated sprouting activity of 
endothelial tip cells and furthermore indentify ephrinB2 as an indispensable molecular 
linkage between these events. The next question to be clarified is what signaling events 
operated downstream of VEGFR2 upon its endocytosis from the cell surface is in charge of 
the filopodial extension process. For example, possible targets for VEGFR2 activation could 
be the convergence of F-actin during the formation of filopodial core actin bundles as well as 
signaling events controlling the adhesion of filopodial protrusions to the extracellular matrix. 
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Regulation of actin dynamic by VEGFR2 signaling Several molecules activated 
downstream of VEGFR2 upon VEGF binding have been shown to directly modulate cell 
migration by affecting actin cytoskeleton dynamics. IQGAP1, whose name derives from the 
presence of calmodulin-binding IQ motifs and a region with sequences similarity to Ras 
GTPase activating proteins (GAPs), is an actin-binding protein which represents a prime 
candidate for VEGFR2-modulation of migratory behavior. IQGAP1 has a well established 
function as an activator of Cdc42 and Rac1 by inhibiting their GTPase activity and thereby 
stabilizing their active GTP-bound form (Hart et al., 1996; Noritake et al., 2004). A potent-
actin assembling machinery involving the diaphanous formin (Dia), which is known to 
promote the formation of linear actin filaments through possessive barbed-end elongation 
(Goode and Eck, 2007), might require binding of Dia1 to IQGAP1 to release Dia1 from its 
autoinhibitory conformation (Brandt and Grosse, 2007). In agreement with this notion, 
activation of cdc42 by IQGAP1 has been shown to induce formation of filopodia (Swart-
Mataraza et al., 2002). It has been reported that VEGF stimulation induced physical 
interaction between IQGAP1 and phosphorylated VEGFR2. This association leads to 
tyrosine phosphorylation of IQGAP1 and induction of migratory and mitogenic responses in 
endothelial cells (Yamaoka-Tojo et al., 2004). The data presented here demonstrate the 
importance of endocytosis for the full activation of VEGFR2. Inhibition of dynamin-
dependent endocytosis which results in a severe reduction of VEGFR2 phosphorylation at 
all the major autophosphorylation sites might as well disrupts the recruitment and activation 
of IQGAP1 and thereby causes the defect in actin filament assembly required for filopodia 
formation.  
 
Integrins and elongation of filopodia protrusions  Cell-adhesion molecules such as 
integrins and cadherins are often found at the filopodia tips or along the shafts (Galbraith et 
al., 2007; Steketee and Tosney, 2002; Vasioukhin et al., 2000). Integrins in an unligated but 
activated state have been reported to accumulate at the tip of filopodia processes to probe 
the extracellular matrix and form initial adhesion sites that facilitate cell migration (Galbraith 
et al., 2007). Stabilization of filopodial structures to the surrounding matrix by integrins, 
translocated to filopodia tips by the actin-based motor protein myosin, is necessary for 
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subsequent elongation of the filopodial processes (Zhang et al., 2004). Interestingly, myosin 
can bind to phosphatidylinositol phosphates which aid its targeting to clathrin-coated 
structures and might contribute to its function during filopodial formation (Mattila and 
Lappalainen, 2008; Spudich et al., 2007). Transient fibronectin deposition in astrocytes and 
localization of fibronectin-type integrins at the tips of endothelial tip cell filopodia enriched 
with VEGFR2 has also been reported in postnatal retinas (Gerhardt et al., 2003). Different 
fibronectin- and laminin-binding integrins are known to exert their function in collaboration 
with VEGFR2 through complex formation of both proteins. Phosphorylation and activation of 
integrins, following induction of VEGFR2 signal transduction that involves  Src kinases and 
PI3K-Akt signaling, play an important role in VEGF-stimulated angiogenic responses 
(Avraamides et al., 2008; Byzova et al., 2000; Somanath et al., 2009). Indeed, the reciprocal 
nature of integrin-VEGFR2 cross-talk that is important not only for activation of integrins, but 
also for prolonged and full activation of VEGFR2 signaling cascades has been demonstrated 
(Somanath et al., 2009; Wijelath et al., 2006). Similar to several RTKs, endocytic trafficking 
is an important mechanism controlling the biological activities of integrins (Caswell et al., 
2009; Jones et al., 2006; Pellinen and Ivaska, 2006). Moreover, engagement of integrins 
can influence intracellular trafficking and signaling downstream of other receptors as 
evidenced in the enhancement of EGF receptor autophosphorylation and mobilization of the 
active receptor. This involves associated recycling of the EGF receptor and integrin α5β1 
towards cellular protrusions at the migrating front to drive Akt-mediated invasive migration 
(Caswell et al., 2008). Given the pivotal role of β1 integrins in developmental and 
pathological angiogenesis as well as its ability to modulate VEGFR2 signaling (Avraamides 
et al., 2008; Wijelath et al., 2006), it is tempting to speculate that the coordinated 
intracellular trafficking of integrin β1-VEGFR2 might as well exist to regulate spatial 
distribution of the associated receptor signaling complex at the matrix-filopodia adhesive 
sites. Such mechanism might be necessary for the attachment of endothelial tip cell filopodia 
to the surrounding matrix and activation of other migratory signals downstream of the 
receptors during guided angiogenic sprouting. 
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7.4. Triggering VEGFR2 signaling: A team effort of VEGF and ephrinB2 
 Endocytosis of VEGFR2 assessed by antibody feeding assay presented here shows 
similar levels of internalized receptor in endothelial cells treated with VEGF or only pre-
clustered EphB4-Fc. VEGF and ephrinB2 most likely work simultaneously in physiological 
conditions to induce VEGFR2 activation and internalization. To confirm this notion, VEGFR2 
internalization upon combinatorial stimulation with both VEGF and EphB4-Fc was 
investigated. However, no significant difference between combinatorial and single agent 
stimulation could be observed (data not shown). This is probably due to the saturation of the 
system. Up to 70% of VEGFR2 was found to be internalized upon treatment with either 
VEGF or EphB4-Fc. Alternatively, one would hypothesize that activation of ephrinB2 by 
EphB4-Fc might be sufficient to induce internalization of VEGFR2 in absence of VEGF. 
Endothelial cells are able to produce VEGF (Maharaj et al., 2006), evaluation of VEGF-
independent ephrinB2 function in VEGFR2 internalization would therefore require 
endothelial cells without endogenous VEGF.  In the experiments presented here, the 
possibility of the presence of endothelial VEGF could not be ruled out. The examination 
filopodial extension in retina explants, which represents a functional readout of VEGFR2 
internalization and activation, on the other hand, pointed to a co-operative effect of VEGF 
and ephrinB2. Extension of endothelial tip cell filopodia was more efficiently induced by 
VEGF than by EphB4-Fc. Importantly, under VEGF-deprived condition following treatment 
with s-Flt1, activation of ephrinB2 signaling by EphB4-Fc partially rescued the vascular 
defect of explanted retinas, suggesting a co-operative rather than independent effect. Low 
levels of VEGF which most likely are still available for tip cells after VEGF sequestering by s-
Flt1 might allow the cells, in which ephrinB2 signaling is highly activated, to efficiently induce 
VEGFR2 internalization and function.    
 
7.5. Interaction between VEGFR2 and ephrinB2 
 Two evidences presented here, the co-localization of ephrinB2 and VEGFR2 on the 
same membrane domains in cultured endothelial cells and the co-immunoprecipitation of the 
two molecules from neonatal mouse brain, suggest that ephrinB2 and VEGFR2 interact to 
exert their biological activities. However, at this stage it cannot be pinpointed whether these 
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two interacting partners can directly associate or other bridging molecules are required to 
mediate such interaction. Several SH2 and/or SH3 adaptor molecules are involved in signal 
transduction of activated VEGFR2 through various pathways. An interesting example among 
the known VEGFR2 adaptor proteins is Nck2 (also known as Nckβ or Grb4) that contains 
three N-terminal juxtaposed SH3 domains and a C-terminal SH2 domain. Nck2 has been 
shown to be recruited to activated VEGFR2 seemingly via its SH2 domain and enable the 
activation of c-jun N-terminal kinase (JNK) and ERK presumably by association with the 
upstream effectors of these proteins via its SH3 domain to promote endothelial cell 
proliferation (Wang et al., 2007). Interestingly, the putative SH3-binding motif presented in 
the cytoplasmic tail of ephrinBs has also been proposed to mediate their binding to Nck2 
which links them to multiple downstream regulators and promotes dendrite morphogenesis 
(Segura et al., 2007; Xu and Henkemeyer, 2009). Therefore, Nck2 may represent a 
plausible linker between VEGFR2 and ephrinB2. Direct physical interaction between the 
VEGFR2 and ephrinB2 via their extracellular regions as well cannot be neglected. Future 
studies will aim to identify the interaction domains of both proteins and other putative 
scaffolding molecules that control ephrinB2-VEGFR2 interaction. This might lead to the 
identification of new therapeutic strategies to inhibit angiogenesis by interfering with the 
association of ephrinB2 and VEGFR2 molecules.        
 
7.6. Molecular mechanism underlying ephrinB2 function in the endocytosis 
of VEGFR2 
 The work presented here demonstrates the critical role of PDZ-dependent reverse 
signaling downstream of ephrinB2 in the regulation of VEGFR2 endocytosis and function 
required for angiogenic sprouting in both physiological and pathological conditions. Further 
insight into the molecular mechanism employed by ephrinB2 to mediate this function seems 
to be an obvious next query. Among PDZ proteins that have been described to be 
expressed in blood vessels and to bind to ephrinB ligands (Makinen et al., 2005), PICK1 
(protein interacting with C-kinase1) and Dvl2 (Dishevelled2) are appealing candidates as 
ephrinB2 effector molecules owing to their reported roles in the regulation of signaling 
receptor endocytosis. 
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 PICK1 is well-known as a key modulator in the trafficking of the neurotransmitter 
receptor AMPAR (α-amino-3-hydroxy-5-methylisoxazole-4-propionic acid receptor) which is 
a fundamental mechanism for the regulation of synaptic strength (Hanley, 2008). The two 
functional domains, PDZ and BAR (Bin/amphiphysin/Rvs),   present in PICK1 confer the 
ability to interact with a number of signaling molecules involved in different cellular 
processes including actin polymerization and phospholipid membrane curvature. The PDZ 
domain of PICK1 shows specificity to a diverse array of ligands such as different subunits of 
AMPAR, ephrinBs, Ephs and other RTKs (Dev, 2007). The ability of BAR domain to 
associate with negatively charged phosphoinositides and to contribute to the invagination of 
the lipid bi-layer membrane suggests that PICK1-lipid association might play an essential 
role in receptor endocytosis and trafficking of intracellular membrane compartments (Jin et 
al., 2006; McMahon and Gallop, 2005; Peter et al., 2004). Moreover, PICK1 BAR domain 
has also been shown to associate with and inhibit the activity of the major catalyst of 
branched actin network Arp2/3 complex and allow AMPAR endocytosis to proceed possibly 
by locally lowering membrane tension (Rocca et al., 2008). Interestingly, there is a predicted 
binding site for PICK1 in the C-terminal domain of VEGFR2 (Dev, 2007) and given the ability 
of PICK1 to form homoligomer presenting two available PDZ motifs (Xia et al., 1999) it 
would be interesting to investigate whether PICK1 is a bridging molecule that might act as a 
transducer of ephrinB2 signaling to trigger the internalization of VEGFR2 from plasma 
membrane. 
 Dvl has been reported to participate in a wide array of molecular machineries 
underlying several different cellular processes ranging from cell fate decision, migration, 
dendritogenesis, to planar polarity (Gao and Chen). The three members of Dvl proteins 
identified in human and mice possess three conserved domains, an N-terminal DIX 
(Dishevelled, Axin) domain required for their polymerization (Schwarz-Romond et al., 2007; 
Wharton, 2003), a central PDZ domain that mediate their interactions with membrane 
receptors and various intracellular effectors, and a C-terminal DEP (Dvl, Egl-10, Pleckstrin) 
domain that is essential for their binding to membrane lipids (Simons et al., 2009) and also a 
number of signaling partners (Gao and Chen). The role of Dvl in endocytosis is well-
established in Wnt (derived from Drosophila Wingless (Wg) and its mammalian homolog 
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Integration sites (Int) signaling pathways). Upon Wnt5a stimulation, Dvl2 is recruited to the 
activated Wnt receptor Frizzled4 in the cell membrane and brings β-arrestin2 to the receptor 
complexes to promote receptor sorting into clathrin-coated pits for internalization (Chen et 
al., 2003). Association of Dvl2, through its DEP domain, with a subunit of the clathrin 
adaptor protein AP-2 has also been shown to be essential for Frizzled4 internalization (Yu et 
al., 2007). The role of β-arrestin2 in clathrin-dependent endocytosis is not only limited to G 
protein-coupled receptors but also known to be involved in the internalization of other 
signaling receptors and adhesion molecules including TGF-β receptor, EGFR, and VE-
Cadherin (Chen et al., 2003; Gavard and Gutkind, 2006; Maudsley et al., 2000). Further 
work will be required to address the possible role of Dvl2 in EphrinB2-mediated VEGFR2 
endocytosis. 
 Identification of other possible interaction partners of ephrinB2 among all the PDZ 
proteins encoded from mouse genome would be of great interest and will require high-
throughput approaches such as protein arrays and mass spectrometry.  
     
7.7. Control of ephrinB2 expression by Notch signaling and tip cell 
function of ephrinB2 
 An emerging role of Notch signaling pathway during the development of the vascular 
system is the regulation of the endothelial tip/stalk cell specification. Notch exerts this 
function via the well-known mechanism of lateral inhibition, which is, at least partially, 
coupled to the VEGF pathway. The initial migratory response of endothelial cells during 
active angiogenic sprouting is induced by gradients of VEGF highly expressed in hypoxic 
regions in absence of functional oxygen-delivering blood vessels. Activation of VEGFR2 by 
VEGF has been shown to upregulate expression of the Notch ligand Dll4 (Liu et al., 2003; 
Lobov et al., 2007). Trans-activation of Notch signaling by Dll4 in adjacent cells suppresses 
sprouting phenotypes and allows only a fraction of endothelial cells to become tip cells 
(Hellstrom et al., 2007; Siekmann and Lawson, 2007). The molecular mechanism underlying 
the tip cell suppression by Notch is not fully understood. Differential regulation of VEGF 
receptor expression in subpopulations of endothelial cells at the sprouting front of growing 
vessels by Notch signaling is thus far the only mechanistic insight that has been described. 
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Several lines of evidences demonstrate that Notch can negatively regulate VEGFR2 
expression possibly through the transcriptional regulator Hey1, whose expression is directly 
controlled by Notch (Henderson et al., 2001; Holderfield et al., 2006; Suchting et al., 2007; 
Williams et al., 2006).Conversely, the VEGF decoy receptor VEGFR1, which can antagonize 
VEGFR2 pro-angiogenic activities, is upregulated by Notch (Harrington et al., 2008). Based 
on these findings, the current model is a negative-feedback loop, in which Dll4 upregulated 
upon VEGF stimulation activates Notch signaling in adjacent cells to suppress VEGFR2 
expression and thereby dampen their angiogenic response (Phng and Gerhardt, 2009). 
Another ligand of Notch, Jagged1, also contributes to lower the Notch activity in the tip cells 
by antagonizing Dll4 expressed in stalk cells (Benedito et al., 2009). 
EphrinB2 has been reported to be a direct downstream target of Notch signaling. 
Binding of NICD-RBPJ complex to ephrinB2 gene transiently activates its expression 
(Grego-Bessa et al., 2007). According to the novel function of ephrinB2 in the regulation of 
endothelial tip cell filopodial extension by modulating VEGFR2 internalization discovered in 
this study, one might wonder how ephrinB2 exerts its function in tip cell when Notch activity 
is seemingly low. Indeed, tip and stalk cells are not stable cell fates. Their specification 
instead represents a dynamic process of cells receiving stimulus of similar strength at the 
sprouting front and constantly battling for the tip cell position at the level of Dll4 and 
VEGFR2 signaling output. Imaging of sprouting zebrafish vessels has shown that tip cells 
can rapidly switch their invasive migratory behavior to become quiescent and integrate into 
nearby vessels (Leslie et al., 2007; Torres-Vazquez et al., 2004). This illustrates the 
dynamic changes of Notch activity once cells encounter a new microenvironment and 
different neighbors. The oscillating expression of Notch signaling components mediated by 
differential protein stability and timing of transcription and translation has been demonstrated 
to control spatial patterning of somitogenesis (Lewis, 2008). Such synchronous oscillation 
might explain the heterogenous expression pattern of NICD and Dll4 which are highly 
expressed, but not only restricted to, stalk and tip cells, respectively (Roca and Adams, 
2007). Furthermore, expression of Dll4 can be regulated not only by VEGF/VEGFR2 
signaling but also other pathways including Notch (Carlson et al., 2005; Shawber et al., 
2003).  The possibility that Notch and its signaling compartments are activated transiently 
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leading to an upregulation of DLL4 as well as ephrinB2 before cells commit to tip cell fate 
cannot be excluded. Staining of retina vessels by EphB4-Fc shows the general expression 
of ephrinB2 in arterial endothelium and all over capillary beds. Both, tip and stalk cells, are 
found positive for ephrinB2, suggesting the stable expression of ephrinB2 protein upon 
transient downregulation of Notch signaling when some endothelial cells are selected to 
become tip cells. Once tip cells are specified, modulation of Dll4 by Notch signaling as well 
as downregulation of Hes/Hey transcription by their own translational products (Lewis, 2008) 
may provide a negative feedback mechanism that potentially could contribute to the 
oscillation of Notch activity in tip cells by the transiently enhanced Dll4 expression in stalk 
cells and allow sustained ephrinB2 expression sufficient to induce migratory response in 
collaboration with VEGFR2. In addition, ephrinB2 expression in tip cells might also be 
regulated independently of VEGFR2 and Notch activities.                       
 
7.8. Different roles of ephrinB2 during angiogenic growth of blood vessels 
 Overexpression of full-length or tyrosine phosphorylation-deficient ephrinB2 in 
primary endothelial cells causes contact-mediated repulsion which prevents these cells from 
integrating into the capillary-like structures formed on 3D matrigel. The PDZ-truncated form 
of ephrinB2, on the other hand, is unable to reproduce such a repulsive phenotype and 
allows strong cellular contacts between endothelial cells during tubular assembly. These 
findings raise an intriguing assumption that ephrinB2 function in vascular development might 
not be limited only to the control of VEGFR2 endocytosis and migratory signal in endothelial 
tip cells, but also be involved in the earlier step when cells selected to become tip cells attain 
invasive phenotypes. Endothelial cells lining the vessel wall in the quiescent condition or 
during maturation of newly formed vessels establish adherens and tight junctions to maintain 
stable cell-cell contacts and keep the integrity of the entire vascular structure which must 
support high-pressure blood flows. Upon exposure to angiogenic stimuli, a subset of 
endothelial cells with changes in their expression profile that is sufficient to overcome the 
suppression mechanism of the invasive phenotype (mainly through Notch signaling as 
mentioned above) will be selected to become tip cells. The cellular contacts between these 
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selected cells and their neighbors need to be accordingly altered to allow a cell polarity 
shifting before the cells sprouting out from an intact vessel (Adams and Alitalo, 2007).  
Eph/ephrin signaling has a well-established function in cell repulsion (Marston et al., 
2003; Zimmer et al., 2003), which is particularly important for axon guidance and formation 
of tissue boundaries during embryogenesis (Palmer et al., 2002). Endocytosis of intact 
Eph/ephrin signaling complex and proteolytic cleavage of the receptor or ligand extracellular 
portions, which results in the removal of Eph/ephrin adhesive complex from cell surface, 
have been shown to convert initial adhesion via ligand/receptor binding to cell repulsion 
(Egea and Klein, 2007). Moreover, the direct control of tight junction formation by ephrinB 
has also been reported. The Par (partitioning defective) polarity complex protein Par-6 is a 
major scaffold molecule that couples the small GTPase Cdc42 to the activation of the 
atypical protein kinase C (aPKC) required for actin rearrangement during the formation of 
tight junctions to  establish and maintain cell-cell contacts (Joberty et al., 2000; Lee et al., 
2008). It has been shown that ephrinB1 can compete with Cdc42 for Par-6 binding and 
thereby interrupts the activation of Par/cdc42 complex that consequently causes the loss of 
epithelial tight junctions during early Xenopus leavis embryogenesis. Overexpression of 
ephrinB1 in blastomere embryos results in effective competition of ephrinB1 over Cdc42 for 
Par-6 interaction and thereby shows disrupt tight junction formation. Tyrosine 
phosphorylation of ephrinB1, on the contrary, interferes with the association of ephrinB1 and 
Par-6 (Lee et al., 2008). Binding of Cdc42 to Par-6 has previously been demonstrated to 
mediate by the semi-CRIB-PDZ domain of Par-6 (Gao and Macara, 2004; Yamanaka et al., 
2001). Although the PDZ-binding motif of ephrinB1 might not be essential for its binding to 
Par-6 (Lee et al., 2008), its importance for the disruption of Cdc42/Par-6 association remains 
to be clarified. Whether a similar mechanism regulated by ephrinB2 applies to the control of 
endothelial cell adhesion and a transient upregulation of ephrinB2 might be operated to alter 
the tight association between these cells for the initiation of sprouting activity are open 
questions that require further investigation. 
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7.9. Eph/ephrin signaling in tumor progression: angiogenesis and beyond 
 The critical role of ephrinB2 PDZ-dependent signaling in tumor-induced 
neovascularization, which is a crucially process required for tumor growth, is clearly 
demonstrated in this study. The angiogenic response of host blood vessels induced by 
astrocytoma tumors and mediated by ephrinB2appears to be endothelial cell-autonomous 
and generic in different tumor microenvironments. Several EphB receptors, expressed in 
astrocytes (Wang et al., 2005) or astrocytoma tumors (Bian et al., 2006; Nakada et al., 
2004), could potentially represent a source of ephrinB2 activation in the endothelium. 
Moreover, various Eph receptors and ephrin ligands have been reported to be widely 
expressed in tumor cells and tumor stromas and their intriguing expression levels correlated 
with cancer progression and metastasis (Pasquale). These facts attract a large number of 
researchers that aim to clarify the functional relevance of Eph and ephrins in these 
processes.  
Depending on the cellular context and/or stages of tumor progression several Eph 
receptors are found to be upregulated or silenced. Similar to the divergence in their 
abundances, both tumor-promoting and tumor-suppressing functions of Eph receptor 
forward signaling by controlling diverse cellular processes including proliferation, survival, 
and invasive migration have been described (Merlos-Suarez and Batlle, 2008; Pasquale). 
Interactions between EphB recptor presented in cororectal cancer cells and ephrinB2 
expressed in villus cells limits the expansion of the cancer cells outside the villus cavity by a 
mechanism involving E-cadherin-mediated cancer cell adhesion (Cortina et al., 2007). 
Recent studies implicate that different signaling outcomes might be achieved from the 
conventional ephrin-mediated Eph receptor tyrosine kinase activities and the ligand-
independent crosstalk between Eph receptor and other oncogenic pathways. EphB4-
mediated downregulation of β1-integrin levels and cell-substrate adhesion independently of 
ephrinB ligands has been shown to inhibit migration of some tumor types (Noren et al., 
2009), whereas EphB2-dependent decreased cell adhesion can also promote invasion of 
other tumors (Nakada et al., 2005). Crosstalk between EphA2 and Akt seems to promote 
tumor invasiveness independent of EphA2 kinase activity. Stimulation of the receptor with 
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ephrinB1, by contrast, counteracts the effect of Akt and inhibits tumor cell migration (Miao et 
al., 2009).                            
 Several evidences have demonstrated that reverse signaling downstream of ephrin 
ligands is also involved in multiple mechanisms within tumor cells that modulate tumor 
progression. Rac1 activation and secretion of matrix metalloproteinase (MMP) have been 
proposed to be regulated by ephrinB signaling in many tumor types (Jiang et al., 2008; 
Nakada et al., 2006; Tanaka et al., 2007). Moreover, ephrinB reverse signaling may also 
influence tumor transformation and invasiveness at the transcriptional level by modulating 
the signal transducer and activator of transcription 3 (STAT3) (Bong et al., 2007). 
  Given the abundance of different Ephs and ephrins in tumor cells and tumor blood 
vessels, interactions between the receptors and ligands on the surfaces of these cells, which 
are in close proximity within the tumor microenvironment, might have other roles in the 
tumor endothelium in addition to its key function in tumor angiogenesis. EphrinB2 expressed 
in the tumor endothelium is able to stimulate EphB4-mediated upregulation of the adhesion 
molecule selectin to promote the recruitment of bone-marrow derived endothelial progenitor 
cells which participate in tumor neovascularization (Foubert et al., 2007). It will be interesting 
to investigate whether EphB-expressing tumor cells might employ similar mechanism to 
intravasate into the blood stream during their metastasis to distant tissues.       
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8. Materials and Methods 
8.1. Materials 
8.1.1. Chemicals, enzymes and commercial kits 
Chemicals were purchased from the companies Merck, Serva, Sigma, Fluka and Roth. 
Water used to prepare all solutions was filtered with the “Milli-Q-Water System” (Millipore). 
Restrictions enzymes were purchased from New England Biolabs (NEB). Plasmid 
preparations, PCR purifications or gel-extractions were done using the Qiagen Plasmid 
Mini/Maxi kit or PCR Purification kit, respectively. Special supplies and kits are mentioned in 
detail with the according method. 
 
8.1.2. Bacteria 
DH5α (Invitrogen) 
TOP10 (Invitrogen) 
 
8.1.3. Cell lines 
Phoenix A: Retroviral packaging line created by introducing gag-pol and viral envelope 
protein expression constructs into 293T cells (a human embryonic kidney line transformed 
with adenovirus E1a).  
 
8.1.4. Primary Cells 
MLEC: Endothelial cells isolated from lungs of new born C57BL/6 mice.  
ASCT: Central nervous system tumor cells which have been transformed from mouse 
astrocytes by the introduction of H-RasV12 and SV40-large T antigen oncogenes. 
 
8.1.5. Media and dissection buffers 
8.1.5.1. Media and antibiotics for bacterial culture 
Luria-Bertani (LB) medium 
Bacto-Tryptone                                      10 g 
Bacto-Yeast extract                                  5 g 
NaCl                                                       5 g 
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Distilled water was added to the final volume of 1l. The pH is 7.5. Solution was sterilized by 
autoclaving and stored at RT. 
LB plates 
LB media                                               1 l 
Bacto-Agar                                          15 g 
Autoclaved and stored at 4°C. 
Antibiotics (1000x stocks) 
Ampicillin                                         100 mg/ml 
Kanamycin monosulfate                     50 mg/ml 
 
8.1.5.2. Media for cell lines (500 ml) 
DMEM+GlutaMAX™-I+4.5 mg/l D-glucose (Gibco)    450 ml 
Penicillin-streptomycin                                                   5 ml   
(100 U/ml penicillin and 100 µg/ml streptomycin in final concentration) 
Fetal bovine serum 10%                                                50 ml 
 
8.1.5.3. Media for primary cell culture 
Sterilization by filtration was done with 0.22 µm filter. All media can be kept at 4ºC maximally 
for 2 months.  
 
8.1.5.3.1 Endothelial cell dissection 
Dissection buffer (500 ml) 
Hank’s buffered salt solution (HBSS)                           450 ml 
FBS 10%                                                                      50 ml 
Collagenase  (2500 units/ml) 
Collagenase type II from Clostridium histolyticum 
(Biochrom AG, 325units/mg)                                      100 mg 
D-PBS                                                                          13 ml  
Collagenase was dissolved in PBS, filtered and aliquoted in small amount and stored at 
20ºC.    
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1% Gelatin 
Gelatin from bovine skin type B                                     10 g 
D-PBS                                                                            1 l 
Solution was sterilized by autoclaving and stored at RT. Filtration before use is required. 
Coupling buffer (50ml) 
HBSS                                                                            50 ml 
BSA 2%                                                                          1 g 
BSA was dissolved in HBSS and sterilized by filtration. 
 
8.1.5.3.2 Endothelial cell culture 
Endothelial cell growth medium (500 ml) 
DMEM+GlutaMAX™-I+4.5 mg/l D-glucose (Gibco)   390 ml 
Penicillin-streptomycin                                                   5 ml   
(100 U/ml penicillin and 100 µg/ml streptomycin in final concentration) 
Fetal bovine serum 20%                                             100 ml 
Endothelial cell growth supplement/Heparin (PAA)        2 ml 
Amphotericin B (Fungizone 250 Units/20 ml, Sigma)     3 ml 
Note: fetal bovine serum used for endothelial cell culture need to be tested not to promote 
cell differentiation and support cell growth for many passages. The serum used for 
embryonic stem cell culture usually worked well with endothelial cells. 
 
8.1.5.3.3 Angiogenesis assay 
Tube formation assay (starving medium, 50 ml) 
DMEM+GlutaMAX™-I+4.5 mg/l D-glucose (Gibco)  49.5 ml 
Fetal bovine serum 1%                                               0.5 ml 
 
8.1.5.3.3 Dissection medium for primary astrocyte isolation 
10x HBSS                                                                     50 ml 
1M HEPES                                                                     5 ml 
7.5% (w/v) NaHCO3  pH 7.35                                      2.5 ml 
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Sterile water was added to fill up the volume to 500 ml. 
 
8.1.5.3.4 Astrocyte and astrocytoma culture media (500 ml) 
Basal Medium Eagle (BME)                                       422 ml 
20% Glucose in BME                                                  15 ml 
100 mM Sodium Pyruvate                                             5 ml 
HEPES                                                                          5 ml 
Horse serum (HS, without heat-inactivation)                50 ml 
MITO serum Extender (BD Biosciences)                     500 µl 
Penicillin-Streptomycin                                              2.5 ml 
(50 U/ml penicillin and 50 µg/ml streptomycin in final concentration) 
 
8.1.6. Plasmids  
YFP-ephrinB2 
The construct for expression of the YFP-fusion ephrinB2 gene were generated as previously 
described (Zimmer et al., 2003). Mouse ephrinB2 gene was cloned to the C-terminus of the 
eYFP gene in the vector pEYFP-N1 (Clontech). 
YFP-ephrinB2∆C 
YFP-ephrinB2∆C was generated by replacing the CFP gene from pJK42 (Lauterbach and 
Klein, 2006) with the YFP gene from pEYFP-N1 at the SalI and BsrGI cloning sites. Most of 
the cytoplasmic domain of ephrinB2 was removed. The remaining cytoplasmic tail contains 
only the amino acid sequence RKHSPQHTTT. 
YFP-ephrinB2∆V 
Generation of YFP-ephrinB2∆V was done by site directed mutagenesis (Stratagene) to 
remove the C-terminal valine from the ephrinB2 gene in the YFP-ephrinB2 plasmid. 
YFP-ephrinB25Y 
To generate YFP-ephrinB25Y, the BbsI-EcoRV fragment encoding the C-terminal part of 
ephrinB2 in the YFP-ephrinB2 plasmid was replaced by a fragment in which five conserved 
tyrosine residues of ephrinB2 were mutated as previously described (Makinen et al., 2005). 
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8.1.7. Oligonucleotides 
All small oligonucleotides were synthesized by MWG (www.mwg-biotech.com) and purified 
with HPSF. 
EphrinB2KI_for:    5’-CGG AGT GCG CAG AAC TGG-3’ 
EphrinB2KI_rev:   5’-GAT TTG GCT TCA CAA AGG GAC T-3’  
Elf-2-S1:                5’-CTC TGT GTG GAA GTA CTG TTG-3’ 
Wtas4:                   5’-CCG CCA ATG TGT GTC TGT AGC-3’ 
LacZ_F:                 5’-CCA GCT GGC GTA ATA GCG AA-3’ 
LacZ_R:                5’-CGC CCG TTG CAC AGA TG-3’ 
 
8.1.8. Solutions and buffers 
8.1.8.1 Standard solutions 
Phosphate-buffered saline (PBS) 
137 mM NaCl                                                       NaCl  8 g 
2.7 mM KCl                                                          KCl  0.2 g 
8 mM Na2HPO4                                                    Na2HPO4  1.15 g 
1.5 mM KH2PO4                                                   KH2PO4  0.24 g 
All ingredients were dissolved in 800 ml of distilled water. pH was adjusted to 7.4 with HCl 
and final volume were adjusted to 1 l. Solution was sterilized by autoclaving and stored at 
RT. 
10× PBS 
1.37 M NaCl                                                      NaCl  80 g 
27 mM KCl                                                           KCl  2 g 
81 mM Na2HPO4                                       Na2HPO4  11.5 g 
15 mM KH2PO4                                            KH2PO4  2.4 g 
All ingredients were dissolved in 800 ml of distilled water. pH was adjusted to 7.4 with HCl 
and final volume were adjusted to 1 l. Solution was sterilized by autoclaving and stored at 
RT. 
4% Paraformaldehyde (PFA) 
PFA 4% (w/v)                                                             20 g 
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D-PBS                                                                      500 ml 
5N NaOH                                                                 200 μl 
HCl min. 37%                                                            75 μl 
PBS was pre-heated to 70°C before PFA powder was added and stirred at high speed. 
NaOH was then added for a completely dissolve PFA. HCl min. 37% was finally added to 
adjust pH to 7.3. Solution was stored in aliquots at -20°C. 
 
8.1.8.2 Solutions for agarose gel electrophoresis 
50x TAE 
Tris Base                                                                  242 g 
0.5 M EDTA pH 8.0                                                 100 ml 
Acetic Acid 100%                                                   57.1 ml 
Tris base was dissolved in 600 ml of distilled water with magnet stirrer. EDTA and acetic 
Acid were then added. Final volume was adjusted to 1 L with distilled water. Solution was 
stored at room temperature. 
Final concentration of the solution: 
2M Tris acetate 
50mM EDTA    
Gel loading buffer 
Glycerol                                                                     25 ml 
50x TAE                                                                      1 ml 
Orange G                                                                  0.1 g 
H2O                                                                            4 ml 
 
8.1.8.3 Solutions and buffers for western blot analysis 
Lysis buffer 
50 mM Tris pH 7.5                        1M Tris pH 7.5     25 ml 
150 mM NaCl                                        5M NaCl      15 ml 
0.5% Nonidet P40 (NP-40)                         NP-40   2.5 ml 
10% Glycerol                                 Glycerol (87%)  57.5 ml 
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Distilled water was added to final volume 500 ml. Solution was stored at 4°C. 
Added freshly to 50 ml: 
Protease inhibitor cocktail tablet (complete) 1 tablet 
20 mM NaF                                              NaF       0.042 g  
10 mM NaPPi                                           NaPPi    0.223 g  
1 mM vanadate                       100 mM Na3VO4        300 μl 
SDS PAGE separating gel 7.5% (10 ml)  
H2O                                                                        4.85 ml 
1.5M Tris pH 8.8, 0.4% SDS                                    2.6 ml 
30% w/v Acrylamind/bisacrylamid                             2.5 ml 
10% APS                                                                   50 μl 
TEMED                                                                       5 μl 
SDS PAGE stacking gel 4% (5 ml) 
H2O                                                                       3.05 ml 
1.5M Tris pH 6.8, 0.4% SDS                                   1.3 ml 
30% w/v Acrylamind/bisacrylamid                             65 ml 
10% APS                                                                  50 μl 
TEMED                                                                      5 μl 
6x Sample buffer for reducing conditions 
12% SDS                                                         SDS 3.6 g 
300 mM Tris-HCl, pH 6.8                           1.5M Tris 6 ml 
600 mM DTT                                                 DTT 2.77 g 
0.6% BPB                                                      BPB 0.18 g 
60% Glycerol                                             Glycerol 18 ml 
Distilled water was added to 30 ml. Buffer was stored in 0.5 ml aliquots at -20°C. Add 50 µl 
β-mercaptoethanol in 1 ml of 4x buffer. 
5x Electrophoresis buffer 
Tris base                                                             154.5 g 
Glycine                                                                  721 g 
SDS                                                                         50 g 
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Distilled water was added to 10 l. Buffer was stored at RT. 
Protein transfer buffer 
Tris base                                                            31.04 g 
Glycine                                                             144.13 g 
Approximately 9 l of distilled water were added. Mixed to dissolve and made up to a 
final volume of 10 l. This 10X buffer was stored at RT. 
Freshly before use: 
35 ml of distilled water was added to 5 ml of the 10x buffer. 10 ml of Methanol was added to 
yield 50 ml 1X buffer.  
Final concentration of the 1x transfer buffer: 
25 mM Tris base 
192 mM Glycine 
20% Methanol 
0.1M Sodium phosphate buffer, pH 7.2 
1) 0.2 M NaH2PO4
.
H2O                                          69.0 g 
2) 0.2 M Na2HPO4
.
7H2O                                      134.1 g 
70 ml of solution 1 was mixed with 180 ml of solution 2. Distilled water was added to mark 
500 ml. pH of the mixture should be 7.2. 
 
PBS-Tween (PBST) 
1x PBS 
0.1% Tween®20 
Solution was kept at RT. 
Blocking solution 
5% skim milk                                         skim milk    0.5 g 
PBST                                                                      10 ml  
Solution was prepared freshly just before use. 
Stripping buffer 
5 mM Sodium Phosphate buffer, pH 7-7.4 
2% SDS 
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Freshly before use, 10 µl of β-Mercaptoethanol was added to 50 ml of the buffer.  
 
8.1.8.4 Solutions for embedding of vibratome sections 
0.1M Acetate buffer, pH 6.5 
1M Sodium acetate                                                 99 ml 
1M Acetic acid                                                       960 μl 
pH adjusted and made up to a final volume of 1 l. Stored at RT. 
Embedding solution 
1) Ovalbumin  
Ovalbumin (Sigma, A-S253)                                    90 g 
0.1M Acetate buffer                                              200 ml 
Albumin was dissolved in acetate buffer by stiring o/n at RT. The solution was 
filtered through a gaze and undissolved albumin or air bubbles were removed. 
2) Gelatin 
Gelatin                                                                   1.5 g 
0.1M Acetate buffer                                              100 ml 
Gelatin was dissolved in warm acetate buffer. After gelatin solution cooled down, it was 
carefully mixed with ovalbumin solution without producing bubbles. The mixed solution was 
aliquoted and stored at -20°C. 
 
8.1.8.5 Solutions for lacZ staining 
1M MgCl2 
MgCl2                                                                50.83 g 
H2O                                                                      250 ml 
0.1M Phosphate Buffer pH 7.3  
0.1M NaH2PO4                                                      115 ml 
0.1M Na2HPO4                                                    385 ml 
The 2 phosphate buffers were mixed at the amount indicated to yield 500 ml buffer with pH 
approximately 7.3   
Fixation solution 
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25% glutaraldehyde                                               0.4 ml 
100 mM EGTA pH 7.3                                           2.5 ml 
1M MgCl2                                                             0.1 ml 
0.1M sodium phosphate pH 7.3                             47 ml 
All ingredients were mixed freshly before use to yield 50 ml solution.  
Wash buffer 
1M MgCl2                                                                2 ml 
deoxycholate (DOC)                                              0.1 g 
NP-40                                                                   0.2 ml 
0.1M sodium phosphate pH 7.3 was added to the final volume of 1 l. Solution was stored at 
RT.  
X-Gal Staining solution 
1) Staining solution 
potassium ferrocyanide (Sigma P-9378)            0.106 g 
potassium ferricyanide (Sigma P-8131)             0.082 g 
wash buffer                                                         50.0 ml 
Solution was kept in the dark at 4ºC. 
2) X-Gal  
X-Gal                                                                   200 mg  
N-N-dimetylformamide.                                            2 ml 
X-Gal solution at the final concentration 100mg/ml was aliquoted and stored at -20ºC. 
0.5 ml of X-Gal solution was added freshly before use to 50 ml staining solution. 
 
8.1.8.6 Solutions for retina staining 
Isolectin B4 
FITC conjugated lectin from Bandeiraea simplicifolia (Isolectin B4, Sigma-Aldrich) was 
dissolved in Dulbecco’s phosphate buffer saline (D-PBS, Sigma) to a final concentration of 
1mg/ml, aliquoted and stored at 4ºC in the dark. 
Lectin blocking buffer 
D-PBS containing 0.5% Triton X-100. 
                                                                     8. Materials and methods 
 
123 
 
BSA was added to the buffer freshly before use to the final concentration of 0.2% (w/v). 
Lectin staining buffer (PBlec) 
D-PBS containing 1% Triton X-100.  
 
8.1.8.7 Solutions for tumor vessel staining 
TE buffer (10 mM Tris, 1 mM EDTA), pH 8.0 
1) 0.5 M EDTA, pH 8.0 
186.1 g of Na2EDTA
.
2H20 was dissolved in 700 ml distilled water. After adjusting pH to 8.0 
by adding approximately 50 ml of 10N NaOH, distilled water was added to bring up the 
volume to 1 l. 
2) 1 M Tris-HCl 
121.1 g Tris Base (TRIZMA) was dissolved in 700 ml distilled water. Concentrated HCl was 
added to desired pH:  
pH 7.4:  70 ml  
pH 8.0:  42 ml  
pH 9.0:  ~8 ml  
Distilled water was added to mark 1 L. 
2 ml of 1 M Tris-HCl, pH 8.0 was mixed with 0.4 ml of 0.5 M EDTA, pH 8.0, and 197.6 ml of 
distilled water was add to mark 200 ml. Solution was sterilized by filtration and stored at RT.  
0.6 % H2O2  
10 ml of concentrated H2O2 (30%) was mixed with 400 ml of PBS to yield 500 ml solution. 
Blocking solution 
PBS containing 0.01% triton X-100 and 20% normal goat serum (NGS). 
Antibody staining solution 
PBS containing 0.01% triton X-100 and 10% NGS. 
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8.1.9. Antibodies 
Table 8-1 Primary antibodies 
 
Antibody Species Company Dilution Application 
PECAM-1           
(MEC13.3) 
mouse 
monoclonal 
BD Pharmingen 1:25 EC isolation 
external Flk-1 
goat 
polyclonal 
R&D Systems 
1:40                            
4 µg:40 µl bead 
Antibody 
feeding    
IP 
internal Flk-1        
(A-3) 
mouse 
monoclonal 
Santa Cruz 
Biotechnology 
1:200 WB 
Tyr1175 
rabbit 
polyclonal 
Cell Signaling 
Technology 
1:1000 WB 
Tyr1212 
rabbit 
polyclonal 
Cell Signaling 
Technology 
1:1000 WB 
Tyr1059 
rabbit 
polyclonal 
Cell Signaling 
Technology 
1:1000 WB 
Tyr951 
rabbit 
polyclonal 
Cell Signaling 
Technology 
1:1000 WB 
Neuropilin             
(H-286) 
rabbit 
polyclonal 
Santa Cruz 1:200 WB 
Akt 
rabbit 
polyclonal 
Cell Signaling 
Technology 
1:1000 WB 
Phospho-Akt 
(Ser473) 
rabbit 
polyclonal 
Cell Signaling 
Technology 
1:2000 WB 
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Cleaved Notch1 
(Val1744) 
rabbit 
polyclonal 
Cell Signaling 
Technology 
1:1000 WB 
SV-40 T antigen 
(PAb416) 
mouse 
monoclonal 
Calbiochem 1:100 WB 
c-H-Ras                    
(F235-1.7.1) 
mouse 
monoclonal 
Calbiochem 1:50 WB 
Tie2 
rat 
monoclonal 
R&D Systems 1:500 WB 
GFAP 
rabbit 
polyclonal 
DAKO 1:70 IHC 
CD34 (MEC14.7) 
rat 
monoclonal 
Abcam 1:100 IHC 
BrdU 
rat 
monoclonal 
AbD Serotec 1:200 IHC 
Histone H3 
rabbit 
polyclonal 
Cell Signaling 
Technology 
1:50 IHC 
 
 
Table 8-2 Secondary antibodies 
Antibody Species Company Dilution Application 
anti-mouse-HRP goat polyclonal 
Jackson 
Immunoresearch 
1:5000 WB 
anti-rabbit-HRP goat polyclonal 
Jackson 
Immunoresearch 
1:5000 WB 
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anti-goat-Cy2 
donkey 
polyclonal 
Jackson 
Immunoresearch 
1:200 IC 
anti-goat-Cy3 
donkey 
polyclonal 
Jackson 
Immunoresearch 
1:200 IC 
anti-hFc-488 
donkey 
polyclonal 
Jackson 
Immunoresearch 
1:100 IC 
anti-hFc-Txred goat polyclonal 
Jackson 
Immunoresearch 
1:100 IC 
anti-hFc-Cy5 
donkey 
polyclonal 
Jackson 
Immunoresearch 
1:100 IC 
anti-rabbit-488 
donkey 
polyclonal 
Molecular Probes 1:400 IC 
anti-rat-HRP goat polyclonal 
Jackson 
Immunoresearch 
1:100 IHC 
 
 
6.1.10. Mouse lines 
EphrinB2
lox/lox
 conditional knockout mice were generated by introduction of the construct 
containing the second exon of mouse ephrinB2 gene flanked by loxP sites into the 
endogenous ephrinB2 locus by homologous recombination. Neo cassette flanked by FRP 
sites was removed by crossing to trangenic mice expressing flp recombinase (Grunwald et 
al., 2004). The line has been maintained in C57Bl/6 background and used for isolation of 
primary ECs. After isolation viral-encoding cre was introduced to the ECs to generate 
ephrinB2 KO ECs.  
EphrinB2
∆V/∆V 
knock-in mice were generated by George Wilkinson in collaboration with Ralf 
Adams (Makinen et al., 2005) by replacing the first exon of the endogenous mouse ephrinB2 
gene with the cDNA lacking the codon encoding valine amino acid at the end of the C-
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terminus. ORF of the cDNA was fused in frame to exon 1. Germline mutant mice were 
generated with standard protocols. Subsequently, neomycin cassette downstream of the 
cDNA was removed by Cre-mediated excision. The line was kept on a genetic background 
enriched for CD1 (due to lethality in newborn homozygous mice on C57Bl/6 background). 
The deficiency of the ephrinB2∆V to interact with PDZ protein was validated by syntenin1 
pull down and EphB4-stimulated syntenin1 and ephrinB2 colocalization experiments.  
EphrinB2
5Y/5Y
 knock-in mice were generated by George Wilkinson (Makinen et al., 2005) 
and maintained on a genetic background enriched for CD1. cDNA encoding ephrinB2 in 
which 5 conserved tyrosine residues were replaced with 4 phenylalanine and a leucine 
residues was inserted into the first exon of the endogenous ephrinB2 gene. EphrinB2
5Y/5Y
 
mutant embryos showed a severe reduction in the tyrosine phosphorylation level (assessed 
by anti-4G10).  
EphrinB2
lacZ/+ 
mice were generated by insertion of the construct encoding tau-lacZ fusion 
protein into the first exon of the endogenous ephrinB2 locus. Tau-lacZ was fused in frame 
after the initiation codon (ATG) of exon 1. Intronic sequence 3′ to exon 1 was replaced by 
PGKneo (Wang et al., 1998). The line was maintained on C57Bl/6 background. 
Note: Fusion of bovine tau, a microtubule binding protein, to E. coli lacZ is aimed for 
lebelling of the entire cellular extent including filopodia extensions as shown in the study on 
axon lebelling (Callahan and Thomas, 1994). 
 
8.2 METHODS 
8.2.1 Molecular Biology 
8.2.1.1. Preparation of plasmid DNA 
Plasmid DNA was purified from small-scale (5 ml, minipreparation) or from large-
scale (200 ml, maxipreparation) bacterial cultures. Single colonies of transformed bacteria or 
from a bacterial glycerol stock were picked each into LB medium containing 100 μg/ml 
ampicillin or kanamycin and grown for 14-18 h at 37°C with vigorous shaking. Mini- and 
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maxipreparation of plasmid DNA were carried out according to the QIAGEN protocol using 
lysis of the cells and binding of the plasmid DNA to a special resin. After washing, elution 
and precipitation the plasmid DNA was redissolved in a suitable volume of buffer EB 
(QIAGEN) for minipreparation or buffer TE pH 8.0 (QIAGEN) for maxipreparation. DNA 
concentration was measured in a UV spectrometer at 260 nm. The following formula was 
used: dsDNA: OD × 50 × dilution factor = X μg/ml 
 
8.2.1.2. Enzymatic treatment of DNA 
Cleavage of plasmid DNA: Approximate 15-20 μg of DNA was cut in with 15-20 units 
(U) of restriction enzymes in 50 μl of the appropriate buffer. The incubation temperatures 
were as indicated for optimal activity of each enzyme.  
Dephosphorylation of DNA fragments: 10×buffer, deionized water and 1 U (1 μl) of 
calf intestine alkaline phosphatase (Roche) were added to the restriction enzyme reaction to 
get a total reaction volume of 100μl, incubated for 20 min at 37°C and heat-inactivated at 
75°C for 15 min. Subsequently the dephosphorylated DNA fragments were purified from the 
reaction mix with the QIAquick Nucleotide Removal Kit (QIAGEN) according manufacturer’s 
protocol. The DNA was eluted in 15 μl of buffer EB. 
Ligating vector and target DNA fragments: A 10 μl reaction containing purified 
linearized vector and DNA fragments in 1:5 molar ratio, 1 μl  of 10x ligation buffer (NEB), 
and 1 μl of T4 DNA ligase (NEB) was incubated O/N at 16°C or at RT for 2 h, followed by 30 
min at 37°C for sticky end ligations. Approximately 2-5 μl of the reaction was used to 
transform competent bacteria. 
 
8.2.1.3. Agarose gel electrophoresis and DNA purification  
According to the DNA sizes, 0.8-2% agarose gel was prepared by microwave 
melting agarose in TAE buffer. After the agarose solution cooled down to ~45°C, ethidium 
bromide was added (6 μl is required for 100 ml agarose gel) and the solution was poured 
into a gel chamber. When the gel solidified DNA solution mixed with loading buffer in 10:1 
volume ratio were loaded onto the gel and run for 30-35 min at 180-200 V. DNA was 
visualized and photographed under UV light using a gel documentation system (BioRad). 
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For purification of DNA, the appropriated DNA band (according to its size) was excised from 
the agarose gel with a scalpel and purified by the QIAquick Gel Extraction Kit (QIAGEN) as 
recommended by the manufacturer. The DNA was eluted in 15 μl of buffer EB. 
 
8.2.1.4 Preparation of competent E.coli 
An o/n culture of DH5α cells was inoculated at 1:100 volume ratio in 1 l of LB 
medium. The bacteria culture was grown at 37°C with vigorous shaking until the optical 
density measured with 600 nm wavelength reached 0.5-0.8. The culture was chilled on ice 
for 30 min followed by centrifuged at 4000xg at 4°C. The pellet was resuspended in 1 l of 
cold sterile water and centrifuged again. 0.5 l of sterile water was used for the second 
resuspension. After centrifugation and harvesting the clean bacteria pellet, 20 ml of 10% 
glycerol was added for resuspension. The bacteria suspension was then centrifuged as 
above and resuspended in 3 ml of 10% glycerol. Aliquots of 50 μl were frozen in liquid 
nitrogen and stored at -80°C. 
 
8.1.2.5 Transformation of competent E.coli by electroporation 
50 μl of competent bacteria was thawed on ice and 0.5 μl of plasmid DNA or 1-5 μl 
of ligation product was added. The mixture was transferred into a sterile, pre-chilled 0.2 cm 
cuvette without making bubbles. The gene pulser apparatus was set to 25 μF and 2.5 kV; 
the pulse controller to 200 Ω. The dried cuvette was placed into the chamber slide and 
pulsed once. Immediately, 200 μl of SOC or LB medium without antibiotic was added to the 
cells, which were then transferred to a 12 ml bacteria culture tube and shaken 60 min at 
37ºC. Subsequently, the bacteria were spread on LB plates containing selective antibiotic 
and grown o/n at 37°C. 
 
8.2.1.6 PCR Genotyping 
Dissolving DNA: Tail samples (1-3 mm) were taken from mice at weaning age (~ 3 weeks). 
To dissolve DNA, tail samples were heated at 95°C for 30 min in 100 μl 50 mM NaOH and 
vortexed thoroughly. Heating step could be repeated once when necessary. Once the 
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samples were well digested, the mixture was neutralized with 10 μl of 1.5 M Tris-HCl (pH 
8.8) and processed with PCR or stored at 4°C. 
PCR: 1-2 μl of DNA was used as template in the PCR reaction containing 200 µM dNTPs 
(25 mM of each dNTP in dNTPs mix stock), 20-50 pmol of each primers to amplify a 
sequence of genomic DNA specific for a given allele, 1x PCR buffer (500mM KCl, 15mM 
MgCl2, 100mM Tris·HCl, pH 8.8, 0.8% Nonidet, NEB) and 0.3-0.5 μl of Taq polymerase 
(NEB). The PCR was carried out in a total volume of 50 μl. Agarose gel electrophoresis was 
used to separate PCR products.  
 
8.2.2. Cell culture 
8.2.2.1. Propagation and freezing of mammalian cell lines 
Cells were grown at 37°C in a humidified incubator supplied with 5% CO2 on non-
coated polystyrene culture dishes (Falcon). Confluent 100 mm dishes were washed once 
with warm PBS, and incubated with 2 ml Trypsin/EDTA (Invitrogen) for ~2 min to detach 
cells from the dish. Growth medium containing FBS was added to stop trypsin enzymatic 
activity. Cells were usually seeded in a 1:10 ratio for experiments in the following day. 
Confluency has no observable effect on Phoenix A cell or astrocytoma growth. The cells 
thus could be seeded at very low confluency for long-term culture. 
Phoenix A and astrocytoma cells were frozen in 46.25 % growth medium, 46.25 % 
FBS, and 7.5 % DMSO.  Cells from a 100 mm confluent plate were aliquot into 3 cryotubes 
(2 ml) which were quickly transferred into an isopropanol container and stored at -80°C. 
Once the cells were frozen they were removed from the isopropanol container and stored at 
-80°C or transferred to liquid nitrogen tank for long-term storage. To recover frozen cells, 
cells were thawed slowly on ice, resuspended in growth medium, pelleted to remove DMSO 
and seeded. 
 
8.2.2.2. Transfection of cell lines using Lipofectamine 
One day before transfection, 3.5x10
6 
cells were plated onto polystyrene culture dish 
(Falcon) with normal growth medium. On the day of transfection, cells (~70-80% confluence) 
were washed once with PBS and medium was changed to growth medium without 
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antibiotics (exposure to antibiotics during transfection will cause cell death). 24 µg of 
plasmid DNA was mixed with 1 ml of basal medium without serum (D-MEM). In a separate 
tube 30 µl of lipofectamine was gently mixed with 1 ml of the basal medium. After 5 min 
incubation at RT, DNA and lipofectamine diluents were mixed and gently and incubated at 
RT for 20 min. The mixture was then added to the cells drop-wise and mixed gently by 
rocking the plate back and forth. Cells were incubated at 37°C in 5% CO2 and transfection 
efficiency could be assessed after 16 h. 
 
8.2.2.3. Primary endothelial cell isolation and culture condition 
The generation of conditional knockout mice ephrinB2
lox/lox
 has been described 
(Grunwald et al., 2004). P1-10 mice were sacrificed. Lungs and brains were removed into 
dissection buffer and minced into small pieces. The tissues were then treated with 
collagenase type II (260 units/ml for lung tissues and 130 units/ml for brain tissues) at 37°C 
in a humidified incubator supplied with 5% CO2 for 30 min with occasional shaking. 0.5 ml of 
collagenase is required per tissue from one mouse. The digested tissues were passed 
through 40 µm disposable cell strainer to remove tissue debris and cell clumps that were not 
well-digested and centrifuged at 1,100 rpm for 5 min at 4°C. Lung tissue pellets were 
collected and resuspended in the dissection buffer. Brain tissue pellets were mixed with 25% 
BSA in PBS and centrifuge at 2,600 rpm for 20 min at 4°C to remove myelin before 
resuspension with dissection buffer. To wash out remaining collagenase and BSA tissue 
suspensions were centrifuged at 1,100 rpm for 5 min at 4°C, pellets were collected and 
resuspended in fresh dissection buffer. After 2 washes, tissue pellets were resuspended in 2 
ml dissection buffer and incubated with anti rat IgG coated magnetic beads (Invitrogen,  
8x10
7 
beads per 1 brain or lung) o/n pre-coupled with rat anti-mouse PECAM-1 (MEC13.3 
BD Pharmingen, 7 µg per one brain or lung) at 4°C for 1 h with gentle rotation. The beads 
were washed 5 times by placing the tube to a magnet (Dynal Biotech), aspirating the 
supernatant, and refilling with dissection buffer.  The washed beads were resuspended in 
endothelial cell growth medium and plated onto 1% gelatin-coated plate. The magnetic 
beads were detached from the cells by trypsinization in the first passage. 
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Mouse lung endothelial cells has higher growth rate as compare to brain endothelial 
cells. The lung cells could be passage for 14-16 times without any obvious change in their 
angiogenic activities whereas the brain cells have reduced proliferation rate after ~10 
passages. Confluency of the culture plays an important role in survival, proliferation, and 
angiogenic activities of the primary endothelial cells. The confluent cultures, which grow in 
monolayer and display cobble stone-like morphology, should be propagated at 1:4 or not 
less than 1:6 ratio. Very sparse cultures result in cell death. Cells should be propagated a 
day before angiogenesis assays to a sub-confluent culture (1.8x10
5
 cells in 60 mm plate, 
~60% confluency). 
 
8.2.2.4 Generation of ephrinB2 knock out endothelial cells 
Endothelial cells isolated from ephrinB2
lox/lox
 mice were infected with adenovirus 
encoding Cre recombinase (Vector Biolabs) at Moi 200 (200 phage forming units/ cell). After 
o/n incubation, medium containing virus was changed to fresh growing medium. The virally 
infected cells were cultured for 1 week before use. 
 
8.2.2.5 Endothelial cell transfection and stimulation 
The ephrinB2 expression constructs were introduced into primary mouse endothelial 
cells by electroporation using basic endothelial nucleofector kit (Amaxa) according to 
manufacturer’s recommended protocol. 2x105 cells were seeded onto 60 mm culture dish 3 
days before transfection. On the day of transfection cells at ~70-80% confluency were 
trypsinized and cell suspension was centrifuged at 1000 rpm for 5 min. Supernatant was 
removed and 500 µl of fresh growth medium was added to resuspend cell pellet. The cells 
were counted to determine cell density and 4-5x10
5
 cells were aliquot into new tube. After 
centrifugation and discarding supernatant, 100 µl of basic nucleofactor solution (without 
supplement provided in the kit) was added to resuspend cell pellet and 1-3 µg of plasmid 
DNA (in less than 5 µl) was added to the suspension. The suspension was transferred into a 
cuvette provided in the kit without making bubbles. The cuvette was placed into the holder in 
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the nucleofactor machine. Cells were electroporated with program T-23. Immediately after 
electroporation finished 500 µl of warm growth medium was added to the cuvette and cells 
suspension was transferred into a gelatin-coated 60 mm culture dish filled with 3.5 ml of 
growth medium. Plastic pipette provided in the kit is recommended for the transferring the 
cells from the cuvette after electroporation to prevent cell damage. The whole process after 
the nucleofactor solution was added should not take longer than 20 min as this reduce cell 
viability. Transfection efficiency could be assessed after 16 h. 
Recombinant mouse EphB4-Fc and ephrinB2-Fc chimeras (R&D) were clustered by 
incubation with the antibody against human Fc (Jackson ImmunoResearch) at a 15:1 w/v 
concentration ratio for 1 h at RT. The pre-clustered recombinant proteins at a final 
concentration of 4 µg/ml in serum-reduced medium were used for stimulation of the primary 
endothelial cells. 
 
8.2.2.6. Primary astrocyte dissection 
Brains were removed from new born mice (P2-5) and transferred into a 60 mm 
culture dish filled with ice cold dissection buffer. Meninges was totally removed from the 
brain and cerebral hemispheres were transferred into a 15 ml plastic tube filled with cold 
dissection buffer. Subsequently dissection buffer was removed and 2 ml of 1X trypsin-EDTA 
(2.5 g/L of Trypsin, 0.38 g/L EDTA•4Na in HBSS without CaCl2, MgCl2, Invitrogen) was 
incubated with the brain for 25 min at 37°C in a humidified incubator supplied with 5% CO2. 
Trypsin enzymatic activity was inhibited by addition of 5 ml of growth medium and brain 
tissues were triturated with fire-polished Pasteur pipette until a homogeneous tissue 
suspension was observed. The suspension was centrifuged for 5 min at 80g and 
supernanant was discarded. Cells were resuspended in 10 ml of growth medium and plated 
in 75 cm
2
 polystyrene culture flask (Nunc) (1 brain/1 flask). Medium was changed after 2-3 
days. 
To remove oligodendrocytes which could grow on top of astrocyte monolayer, 
primary cells cultured for 1 week after isolation were washed with PBS and fresh growth 
                                                                     8. Materials and methods 
 
134 
 
medium was added. To prevent contamination culture flask cap was wrapped with parafilm 
and the flask was put in a latex glove and sealed tightly before the flask was shaked at 250 
rpm, at 37°C in a bacteria incubator. Cells were washed with PBS and medium with 
detached cells was changed twice every 24 h. Purity of the astrocyte culture was assessed 
by staining with anti-GFAP antibody. 
 
8.2.2.7 Generation of murine astrocytomas  
Immortalization 
pOT vector harboring SV40 Large-T antigen (gift from T. Acker) was linearized at 
SalI restriction site for stable transfection. As pOT vector has no mammalian selectable 
marker, eYFP-N1 (Clontech) harboring neoR was to co-transfected with pOT. eYFP-N1 was 
linealized by DraIII digestion. Both linealized vectors were purified by PCR purification 
column and dissolved in small volumes of elution buffer. On the day of transfection primary 
astrocytes (from 70-80% confluent plate) were harvested and 1-2x10
6
 cells were suspended 
in 100 µl basic endothelial cell nucleofactor solution. 5 µg of pOT and 1.5 µg of eYFP-N1 
(>3:1 ratio) in less than 5 µl in total were added to the cell suspension. Astrocytes were 
electroporated with Amaxa nucleofactor machine with program T-20. 48-64 h 
posttransfection, stably transfected cells were selected in astrocyte growth medium 
containing 300µg/ml geneticin (Gibco) for 3 weeks. Resistant colonies were pooled and 
proceed with H-Ras viral infection. 
H-RasV12 virus production 
pBABE-Hygro retroviral vector (Addgene) harboring H-RasV12 was introduced into 
Phoenix A cells by lipofectamin transfection as described. Medium was changed at 24 h 
after transfection (8 ml/100 mm diameter plate). Transfected cells were cultured for another 
24 h and 48 h when supernatant containing virus particles was collected and filtered through 
a 0.45 µm filter to remove detached cells. Supernatant was aliquoted in 2-4 ml volumes and 
kept at -80°C. Note: Medium used throughout the process contained no antibiotic. 
                                                                     8. Materials and methods 
 
135 
 
Viral infection 
Immortalized astrocytes were passaged a day before infection at 3x10
5
 cells in a 100 
mm culture dish. On the day of infection (cells should reach 40-50% confluency) cell were 
washed once with PBS and 4 ml of virus supernatant mixed with 4 µg/ml polybrene (Sigma) 
and 4 ml of growth medium was added to the cells. 48 h postinfection, 2 µg/ml puromycin 
(Sigma-Aldrich) was added to growth medium to select for stably transfected cells. Colonies 
grew after 3 weeks of selection were pooled and expression of SV-40 Large T antigen and 
H-RasV12 proteins was confirmed by immunoblot analysis. 
 
8.2.3. Angiogenesis assay with primary endothelial cells 
8.2.3.1. Tube formation assay 
Matrigel, a solubilized basement membrane matrix extracted from Engel-Holm-
Swarm (EHS) mouse sarcomas (BD Biosciences) has been used in the endothelial cell 
capillary-like structure formation. In fact, it has been shown that some other cell types such 
as fibroblasts were able to from a similar network structure when seeded onto the matrigel.  
Matrigel is mainly consisted of laminin with some other membrane matrix protein including 
collagen IV and heparin sulfate proteoglycans. It also contains fibroblast growth factor 
(bFGF), TGF-β and other growth factors naturally produced by EHS tumors. As matrigel was 
extracted from sarcomas, different production batches could be varied in the compositions. 
Matrigel is in liquid form when temperature is lower than 4°C and polymerized at RT. For the 
formation assay in a 48-well manner, 150 µl of ice-cold matrigel was added to layer each 
well of a plate pre-cooled on ice. The gel was left to polymerize at RT for 5 min. Endothelial 
cells from sub-confluent culture were detached from plate with accutase (PAA), 
resuspended in starving medium containing 1% fetal bovine serum, and plated onto the 
matrigel-layered well. 1.5x10
4
 cells were required for each well. The plate was incubated at 
37°C in a humidified incubator supplied with 5% CO2 for 6-8 hours. 
Quantitative measurement of the tubular network based on the percentage of area 
covered with capillary structures was done by using ImageJ (NIH). EphrinB2KO cells were 
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still able to form tubular structures although these tubes showed a 2.4 fold increase in tube 
disruption. However ephrinB2KO tubes were suitable for re-introduction of wild type and 
signaling mutants to study the repulsive activity conferred by ephrinB2 signaling. For the 
quantification of percentage of non-integrated cells, all YFP-expressing cells were identified 
at the beginning of each movie and their movements were followed until the tubular network 
was formed at end of the movie. Cells that died or exit from the frame were excluded from 
the quantification. The percentage of cells that were not integrated into the tubular structures 
compared to the total number of green cells, remained in the frame at the end of the movie 
was calculated. 
 
8.2.2.2. Time lapse imaging 
Live-cell imaging of primary endothelial cells seeded on matrigel was performed 
using a Zeiss Axiovert 200M microscope equipped with a temperature controlled CO2-
incubation chamber. Temperature was set to 37°C and CO2 level to 5%. The chamber was 
humidified by passing CO2 gas though a water container and sponge soaked in sterile 
water. Images were acquired using a 20x objective with a CoolSNAP-fx camera at a rate of 
one frame per 40 seconds or one minute. Images were processed using MetaMorph 
software (Molecular Devices). 
 
8.2.4. Immunocytochemistry 
8.2.4.1. Antibody Feeding Assay 
Sub-confluent culture of primary mouse endothelial cells was split a day before the 
assay. 40,000 cells were seeded onto 1% gelatin-coated 13 mm glass cover slip in each 
well of a 24-well culture plated. Cells were blocked at 37°C for 10 min in blocking solution 
consisted of DMEM, 2% (w/v) bovine serum albumin and 4% (v/v) goat serum (Jackson 
ImmunoResearch). Anti-Flk1 primary antibody (R&D, 1:40) in the blocking solution was 
incubated with cells at 37°C for 20 min. After 2 washes with warm D-PBS + Ca
2+
/Mg
2+
 cells 
were stimulated with recombinant human VEGF165, pre-clustered EphB4-Fc or human Fc in 
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endothelial growth medium at 37°C for 30 min, and fixed with 4% PFA in PBS at 4°C for 30 
min. After incubation with 50 mM NH4Cl for 10 min at RT, cover slips were washed once 
with PBS and transferred onto a dark humidified tray. Surface receptors were detected by 
incubation with Cy2- conjugated secondary antibodies (Jackson ImmunoResearch, 1:200) in 
blocking solution (PBS containing 2% (w/v) bovine serum albumin and 4% (v/v) donkey 
serum) without permeabilization for 2 h at room temperature. After 3 washes with PBS, cells 
were permeabilized for 30 min with ice cold blocking solution containing 0.25% (v/v) Triton 
X-100 and Cy3-conjugated secondary antibody (Jackson ImmunoResearch, 1:200) was 
incubated with the cells for 1 h at room temperature to visualize internalized receptors. 
A digital camera (SpotRT; Diagnostic Instruments) attached to an epifluorescence 
microscope (Zeiss) equipped with a 63x objective (Plan-Apochromat; Zeiss) was used for 
imaging. Quantitative measurements based on fluorescent intensities were performed using 
MetaMorph software (Molecular Devices). Percentages of internalized receptors (red 
fluorescent) as compared to total amount of receptors (green fluorescent + red fluorescent) 
were calculated from at least 10 endothelial cells from each group, 4 independent 
experiments were performed. Depending on the equality of variances between the tested 
populations examined by F-test, type-one or type-two Student’s t tests were used to assess 
statistical significance of their differences. n=number of experiments. 
 
8.2.4.2. Staining of surface ephrinB2 with recombinant protein EphB4-Fc 
Sub-confluent culture of endothelial cells was seeded on gelatin-coated cover slip in 
24-well plate and Recombinant EphB4-Fc was pre-clustered as described. A final 
concentration of 4 µg/ml of clustered EphB4-Fc in a starving medium containing 2% FBS 
without growth supplement was used to stimulate endothelial cells at 37°C for 15 min. 200 µl 
of medium is required for each well. After stimulation, endothelial cells were fixed in 4% PFA 
in PBS at 4°C for 30 min. Following washing of PFA with PBS, cells were incubated with 50 
mM NH4Cl (to reduce auto-fluorescent) for 10 min at room temperature then washed once 
with PBS. Cover slips were transferred to a dark humidified tray. 100 µl of blocking solution 
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(PBS containing 2% (w/v) bovine serum albumin and 4% (v/v) donkey serum) was gently 
overlaid each cover slip and incubated for 1 h at RT. 0.25% Triton X-100 was added to the 
blocking solution when permeabilization is required. Next, blocking solution was removed 
and fluorochrome-conjugated antibody raised against human Fc (Jackson Immunoresearch) 
in blocking solution at 1:200 volume ratio was incubated with cells for 1 h at RT. Cells were 
washed for 3 times with PBS and cover slips were mounted with vectashield mounting 
medium containing DAPI. Slides was kept in the dark o/n, sealed with nail polish and kept at 
4°C. Note that pipeting during solution changing and washing steps should be done gently 
but quick enough not to let the cover slip dried as buffer precipitates causes background.  
 
8.2.5. Biochemistry 
 
9.2.5.1. Tissue lysis and protein immunoprecipitation  
 
Lysis: Neonatal mouse brains were lysed with 3X volume to weight of cold NP-40 lysis 
buffer in a glass Teflon dounce homogenizer.  Tissue lysate was transferred into 2 ml 
eppendorf tubes and further lysed at 4°C on a rotating wheel for 30 min. Insoluble material 
was removed by centrifugation for 15 min at 13000 rpm at 4°C. Supernatants were collected 
and protein concentrations were measured using the DC Protein Assay (BioRad). 
Supernatants were used immediately or frozen in liquid nitrogen and stored at -80°C. 
Immunoprecipitation: To lower the amount of non-specific proteins 1-2 mg of tissue protein 
samples each was incubated with 45 µl protein G-Sepharose beads (for mouse monoclonal 
or goat polyclonal antibodies, Amersham) or protein A-Sepharose beads (for rabbit 
polyclonal antibodies, Amersham), which were pre-cleaned from methanol by washing with 
PBS, on a rotating wheel for 30 min at 4°C. Beads were removed by centrifugation at 4,000 
rpm for 5 min and supernatant was incubated with 45 µl methanol-free beads pre-bound 
with 4 µg anti-flk1 antibody (R&D systems) for 2 h at 4°C. The supernatants were then 
discarded and the beads were washed three times with lysis buffer to remove uncoupled 
proteins. 12 μl of 6x SDS sample buffer was added to the beads and the samples denatured 
by boiling at 95°C for 3 min before loading on a polyacrylamide gel. 
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8.2.5.2. Immunoblotting 
Protein samples were separated in 7.5% SDS-PAGE and transferred to 0.45 μm 
nitrocellulose membranes (Schleicher & Schuell) by semi-dry blotting (1 mA per cm
2
 of 
membrane for 45-120 min according to protein sizes). Membrane was incubated with 
blocking solution (5% BSA or 5% non-fat milk in PBST) for 1 h and primary antibody diluted 
in PBST was incubated with the membrane for 1 h at RT (or diluted in blocking solution and 
incubated o/n at 4°C) with continuous rocking. After 3 washings for 5 min with PBST 
secondary antibody diluted in PBST was applied to the membrane and incubated for 1 h at 
RT. Subsequently, antibody solution was removed and the membrane was washed for 3 
times with PBST. Finally, the membrane was incubated with 1 ml of ECL solution 
(Amersham) and exposed to X-ray films (Kodak, Biomax) to visualize signals. If subsequent 
detection of another protein was necessary the membrane was incubated with stripping 
buffer (PBS containing 2% SDS and 0.02% β-mercaptoethanol) for 30 min at 65°C and re-
blotted as described above. 
 
8.2.6. Analysis of postnatal retinal angiogenesis 
8.2.6.1. Retina dissection 
Neonatal mice from P1 to P7 were sacrificed. Eyes were removed and fixed with 4% 
PFA at 4°C o/n. Eyes were washed with PBS and put in a culture dish filled with PBS. Under 
a stereo microscope equipped with internal light source, eye was hold with a blunt forceps at 
tissue surrounding the eye ball and a small cut was made above the eye lens. Len and iris 
were extracted with fine forceps.  Retina was subsequently extracted from the eye cup by 
inserting blunt end forceps between retina and eyecup and then shearing eye cup and 
forceps in opposite directions. Vitreous body and hyaloids vessels were totally removed from 
retina with sharp end forceps without touching the retina tissue. Retinas were processed for 
vessel staining or passed through a series of continuous increased concentrations of 
methanol diluted in PBS (25%, 50%, 75%, and 100%) for dehydration and stored at -20°C in 
100% methanol.  
                                                                     8. Materials and methods 
 
140 
 
8.2.6.3. Retina vessel staining  
Visualization of retinal vessels was done as described (Gerhardt et al., 2003) with 
minor modifications. Briefly, retinas dissected from neonatal mice were permeabilized and 
stained with 40 µg/ml
 
FITC conjugated lectin from Bandeiraea simplicifolia (Isolectin B4, 
Sigma-Aldrich) at 4°C overnight. After 5 washes with PBS, retinas were post-fixed in 4% 
paraformaldehyde (PFA) and flat mounted with Vectashield mounting medium containing 
DAPI (Vector Laboratories). 
 
8.2.6.3. Retina whole mount LacZ staining 
Retinas were dissected from eye cups and fixed in freshly made glutathione fixative 
for 1h at RT, washed 3 times 10 min each in wash buffer and incubated in X-Gal staining 
solution (X-Gal 1 mg/ml as a final concentration) at 37 °C in the dark for 1-2 h. Retinas were 
washed 3 times for 10 min in wash buffer and postfixed in 4% PFA at RT for 30 m. After 
washing once with PBS retinas were flat-mounted with Vectashield mounting medium. 
 
8.2.6.4. Retina endothelial cell proliferation assay 
P7 pups were injected with BrdU (100 µg/ g body weight) intraperitoneally 2 h prior 
to eye dissection. Following an o/n 4% PFA fixation retinas were stained with isolectinB4 as 
described. Subsequently, retinas were post fixed for 1 h at RT with 4% PFA, washed 3 times 
with PBS and incubated with PBS containing 6 M HCl and 0.1% Triton X-100 for 1 h at RT. 
After 5 washes in PBS with 0.1 % Triton X-100, retinas were incubated o/n sequentially with 
BrdU antibody (AbD Serotec, 1:100) and Alexa Fluor-coupled secondary antibody. Retinas 
were washed 3 times for 1 h and flat-mounted on glass slices with Vectashield mounting 
medium.  
 
 
8.2.6.5 Quantification of retinal angiogenesis 
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Quantification of retinal angiogenesis in CD1 mice was done in P7 retinas. Number 
of branch points and filopodia bursts in randomly defined fields in arterial zones were 
counted manually. The values were normalized with field sizes. Filopodia per tip cell were 
counted from at least 30 tip cells (inside the vascular beds) in each mouse. Filopodia 
extension at the sprouting fronts was quantified based on number of filopodia per 100 µm of 
vessel length (measured from lines drew along the border of vascular fronts). Vascular 
density measurement was done by calculation of areas covered with vessel in at least five 
arterial zones in each retina using ImageJ. For the P2 C57/Bl6 mouse retinas, the radial 
length of the vascular network was measured from the average length of at least 3 lines 
drawn from the center of the retina in the optic disc to the edge of the network. Vascular 
density was measured from the vascular areas in 300x300 µm fields next to the optic discs. 
Endothelial cell proliferation was assessed based on number of BrdU positive cells per 
vascular area. 6-8 retinas from each genotype were used for all quantifications. Filopodia 
protrusions at the vascular front were analyzed from 20 microscopic fields picked from 10-12 
retinas per group for ephrinB2
V/V
 and control littermates and quantified using MetaMorph 
software (Molecular Devices). Depending on the equality of variances between the tested 
populations examined by F-test, type-one or type-two Student’s t tests were used to assess 
statistical significance of their differences.  
 
8.2.7 Acute retina explantation 
Eyes were enucleated from new born pups (P4-5) and transferred to FBS free 
DMEM medium. Retinas were dissected from eye cups and vitreous bodies were totally 
removed. Retinas were flat-mounted onto the hydrophilic polytetrafluoroethylene (PTFE) 
membrane of Millicell inserts (Millipore) with photoreceptor layer on top and nerve fiber layer 
attached to the membrane. DMEM with 10% FBS was layered underneath the membrane 
and dropped on retinas to prevent dryness. Retina explants were incubated at 35°C in a 
humidified incubator with 5% CO2 for 2-4 h before stimulation. For stimulation of retina 
endothelial tip cells all factors diluted in DMEM with 3% FBS were layered underneath the 
insert membrane and dropped on the explants. Concentrations of VEGF164 and EphB4Fc 
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or hFc used were 1 µg/ml and 10 µg/ml, respectively. Soluble Flt-1 at a concentration of 1 
µg/ml and 0.32 mM of dynasore were added to the medium when required. Stimulation were 
carried out at 35°C in a humidified incubator with 5% CO2 for 4 h. Explants were fixed with 
4% PFA at 35°C for 4h and proceeded for isolectin staining of vessels as described. 
 
8.2.8 Surface biotinylation assay in cortical slices  
Acute cortical slices (400 µm thick) were prepared from brains of P8-9 mice using 
custom made slicer. Slices were kept in artificial cerebrospinal fluid (ACSF: 124 mM NaCl, 3 
mM KCl, 1.25 mM KH2PO4, 2.5 mM CaCl2, 2 mM MgSO4, 26 mM NaHCO3, 10 mM glucose, 
saturated with 95% O2 and 5% CO2) for 1-2 h at room temperature. To label surface 
proteins slices were incubated on ice with EZlink-NHS-SS-Biotin (Pierce, Rockford, Illinois) 
at a concentration of 0.5 mg/ml ACSF for 1 h. After 2 washes with ACSF, 10 µg/ml EphB4Fc 
or control hFc proteins were applied to the slices. Stimulations were carried out for 1-1.5 h at 
room temperature. Remaining surface biotin was stripped out by incubation with 2.3 g/ml 
reduced L-Glutathione (Sigma) for 30 min on ice. Glutathione was subsequently neutralized 
by incubation with Ethanolamide (0.9 µl/ml ACSF) on ice for 30 min. Slices were washed 
twice with ACSF and cells were lysed with NP-40 lysis buffer (see immunoprecipitation). 
Equal amounts of proteins from each sample were incubated with Neutravidin sepharose 
(Pierce, Rockford, Ilinois) on a rotating wheel overnight at 4°C. Beads were washed for 3 
times with lysis buffer and boiled at 95°C in SDS sample buffer before proceed for western 
blot analysis. 
 
8.2.9. Histology 
8.2.9.1 Cardiac injection of FITC-Dextran 
Mice were anesthetized with an intraperitoneal injection of chloralhydrate (8% 
chloralhydrate, 0.9% NaCl in H2O). 1.5 ml of 50 mg/ml fluorescein isothiocyanate dextran, 
molecular weight 2x10
6
 (Sigma-Aldrich), in PBS were injected intracardially. Brains and eyes 
were dissected and fixed with 4% PFA at 4°C overnight. 60 µm coronal brain sections were 
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obtained with a vibratome and mounted with Vectashield mounting medium containing 
DAPI. Retinas were dissected and flat-mounted as described. Confocal images of brain and 
retina vessels were used to analyze vessel density based on areas of the brain or retina 
tissues covered with vessels by ImageJ. Four mice from each genotype were used for 
quantification. Depending on the equality of variances between the tested populations 
examined by F-test, type-one or type-two Student’s t tests were used to assess statistical 
significance of their differences. 
 
8.2.9.2 Whole mount retina staining  
Retinas dissected from eyes fixed overnight in 4% PFA were blocked in D-PBS 
containing 0.5 % Triton X-100, 2 % (w/v) BSA and 4 % (v/v) donkey or goat serum (depend 
on species of secondary antibody) for 2 h at RT. Subsequently, retinas were incubated with 
primary antibody (and isolectin when vessel staining in required) for 64 h at 4°C with gentle 
rocking. A volume of 0.4 ml in 24-well plate is suitable for 2-4 retinas. Concentration of 
primary antibody and recombinant proteins used: rabbit anti-GFAP (DAKO) 1:70, EphB4-Fc 
(R&D) 1:20, EphrinB2-Fc (R&D) 1:20. Primary antibody adhered non-specifically to the 
retina tissue was washed out with PBS 3 times for 1 h.  Retinas were incubated with 
secondary antibody in blocking buffer o/n at 4°C, washed 5 times for 1 h, and post-fixed for 
30 m with 4 % PFA before flat-mounted with Vectashield mounting medium (Vector 
Laboratories, Burlingames, CA). Note: secondary antibody Cy5-conjugated goat anti hFc 
(Jackson Immunoresearch) was used at a concentration of 1:100. To prevent any 
precipitates from PFA and serum in blocking buffer to adhere to the tissue and cause 
background, PFA and blocking buffer were filtered through 0.45 µm filter before use. 
Fixation time can be crucial to the staining. For some epitopes, eyes could be fixed with 4 % 
PFA on ice for 4-6 h prior to retina dissection and staining. 
 
 
8.2.9.3. Vibratome sections 
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Perfused and postfixed brains were embedded in a gelatine-albumin (gel/alb) 
mixture (0.5g gelatine in 100ml PBS, then dissolved 30g egg albumin in this solution). A 
layer of 2ml gel/alb vigorously mixed with 100 µl 25% glutaraldehyde was poured into a 
small plastic mould and left to polymerize for 2-5 min. Brain was placed on top and 3ml 
gel/alb with 150 μl glutaraldehyde was poured into the mould to cover it. The mould was left 
to set for 5minutes at RT and submersed in cold PBS for 1-2 h to ensure complete 
polymerization. The gel/alb block was trimmed and glued to the vibratome platform and 
placed into the vibratome chamber filled with cold PBS. Generally, 40-80 μm coronal 
sections (for immunofluorescense) were cut at low speed and high vibration frequency. 
 
8.2.9.4 Tumor transplantation  
CD1 ephrinB2
∆V/∆V
 and control littermate or C57B/BL6 ephrinB2iEC and control 
littermate (ephrinB2WT/loxPCre
-
 treated with Tamoxifen) mice were anesthetized and 
placed into a stereotactic apparatus (Kopf instruments). A burr hole was made 2 mm left of 
the sagittal suture and 0.5 mm anterior to the bregma using a dental drill 0.7 mm in 
diameter. For transplantation 5x10
4
 CD1 astrocytoma cells (see above) or C57B/BL6-Gl261 
astrocytoma cells were resuspended in cold, CO2-independent medium and slowly injected 
at a depth of 3.5 mm from the dura using a 2.5 µl Hamilton microsyringe with an unbeveled 
33G needle. Mice were maintained until the development of neurological symptoms. Two 
separate transplantation experiments were performed with independently generated 
astrocytoma lines in a total of 18 animals (11 controls and 7 ephrinB2∆V). Tumor bearing 
mice were injected with 100 µg biotinylated tomato lectin (Vector Laboratories, Burlingame, 
CA, USA) retrobulbarly, 5 minutes prior to cardiac perfusion with 4% PFA in PBS. Tumor 
volume was determined by tracing the tumor area using the semi-automated stereological 
system Stereo Investigator 4.34 (MicroBrightField Inc., Williston, VT, USA) and a Zeiss 
Axiophot microscope (Carl Zeiss, Jena, Germany), equipped with a Hitachi HV-C20A 
(Hitachi) camera. Series of every twelfth section (480 µm interval) throughout the brain were 
analyzed. For subcutaneous tumor injections CD1 ephrinB2ΔV and control littermate were 
anesthetized, shaved and 2x10
6
 CD1 astrocytoma cells resuspended in PBS/Matrigel were 
injected in a total volume of 200µl into either flank of the mice. Tumor bearing animals were 
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maintained for 21 days until tumors exceeded a volume of 800 mm
3
. Tumors were frozen in 
TissueTek for further histological analysis. Statistical comparisons of the measurements 
were made using type-one or type-two Student`s t-test depending on the equality of their 
variances examined by F-test. 
 
8.2.9.5. Antibody staining of brain tumor sections 
 Tumor samples were frozen and cut into 40 µm (intracranial tumor) or 8 µm 
(subcutaneous tumor) thick sections. For hematoxylin-eosin (HE) staining, they were first 
stained with Mayer´s hematoxylin (10 min) and then counterstained with alcoholic eosin for 2 
minutes. For immunohistochemical studies, free-floating (intracranial tumor) or mounted 
(subcutaneous tumor) sections were washed in PBS. Endogenous peroxidase was 
neutralized with 0.6 % H2O2 in PBS for 30 min. After washing again in PBS, sections were 
mounted on microscope slides and dried for 3 h at room temperature (intracranial tumor). 
Antigen retrieval was performed for 10 minutes in Tris-EDTA (TE) buffer, pH 8.0, in a 
steamer. Sections were blocked with 20 % normal goat serum (NGS)/0.01 % Triton in PBS 
for 1 h. For CD34 staining sections were blocked with 5% bovine serum albumin 
(BSA)/0.01% Triton for 1 h. Subsequently a second blocking step was performed using 20% 
NGS/0.01% Triton in PBS for 1.5 h. The sections were then treated overnight at 4 °C with 
CD34 primary antibody (1:100, clone MEC14.7, Abcam) in 10% NGS/0.01% Triton in PBS. 
After washing in PBS, sections were incubated with secondary antibody peroxidase-
conjugated goat anti rat IgG, diluted 1:100 in 10% NGS/0.01% Triton in PBS for 1 h. After a 
PBS wash, visualization was performed using the CSA II, Biotin-Free Catalyzed 
Amplification System (Dako, Glostrup, Denmark) according to the manufacturer’s 
instructions. After washing in PBS, sections were counterstained in hematoxylin for 8 min 
and mounted in Aquatex (Merck, Darmstadt, Germany). Vessel density was quantified by 
measuring blood vessels area stained with CD34 in 10 randomly chosen optical fields per 
tumor. Depending on the equality of variances between the tested populations examined by 
F-test, type-one or type-two Student’s t tests were used to assess statistical significance of 
their differences. 
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